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Stress is known to affect energy metabolism in humans and animals. This thesis 
aimed to investigate the effects of chronic social stress (CSS) on energy expenditure 
(EE), respiratory exchange ratio (RER), neuroendocrine regulators of feeding and the 
serotonergic system.  
Adult male C57BL/6 mice were exposed to 15 days of social stress or control 
handling. In an iterative series of experiments, food intake (FI) and body weight (BW) 
were measured daily, indirect calorimetry was evaluated before and after the CSS 
period, and glucose homeostasis was evaluated using a glucose tolerance test. At 
termination, plasma and adipose tissues were collected for determination of ghrelin, 
leptin and insulin concentrations, as well as gene expression of leptin and leptin 
receptor. In discrete brain areas, ghrelin receptor (Ghs-r1a) immunopositive cell count, 
gene expression of ghrelin and leptin receptors, as well as serotonin 5-HT1A, 5-HT2A 
and 5-HT2C receptor binding (by means of autoradiography) and gene expression, 
were analysed.  
The present results are consistent with CSS leading to a reduced conversion of 
FI into an increased BW, as demonstrated by an increased FI with an absence of BW 
effect or by unaffected FI with an attenuated BW increase. Increased RER was 
observed in CSS mice, indicating a greater carbohydrate utilisation as fuel source. This 
study also identified markers of increased hunger signalling i.e. increased plasma 
ghrelin and ventromedial hypothalamic Ghs-r1a mRNA expression, and decreased 
satiety signalling i.e. decreased plasma leptin and WAT Lep mRNA expression. The 





suggested by decreased insulin levels. CSS affected the serotonergic system through 
modifications of the binding activity and gene expression of serotonin receptors, and 
by modification of serotonin transporter gene expression.  
In conclusion, the present thesis demonstrated that CSS in mice leads to both 
central and peripheral changes consistent with increased energetic requirements, 
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1.1. Energy metabolism 
 
Energy metabolism, as the set of biochemical reactions performed within a 
living organism (Kornberg, 2017), comprises the synthesis (i.e. anabolism) and 
breakdown (i.e. catabolism) of bioactive substances for energy production  (Lazar and 
Birnbaum, 2012). Regulation of energy metabolism involves many factors, in 
particular: genetic, through expression of genes implicated in the regulation of food 
intake (Herrera and Lindgren, 2010) and energy expenditure (EE) (Almind and Kahn, 
2004; Alonso et al., 2015), and environmental, such as diet, lifestyle (e.g. physical 
activity) and stress (Qi and Cho, 2008; Yamaoka and Tango, 2012; Bassi et al., 2014). 
This combination of genes and environment determines an individual’s susceptibility 
to obesity (Romieu et al., 2017) and other metabolism-related disorders (Heindel et 
al., 2017). 
Control of nutrient consumption and utilisation, as well as regulation of EE, 
have long been contemplated for development of interventions that better target 
diseases associated with obesity (Galgani and Ravussin, 2008; Geisler, 2011; Lam and 
Ravussin, 2016). To treat obesity and related disorders it is necessary to comprehend 
the mechanisms through which the body regulates energy intake versus EE, and how 
these are affected by environmental factors such as chronic stress. 
 
1.1.1. Energy balance – Food intake versus Energy expenditure 
Energy balance is a term used to describe the equilibrium between “energy in”, 
in the form of calories taken, and “energy out”, as EE (Hall et al., 2012). Feeding exerts 




an essential role in the regulation of energy balance. Nonetheless, in order to maintain 
homeostasis, food intake must be balanced out by EE, and vice versa. 
 
1.1.1.1. Energy expenditure 
Energy expenditure can be described as the amount of energy an individual 
uses to maintain body homeostasis. Total energy expenditure (TEE) comprises three 
elements: resting metabolic rate (RMR), the main component of TEE (60-70%) that 
corresponds to the energy required for the performance of vital biological processes 
over 24 hours; thermic effect of food, or the energy required for nutrient utilisation and 
physical activity (Speakman, 2013; Westerterp, 2017). 
Various factors influence EE (Romieu et al., 2017). Fat-free mass, for instance, 
is the best direct predictor of RMR (Cunningham, 1991; Westerterp, 2017). Body size 
can also exert an effect on RMR, however, indirectly: the larger the body size, the 
greater the amount of fat-free mass, consequently the greater the energy requirement. 
In regards to the thermic effect of food, it can take up to 10% of TEE when limited to 
homeostatic needs. However, in the case of overfeeding, there can be an increase not 
only in this element of TEE but also in RMR as a function of fat-free mass, since high-
calorie intake commonly leads to increased body mass (Harris et al., 2006). Physical 
activity, on the contrary, is a far more variable component of TEE. For overweight 
individuals, there is a high energy cost in performing physical activity (Nantel et al., 
2011), and although physical activity is highly recommended for weight loss, its 








1.1.1.2.1. Adaptive thermogenesis 
EE is also subject to brown adipose tissue (BAT) thermogenesis (Morrison et 
al., 2014; Razzoli and Bartolomucci, 2016), activated during periods of chronic cold 
exposure or hyperphagia. This is the case in many species including mice (Virtue and 
Vidal-Puig, 2013) and humans (Ouellet et al., 2012; Saito, 2013). Whereas white 
adipose tissue (WAT) is accountable for energy storage, BAT is associated with EE. 
A transitional form of WAT characterised by the presence of brown adipocytes, named 
beige adipose tissue, has also been observed in rats and mice following cold stress 
(Young et al., 1984; Lonçar et al., 1988). The comparable features of the adipocytes 
in beige and brown adipose tissues were described recently (Ikeda et al., 2018). 
The BAT is a thermogenic tissue that contains small brown adipocyte droplets 
surrounded by mitochondria, which allow for the production of heat. The thermogenic 
process associated with BAT is controlled foremost by the noradrenaline receptors (, 
1, 2) expressed on the membrane of the brown adipocyte (Ueta et al., 2012; Madden 
et al., 2013). Nevertheless, the adrenergic pathway seems not to be the only factor for 
cold-induced BAT browning (Razzoli et al., 2016). There are known effects of 
glucocorticoids (GC) on BAT, of relevance to stress, as addressed below in Section 
1.3 of this chapter. Once activated, adrenergic receptors trigger a cascade of enzymatic 
reactions for triglyceride hydrolysis and fatty acid release, with subsequent activation 
of the mitochondrial transmembrane uncoupling protein 1 (Ucp-1) (Cannon and 
Nedergaard, 2004; Contreras et al., 2016). The Ucp-1 protein is accountable for heat 
production through non-shivering thermogenesis. Whenever this proton carrier is 
activated, through an oxidative process not “coupled” to the synthesis of ATP, 
dissipation of heat is prompted (Figure 1.1). 





Figure 1.1. Effect of cold exposure and food intake on the sympathetic nervous system with 
subsequent activation of -adrenergic receptors on white, beige and brown adipocytes. 
Electron transport chain forms an H+ gradient between the mitochondrial intermembrane space 
and matrix, which can be used for the synthesis of ATP by ATP synthase or heat production 
by uncoupling proteins. Figure adapted from Saito et al. (2013), Diabetes and Metabolism 
Journal, p23, and Collins and Surwit (2001), The Endocrine Society, p310. 
 
In mice, BAT is located subcutaneously, mainly in the dorsal back of the 
interscapular (iBAT) and subscapular (subscapular BAT) regions. Supraclavicular 
BAT (sBAT) was also recently characterised (Mo et al., 2017). In humans, BAT is 
reported to be primarily in the supraclavicular regions (Sacks and Symonds, 2013). 
Although human BAT is found prominently in newborns to control body temperature, 
studies using fluorodeoxyglucose (FDG)-positron emission tomography (PET) 
demonstrated the presence of metabolically active BAT in adult humans (Nedergaard 
et al., 2007). Despite localisation differences, sBAT and iBAT mitochondria from 
humans and mice, respectively, have comparable Ucp-1 function (Porter et al., 2016), 
validating the use of animal models in translational studies. 
 




1.1.2. Neurocircuits of homeostatic feeding 
The regulation of energy balance involves a complex interaction of peripheral 
organs and the central nervous system (CNS), the latter being responsible for detecting 
satiety and adiposity signals and responding according to the homeostatic body needs 
(Woods and Seeley, 2000; Chambers et al., 2013). Within CNS, the brain receives 
short-term satiety signals from peripheral organs via afferent fibres of the vagus nerve 
(Browning et al., 2017). Within the brainstem, nucleus tractus solitarius (NTS) neurons 
receive inputs from the gastrointestinal (GI) tract (e.g. volume of ingested food) and 
project to the paraventricular nucleus of the hypothalamus (PVN) (Katsurada et al., 
2014) for the regulation of food intake. Ghrelin, for instance, stimulates appetite by 
inhibition of vagal afferent activity (Date et al., 2002). It also regulates feeding by 
acting directly on hypothalamic nuclei, more specifically the arcuate nucleus of the 
hypothalamus (ARC) (Riediger et al., 2003). Other gut peptide hormones such as 
glucagon-like peptide 1 (GLP-1), peptide YY (PYY) and cholecystokinin (CCK) are 
involved in the perception of satiety and meal termination (Little et al., 2005; Karra et 
al., 2009; Shah and Vella, 2014).  
The brain also perceives variations in energy stores in the body. In a process 
referred to as ‘adiposity negative feedback’, long-term adiposity signals from 
hormones such as leptin and insulin, levels of which in the circulation are proportional 
to body fat stores, act directly at the ARC of the hypothalamus to reduce body fat and 
food intake (Cowley et al., 2001; Loh et al., 2017). The ARC of the hypothalamus acts 
therefore as an integrative centre of satiety and adiposity signals in order to determine 
food intake (Figure 1.2); its proximity to the third ventricle and median eminence 
means it is highly sensitive to circulating peripheral inputs (Rodríguez et al., 2010). 





Figure 1.2. Schematic representation of the hypothalamic nuclei and main inputs from 
circulating peripheral peptides and reward-related brain regions. Abbreviations: ARC, arcuate 
nucleus of the hypothalamus; VMN, ventromedial hypothalamic nucleus; DMH, dorsomedial 
hypothalamic nucleus; LH, lateral hypothalamus; PVN, paraventricular nucleus; VTA, ventral 
tegmental area; DRN; dorsal raphe nucleus; NTS, nucleus tractus solitaries; CART, cocaine- 
and amphetamine-regulated transcript; CRF, corticotropin-releasing factor; GLP-1, glucagon-
like peptide 1; MCH, melanin-concentrating hormone; OXT, oxytocin; AVP, vasopressin; 
TRH, thyrotropin-releasing hormone; NA, noradrenaline; A, adrenaline; PrRP, prolactin-
releasing peptide; PYY, peptide YY residues; OXM, oxyntomodulin; CCK, cholecystokinin. 
MC3R and MC4R, melanocortin receptors; NPY1R and NPY5R, NPY receptors; LEPRb, 
long isoform of the leptin receptor; INSR, insulin receptor; GHS-R, ghrelin receptor; GLP-
1R, GLP-1 receptor; 3V, third ventricle. Figure reprinted from Yeo and Heisler (2012), Nature 
Neuroscience, p1346, ©2012 Nature America, Inc. 
 




1.1.2.1. Hypothalamic control of energy balance 
1.1.2.1.1. Melanocortin system 
The neurocircuitry regulating homeostatic feeding has two key neuronal 
subpopulations which are part of the melanocortin system, located in the ARC of the 
hypothalamus: neuropeptide Y (NPY) / agouti-related protein (AgRP) and pro-
opiomelanocortin (POMC) / cocaine and amphetamine-regulated transcript (CART) 
(Figure 1.3). Activation of ARC NPY/AgRP neurons is known to increase motivation 
for feeding and enhance body weight gain (Krashes et al., 2011), whereas ARC 
POMC/CART neurons are known to inhibit food intake, by releasing -melanocyte 
stimulating hormone (-MSH) and activating neuronal melanocortin receptors 
(Cowley et al., 2001). While AgRP acts as an antagonist of melanocortin receptor type 
3 (MC3R) and type 4 (MC4R) (Ollmann et al., 1997), NPY acts indirectly on 
melanocortin receptors, inhibiting POMC/CART neurons via NPY receptors 





















Figure 1.3. Hypothalamic melanocortin neuronal subpopulations. Abbreviations: PVN, 
paraventricular nucleus, GABA, gaba-aminobutyric acid; MSH, melanocortin stimulating 
hormone; MC4R, melanocortin receptor type 4; NPY, neuropeptide Y; AgRP, agouti-related 
protein; POMC, pro-opiomelanocortin; GHS-R, growth hormone secretagogue receptor. 
Figure reprinted from Nasrallah and Horvath (2014), Nature Reviews Endocrinology, p3, 
©2014 Macmillan Publishers Ltd. 
 
In addition to the NPY peptide, the gut hormone PYY also binds to NPY 
receptors located in ARC NPY/AgRP neurons, and it is thought to inhibit food intake 
(Batterham et al., 2002). Nonetheless, the mechanism by which PYY regulates food 
intake appears to be independent of the melanocortin system (Halatchev et al., 2004). 
 




1.1.2.1.2. Intrahypothalamic connections 
Much of the research on energy metabolism has focused on ARC. 
Nevertheless, homeostatic feeding and EE are also regulated through the interaction 
of ARC neuronal subpopulations with other hypothalamic nuclei (Waterson and 
Horvath, 2015) (Figure 1.2). For instance, ARC NPY/AgRP and POMC/CART 
neuronal subpopulations were shown to project to PVN, where MC4R is highly 
expressed and modulates feeding behaviour (Skibicka and Grill, 2009). For a full 
review on PVN pathways controlling energy homeostasis, see Hill (2012). 
The connection between ARC and ventromedial hypothalamus (VMH) was 
also shown to be involved in the regulation of energy homeostasis (Sternson et al., 
2005). Activation of VMH MC4R was shown to control energy balance, regulated by 
brain-derived neurotrophic factor (BDNF) (Xu et al., 2003). BDNF is a neurotrophic 
factor abundantly expressed in the brain, which regulates neuronal development and 
exerts neuroprotective effects (e.g. Greenberg et al., 2009). Interestingly, a selective 
BDNF knockdown in the VMH resulted in hyperphagia and obesity in mice (Unger et 
al., 2007). Furthermore, selective knockdown of the thyroid hormone receptor beta 
(TR𝛽) in the VMH stimulated an obese phenotype that was possibly due to a 
downstream modulation of hypothalamic regulators of feeding (Hameed et al., 2017). 
In addition to PVN and VMH, ARC is also known to regulate energy balance 
by connecting to the lateral hypothalamic area (LHA) and dorsomedial hypothalamus 
(DMH). For instance, Betley et al. (2013) observed that optogenetic stimulation of 
AgRP projection from ARC to LHA increased feeding. Moreover, it was shown that 
the anorexigenic hormone leptin regulated ARC NPY and POMC neuronal 
subpopulations that project to LHA (Elias et al., 1999). Further, the ARC cells were 




also shown to modulate DMH and exert an effect on feeding (Bellinger and Bernardis, 
2002). 
 
1.1.2.1.3. Extrahypothalamic connections 
The hypothalamus is also connected with extrahypothalamic nuclei for the 
regulation of food intake and EE. An increase in feeding following optogenetic 
stimulation of GABAergic fibres originating in the LHA and projecting to the ventral 
tegmental area (VTA) was observed (Nieh et al., 2015). Stimulation of inhibitory 
GABAergic neurons projecting to the VTA may drive feeding by modulation of 
dopaminergic VTA neuronal activity and reward-related behaviour. It was also 
observed that activation of MC4R in the NTS, where they are highly expressed (Kishi 
et al., 2003), by ARC POMC descending projections suppressed food intake (Zheng 
et al., 2010). Additionally, PVN neurons were shown to control gastric distension and 
thus feeding behaviour by increasing the response of NTS neurons to vagal signals 
(Rogers and Hermann, 1985). In regard to the regulation of EE, neuronal projections 
from PVN to raphe pallidus (RPa) were shown to suppress BAT thermogenesis 
(Madden and Morrison, 2009), likely through the release of NPY peptides (Chao et 
al., 2011). 
 
1.1.3. Satiety and adiposity signals 
1.1.3.1. Ghrelin 
Encoded by the Ghrl gene and first identified as growth hormone (GH) 
stimulating peptide, ghrelin is a 28 amino acid peptide hormone secreted from the 
stomach into the circulation and that functions to stimulate in meal initiation (for 
review, see Patterson et al., 2011 and Müller et al., 2015). Of note, ghrelin is the only 




identified satiety-signal from the GI tract that increases meal size (Woods, 2003). It is 
found in two forms: acyl ghrelin, which activates cells expressing the growth hormone 
secretagogue receptor (GHS-R), and the non-modified des-n-octanoyl form of ghrelin 
(des-acyl ghrelin), which has no activity at the only known GHS-R. Circulating ghrelin 
consists of more than 90% of des-acyl ghrelin (Patterson et al., 2005), nevertheless, 
acylation of the serine 3 residue, by ghrelin-o-acyltransferase (GOAT), is imperative 
for its hormonal activity (Hosoda et al., 2000; Kojima et al., 2001). 
Peptide hormones cannot generally freely access the brain, nevertheless, 
ghrelin crosses the blood-brain barrier (BBB) via passive diffusion (Schaeffer et al., 
2013). This transport is limited to specific brain regions. Within the brain, Ghrl and 
Ghs-r gene expression were reported predominantly in the pituitary and in 
hypothalamic nuclei (Sun et al., 2004; Kineman et al., 2007). In humans and rodents, 
ghrelin is commonly associated with the hypothalamic regulation of energy 
homeostasis  (Cummings et al., 2001; Nakazato et al., 2001; Klok et al., 2007). In rats, 
the highest levels of GHS-R expression were shown to be in ARC and VMH, with 
increased levels in ARC following fasting (Nogueiras et al., 2004). Following 
intracerebroventricular (i.c.v) administration of ghrelin, c-Fos protein, a marker of 
cellular activity, was found to be increased in NPY/AgRP neurons in rats (Nakazato 
et al., 2001).  
In addition to the hypothalamus, GHS-R is found in other areas of the brain 
including VTA, nucleus accumbens (NAcc), hippocampus (Hipp) and amygdala 
(Amy); GHS-R expressed in the VTA could be of particular importance. VTA is part 
of the mesocorticolimbic dopamine system implicated in the motivational and learning 
aspects of feeding (Abizaid et al., 2006; Perelló and Zigman, 2012). Peripheral 
administration of ghrelin was reported to evoke a preference for energy-dense 




palatable/rewarding foods (Egecioglu et al., 2010). Direct administration of ghrelin 
into VTA enhanced feeding in mice (Abizaid et al., 2006) and rats (Naleid et al., 2005). 
Furthermore, an attenuated feeding response was observed in GHS-R-deficient mice 
(Abizaid et al., 2006).  
Ghrelin has not only been implicated in the regulation of food intake but also 
EE and thermogenesis. Various studies have shown that ghrelin favours adiposity by 
decreasing fat utilisation and promoting increase in carbohydrate (CHO) usage as a 
fuel source (Tschop et al., 2000; Tsubone et al., 2005; Patterson et al., 2013). When 
administrated peripherally in rats, ghrelin reduced BAT temperature thus decreasing 
EE (Yasuda et al., 2003). When administered centrally in mice, ghrelin reduced BAT 




Encoded by the Ob gene, leptin is a 146 amino acid peptide hormone secreted 
from adipocytes into the circulation and best understood as a long-term signal of 
adiposity, as a peripheral signal of nutritional status to the CNS, as well as in the 
regulation of EE (for review, see Friedman 2014). There is a consensus that leptin 
levels are correlated with adiposity (Caron et al., 2018). Leptin is mainly secreted from 
visceral WAT in rodents (Trayhurn et al., 1995) and subcutaneous WAT in humans 
(Hube et al., 1996). With the discovery of leptin, adipose tissue is no longer just a 
tissue correlated with body weight but an endocrine organ with feedback loops 
between the brain and peripheral organs (Coelho et al., 2013). 
Via alternative mRNA splicing, a single leptin receptor (Lepr) gene produces 
six LEPR isoforms. However, it is only through the activation of the long form of the 




leptin receptor (LEPRb) that leptin exerts its biological functions. Leprb (coding gene 
for LEPRb) was shown to be greatly expressed in many brain regions, and 
hypothalamus was identified as its principal site of action, particularly ARC (Elmquist 
et al., 1998; Scott et al., 2009). 
Within ARC, NPY/AgRP and POMC/CART neuronal subpopulations were 
identified as fundamental for the leptin-associated homeostatic regulation of appetite. 
It was shown that leptin acts in part by activation of POMC and inhibition of AgRP 
neurons (Cowley et al., 2001; Van Den Top et al., 2004). Leptin i.c.v. injections were 
shown to decrease food intake in rodents while decreasing ARC Npy mRNA 
expression (Schwartz et al., 1996). Beyond the hypothalamus, studies also reported the 
effects of leptin on the regulation of energy balance via action on the midbrain and 
brainstem. Administration of leptin into VTA, for instance, decreased food intake 
(Hommel et al., 2006). Further, intravenous (i.v.) administration of leptin increased 
STAT3 phosphorylation in the brainstem of mice, a transcription factor essential for 
the metabolic actions of leptin (Hosoi et al., 2002). 
Besides its function as an appetite regulator, leptin also contributes to the 
regulation of EE. Whenever leptin binds to its receptor in ARC and stimulates the 
production of POMC peptides, 𝛼-MSH peptides are produced. Binding of -MSH to 
MC4R located in the pituitary was shown to stimulate secretion of thyrotropin 
releasing hormone (TRH) and increase EE (Flier et al., 2000). Moreover, direct leptin 
activation of NTS was shown to increase Ucp-1 mRNA expression (Matheny et al., 
2014). By acting on the sympathetic nervous system (SNS), studies showed that leptin 
promoted WAT triglycerides breakdown and browning (Dodd et al., 2015) and 
increased BAT glucose uptake (Haque et al., 1999). Interestingly, leptin levels were 
found to be decreased in situations of cold exposure and fasting (Hardie et al., 1996). 




This suggests that leptin is more likely to reflect one’s energy demand rather than body 
lipid content. 
Leptin is known to play an important role in metabolic disorders, and there are 
significant links between leptin and obesity (Montague et al., 1997; Clément et al., 
1998). Importantly, in obese humans and rodents, although leptin levels are recurrently 
high (Maffei et al., 1995), the leptin transport across BBB is impaired (Banks et al., 
1999). Various studies support the strong association between obesity and leptin 
resistance (for review, see Zhou and Rui, 2014). Recently, Mazor et al. (2018) showed 
that obesity induced by high-fat diet (HFD) was associated with leptin receptor 
degradation and leptin resistance in mice. Further, dysfunctional LEPR-STAT3 
signalling pathway was associated with an obese phenotype in mice (Saadat et al., 
2012). Using adenoviral gene therapy to express ARC Lepr, Morton et al. (2003) 
reported that restoration of ARC Lepr mRNA expression was sufficient to attenuate 
obesity phenotype in leptin receptor-deficient rats. Nonetheless, it is still unclear 
whether leptin sensitivity is the cause or consequence of diet-induced obesity (de Git 
et al., 2018). 
 
1.1.3.3. Insulin 
Encoded by the INS gene, insulin biosynthesis begins with its precursor, 
preproinsulin, that undergoes posttranslational translocation and cleavage until the 
formation of the mature form of insulin (Liu et al., 2018). Insulin is a 51 amino acid 
peptide hormone secreted from pancreatic -cells best known for its role in glucose 
homeostasis (for review, see Plum et al., 2006). The primary function of insulin is to 
control blood glucose levels by stimulating glucose uptake into cells. During a 
hyperglycemic state, insulin has potent physiological anabolic effects, promoting 




synthesis of lipids, protein and carbohydrates and inhibiting their breakdown. It was 
shown to promote intestinal glucose absorption (Ussar et al., 2017), increase 
lipogenesis (Larger, 2005; Scherer et al., 2011) and liver glycogenesis (Han et al., 
2016) and inhibit hepatic gluconeogenesis (i.e. glucose synthesis) (Lee et al., 2016). 
For peripheral tissues, insulin is essential for the regulation of glucose 
homeostasis and energy balance. When insulin binds to its receptor in the membrane 
of target cells, it stimulates the translocation of glucose transporter type 4 (GLUT4) 
proteins to the plasma membrane, through exocytosis, at the same time that attenuates 
its endocytosis (Furtado et al., 2002). Whenever the concentration of GLUT4 proteins 
is enriched at the plasma membrane, transport of glucose into the cell is augmented. 
In the absence of insulin, GLUT4 recycles itself within the cell and glucose uptake is 
reduced (Huang and Czech, 2007). 
Within the brain, glucose transport into most neurons is dependent on the 
glucose transporter type 3 (GLUT3) (Uemura and Greenlee, 2006), with the exception 
of a few selected nuclei that express GLUT4, and glia and brain endothelial cells that 
express glucose transporter type 1 (GLUT1) (McEwen and Reagan, 2004). Since 
insulin is not required for GLUT1- and GLUT3-mediated glucose transport, insulin is 
not necessary for glucose uptake into most brain cells (for review, see Gray et al., 
2014). 
Interestingly, the brain is an important target for insulin action. It reaches the 
brain by crossing the BBB, but the brain itself also produces endogenous insulin 
(Blázquez et al., 2014). Insulin receptors are widely expressed within the brain (Plum 
et al., 2005) and its activation, mostly within the hypothalamus, regulates feeding 
behaviour and energy stores (Obici et al., 2002). For instance, i.c.v. injection of insulin 
in fasted rats increased expression of POMC mRNA (Benoit et al., 2002).  




There is considerable evidence for interactions between the leptin and insulin 
system. In vitro studies showed that insulin induced Lep mRNA expression in 
adipocytes, suggesting that insulin may stimulates leptin secretion (Leroy et al., 1996). 
Conversely, it was suggested that leptin interferes with glucose metabolism, mediating 
insulin secretion and sensitivity in peripheral tissues (for review, see Morton and 
Schwartz, 2011). 
 
1.1.4. Neurocircuit of feeding motivation and behaviour 
Based to a large extent on the inputs from the homeostatic system regarding 
metabolic needs, limbic and cortical regions such as Amy and NAcc modulate the 
motivational aspects of feeding, through control of food-directed behaviour (Volkow 
et al., 2011). The functional and anatomical overlap of the homeostatic and brain 
circuits suggests substantial interaction (Rossi and Stuber, 2017). Indeed, such 
interaction between the systems is required in order to remain healthy and prevent the 
development of metabolic abnormalities. 
 
1.1.4.1. Monoaminergic systems 
Monoamine neurotransmitters such as dopamine (DA) and serotonin (5-HT) 
are highly implicated in feeding motivation and behaviour. The mesolimbic 
dopaminergic pathway comprises neurons in the VTA that project to the ventral 
striatum (NAcc), Amy, Hipp and prefrontal cortex, whereas the serotonergic pathway 
comprises neurons from the raphe nuclei (RN) to the thalamus, hypothalamus, basal 
ganglia and cortex (Charnay and Léger, 2010) (Figure 1.4). 
 




A. B.  
Figure 1.4. Central dopaminergic (A) and serotonergic (B) pathways and their ascending 
projections, shown for human brain. Figure adapted from Kalat (1998). 
 
1.1.4.1.1. Dopaminergic system 
The role of the dopaminergic system in feeding motivation and behaviour has 
been well-characterised (Volkow et al., 2011; Salamone and Correa, 2012). DA 
modulates food intake and reward mechanisms mainly through neuronal projections 
from VTA to NAcc in the mesolimbic circuit. Studies showed that NAcc DA D2 
receptor blocking following systemic injection of haloperidol in food-deprived rats 
significantly decreased lever pressing for food (Salamone et al., 1991). Moreover, 
mice showing chronic elevation of extracellular DA levels, by using DA transporter 
knockdown, had increased motivation for food reward (Cagniard et al., 2006). 
In conditioned learning, potentially rewarding foods can promote eating and 
generate learning about a conditioned (initially neutral) stimulus associated with the 
reward (Dayan and Balleine, 2002). In studies using pairing sessions of conditioned 
cues (Pavlovian conditioned stimulus, CS) and food reinforcement (unconditioned 
stimulus, US), rats with lesioned NAcc were significantly impaired during the 
Pavlovian sessions (Parkinson et al., 1999). Interestingly, DA in the dorsal striatum 




(DS) is also involved in food motivation in humans, independent of its role in NAcc. 
Exposure to conditioned non-palatable food cues as well as ingestion of palatable food 
promoted DA release in the DS that was associated with the desire to eat the food 
(Volkow et al., 2002; Small et al., 2003). 
 
1.1.4.1.2. Serotonergic system 
Serotonin, also known as 5-hydroxytryptamine or 5-HT, is a biogenic 
monoamine derivative of tryptophan, an essential amino acid obtained through diet 
nutrients; the pathway comprises two steps of hydroxylation and decarboxylation that 
occur almost instantaneously in the presence of tryptophan (Figure 1.5) (Mohammad-
Zadeh et al., 2008). 
 
 
Figure 1.5. Chemical conversion of tryptophan into serotonin. Step 1. Loss of a hydroxyl 
group by tryptophan hydroxylase enzyme. Step 2. Loss of a carboxyl group by aromatic-L-
amino-acid decarboxylase. Figure from Coelho (2014), Journal of the Brazilian Chemical 
Society. 
 
5-HT is present in the brain, GI tract and blood platelets, although it is mostly 
linked with the enteric system (Gershon and Tack, 2007). Since 5-HT does not cross 
the BBB, its pool used in the nervous system must be produced within it. This 
neurotransmitter, with its various receptors, each of which is expressed in discrete 
brain regions, is the focus of much interest due to its implication in almost every 
physiological function (Charnay and Léger, 2010). Among its many functions, 5-HT 




is accountable for the modulation of aversive stimuli and reward processing; it has 
been widely associated with the maintenance of mood and social behaviour, appetite 
and digestion, as well as with a wide range of neuropsychiatric and neurological 
conditions such as eating disorders and depression (Opacka-Juffry, 2008). 
Serotonergic neurons are the main components of RN in the brainstem of 
humans and rodents. Based on its neuron clusters distribution and main projections, 
the serotonergic system is divided into two groups. The rostral group, which accounts 
for 85% of serotonergic neurons in the human brain, is restricted to the mesencephalon 
region and rostral pons (Hornung, 2003). Neurons from the rostral raphe complex 
within these areas project primarily to cortical areas, thalamus, hypothalamus, 
amygdala, basal ganglia and hippocampus. The caudal group, with the remaining 15% 
of the neurons, is confined to the caudal pons and medulla, and extends its projections 
to the caudal brainstem and spinal cord (for review on human serotonergic system, see 
Hornung, 2003). 
 
1.1.4.1.2.1. Serotonin in the regulation of feeding 
5-HT has been implicated in the regulation of satiety as well as reward 
behaviours. The properties of anti-serotonergic drugs used to modulate appetite have 
been observed since 1960 (Bergen, 1964, cited by Voigt and Fink, 2015). Increased 
serotonergic activity, as an effect of higher 5-HT synthesis that follows  administration 
of tryptophan, was shown to decrease food intake (Gartner et al., 2018). Conversely, 
decreased serotonergic activity, due to activation of somatodendritic 5-HT1 
autoreceptors for instance (Dourish et al., 1989), increases food intake. Surprisingly, 
low dose of the 5-HT receptor agonist 8-OH-DPAT was shown to increase food intake 




in humans (Dourish et al., 1985); in pigs, tryptophan enhanced ghrelin expression and 
promoted feeding (Zhang et al., 2007). 
The central serotonergic system has been implicated in the regulation of 
feeding behaviour, especially in hypothalamic regions (Lam et al., 2010). Within the 
hypothalamus, the effects of 5-HT are thought to be due to the modulation of the NPY 
peptide and melanocortin receptors (i.e. MC3R, MC4R) (Heisler et al., 2006). As 
previously mentioned, NPY is an essential stimulator of food intake, and projections 
from ARC NPY-expressing neurons to PVN are shown to mediate feeding effects of 
5-HT (Kalra et al., 1991). For instance, acute and chronic systemic administration of 
fenfluramine, which causes 5-HT release by disrupting its vesicular storage, decreased 
hypothalamic NPY mRNA expression and NPY concentration, and resulted in 
anorexigenic effects in rats (Rogers et al., 1991; Choi et al., 2006). Additionally, the 
5-HT antagonist methysergide increased NPY and induced feeding in rats (Dryden et 
al., 1995). Further, the 5-HT reuptake inhibitor sibutramine reduced appetite and 
induced weight loss (Luque and Rey, 2002). Although modulation of 5-HT affects 
feeding behaviour, anti-obesity drugs such as fenfluramine and sibutramine were 
removed from the market due to their adverse effects (Wharton, 2016). 
 
1.1.4.1.2.2. Serotonin receptors 
Allocated to seven different families, 5-HT receptors have structurally and 
pharmacologically distinct members that have been classified according to their 
location and function (Hoyer and Martin, 1997; Hoyer et al., 2002), as summarised in 
Table 1 below. 
 
 




Table 1.1. 5-HT receptor subtypes and some of their functions, based on Hoyer and Martin 
(1997) and Hoyer et al. (2002) 
Receptor type Subtype Function 
5-HT1 5-HT1A* mood, anxiety, appetite, thermoregulation 
 5-HT1B* mood, anxiety, aggression, addiction 
 5-HT1D* anxiety, vasoconstriction, locomotion 
 5-HT1E (unknown) 
 5-HT1F vasoconstriction, migraine 
5-HT2 5-HT2A* mood, anxiety, appetite, thermoregulation 
 5-HT2B anxiety, appetite 
 5-HT2C mood, anxiety, appetite, thermoregulation 
5-HT3  anxiety, memory, gut motility 





5-HT6  mood, anxiety, memory 
5-HT7*  mood, anxiety, thermoregulation 
*Autoreceptor 
 
Importantly, individual neurons can express more than one receptor (Berger et 
al., 2009). For instance, cultured rat dorsal root ganglion sensory neurons were shown 
to express 5-HT1B predominantly, but also 5-HT1D and 5-HT2A (Chen et al., 1998). 
The co-expression of 5-HT receptors may explain serotonin’s pleiotropic behavioural 
effects and modulation of a wide variety of brain circuits (Berger et al., 2009). With 
the exception of the 5-HT3 receptor, a ligand-gated ion channel also known as 
ionotropic receptor, the other receptors are classified as metabotropic receptors; they 
belong to the G protein-coupled receptors (GPCRs) that couple to Gi/o protein to inhibit 
the formation of cyclic adenosine monophosphate (cAMP) (Barnes and Sharp, 1999). 
Some of these receptors are known as autoreceptors, such as 5-HT1A at 
somatodendritic locations of the RN or 5-HT1B at axon terminals (Riad et al., 2000; 




Belmer and Maroteaux, 2018). They negatively regulate the excitability and firing rate 
of serotonergic neurons (Garcia-Garcia et al., 2014) (Figure 1.6). Other receptor 
subtypes such as 5-HT2C are expressed in post-synaptic regions of serotonergic, but 
also of non-serotonergic neurons (e.g. GABAergic neurons) (Serrats et al., 2005).  
 
 
Figure 1.6. Schematic diagram depicting 5-HT synthesis, release, re-uptake and signalling. 
Abbreviations: TRYP, tryptophan; TH, tryptophan hydroxylase; AADC, aromatic amino acid 
decarboxylase; 5-HT, 5-hydroxytryptamine; 5-HIAA, 5-hydroxyindoleacetic acid; SSRIs, 
selective serotonin reuptake inhibitors, MAO, monoamine oxidase; ATP, adenosine 
triphosphate; cAMP, cyclic adenosine monophosphate; AC, adenylate cyclase; IP3, inositol-
1,4,5-trisphosphate; DAG, diacylglycerol; PIP2, phosphatidylinositol-4,5-biphosphate. Figure 
reprinted from Wong et al., (2005), Nature Reviews Drug Discovery, p767, ©2005 Nature 
Publishing Group. 
 
5-HT receptors, particularly 5-HT1A, 5-HT2A and 5-HT2C receptors, exert 








1.1.4.1.2.2.1. Serotonin 5-HT1A receptor 
Encoded by the gene HTR1A, 5-HT1A receptors are GPCRs with seven 
transmembrane domains, expressed by all serotonergic neurons as autoreceptors, and 
by many non-serotonergic neurons as heteroreceptors (Charnay and Léger, 2010). 
They exert their effects through two different mechanisms: inhibition of adenylate 
cyclase activity and the opening of potassium (K+) channels. In terminal areas of 
serotonergic innervation such as hippocampus and amygdala, 5-HT1A receptors are 
coupled to both effector systems. In the RN, however, they are located as presynaptic 
autoreceptors and coupled only to the opening of K+ channels (Polter and Li, 2010). 
Whenever 5-HT concentration is enhanced, and inhibitory autoreceptors are 
stimulated, neurons are hyperpolarised, and firing is inhibited. Of note, 5-HT1A 
autoreceptors are also inhibited by dendritic 5-HT vesicular release, which occurs 
independently of action potentials by neuronal firing, and are induced by excitatory 
glutamatergic inputs to the dorsal raphe nucleus (DRN) (Belmer and Maroteaux, 
2018). 
Modulation of 5-HT1A has also been implicated in the regulation of food 
intake. In studies that used agonists of 5-HT1A receptors such as DPAT and NAN-
190, these drugs stimulated feeding in rats (Williams and Dourish, 1992; Voigt et al., 
2002), likely via a reduction in 5-HT release.  
 
1.1.4.1.2.2.2. Serotonin 5-HT2A receptor 
Encoded by the gene HTR2A, 5-HT2A receptors are also GPCRs (Guiard and 
Di Giovanni, 2015). Several factors are related to the signalling mechanisms that 
underpin the activity of this receptor and can be crucial in dictating the direction of 
response. Firstly, 5-HT2A receptor signalling can be regulated by its interactions with 




other proteins such as -arrestin, which plays an important role in the induction of 
behavioural effects such as head twitch in mice (Schmid et al., 2008); 5-HT2A can 
also be regulated by its homo- and hetero-dimerisation. Secondly, 5-HT2A effects can 
be direct or indirect and mediated via interactions with glutamatergic or GABAergic 
neurons (Di Giovanni, 2013). In the VTA, for instance, 5-HT2A receptors in 
GABAergic interneurons were shown to inhibit dopaminergic activity, presumably via 
the latters’ inhibition of DA neurons (Doherty and Pickel, 2000), whereas 5-HT2A 
receptors in VTA dopaminergic neurons stimulated dopaminergic activity (Howell 
and Cunningham, 2015). In the DRN, GABAergic interneurons expressing 5-HT2A 
receptors project onto serotonergic neurons and regulate their firing activity (Guiard 
and Di Giovanni, 2015). It is a well-characterised receptor in the cerebral cortex; it 
mediates neuronal depolarisation and closing of potassium channels (Jiang et al., 
2009).  
5-HT2A receptors are linked not only to central physiological functions such 
as perception, mood, cognition and reward behaviour but also to neuropsychiatric 
disorders like depression and epilepsy. The central role of 5-HT2A in depressive 
disorders is not well-established. In the amygdala, 5-HT2A receptors are primarily 
located in GABAergic interneurons (Jiang et al., 2009); impaired modulation of 5-HT 
in the amygdala was shown to be implicated in the development of mood disorders 
(Cools et al., 2008). 
5-HT2A receptors were also shown to modulate feeding behaviour, and appear 
critical for the anorectic action of GLP-1 agonists (Anderberg et al., 2017). 
Interestingly, reduction of hypothalamic Htr2a mRNA expression by liraglutide, a 
GLP-1 receptor agonist, reduced appetite in mice, independently of 5-HT synthesis 
(Nonogaki and Kaji, 2018). Earlier studies also described a relationship between 5-




HT2A polymorphism and eating disorders such as bulimia and anorexia nervosa 
(Ricca et al., 2002) and with food preference in humans on a stable diet (Prado-Lima 
et al., 2006). 
 
1.1.4.1.2.2.3. Serotonin 5-HT2C receptor 
Encoded by the gene HTR2C, 5-HT2C receptors (formerly 5-HT1C) are 
strategically localised in cortico-limbic regions implicated in the aetiology and 
modulation of emotional states. At post-synaptic level, its localisation is mainly in the 
choroid plexus, subthalamic nuclei, hypothalamus, hippocampus, periaqueductal grey 
matter and amygdala of rodents (Mengod et al., 1990). The receptor localisation in the 
mammalian brain is consistent with its potential involvement in states of anxiety and 
depression, since most of these brain regions belong to the main neural circuits that 
are implicated in emotional behaviours. However, the real understanding of the role of 
5-HT2C receptors has been hampered by the lack of more selective ligands and by the 
very complex nature of these receptors. In the process of synthesis of 5-HT2C 
receptors, there may be changes in the mRNA transcription, with a consequent 
modification in protein synthesis and generation of up to 24 different isoforms 
(Gardiner and Du, 2006). As 5-HT is responsible for regulating a wide variety of 
behaviours, modulation of 5-HT signalling by RNA editing may be relevant to 
understanding mood-related psychopathologies. For instance, stress and depression 
states may alter mRNA editing, modifying the types of isoforms expressed in certain 
brain areas (Yamashita et al., 2011). 
5-HT2C receptors are thought to be imperative in the relationship between food 
intake and energy balance. Pharmacological studies demonstrated some of the effects 
of 5-HT2C manipulation on the regulation of food intake, through its interactions with 




ARC NPY/AgRP and POMC neurons (for review, see Voigt and Fink, 2015). For 
instance, 5-HT2C agonists were shown to decrease food intake (De Vry and Schreiber, 
2000) and glucose consumption (Higgs et al., 2016), likely via downstream activation 
of MC4R (Lam et al., 2008); it also attenuated the motivation for palatable food (Ward 
et al., 2008). Of note, the 5-HT2C receptor agonist lorcaserin was approved as an anti-
obesity drug (Brashier et al., 2014). Lorcaserin acts on POMC neurons causing 𝛼-
MSH release and activation of PVN MC4R, thus decreasing appetite. Furthermore, 
selective activation of neurons expressing 5-HT2C receptors in NTS was shown to 
decrease food intake in mice; POMC-expressing neurons in both ARC and NTS were 
required for the reduction in food intake promoted by 5-HT2C agonists (D’Agostino 
et al., 2018). The 5-HT2C receptor antagonist RS-102221, on the other hand, increased 
feeding and promoted weight gain (Bonhaus et al., 1997). More recent studies showed 
that rats treated with the 5-HT2C antagonist risperidone had increased food intake and 
body weight, as well as decreased POMC mRNA expression in hypothalamic nuclei 
(Kursungoz et al., 2015).  
 
1.1.4.1.2.3. Serotonin transporter 
Encoded by the gene SLC6A4, serotonin transporter (SERT), situated on the 
presynaptic membrane of serotonergic neurons, is mainly involved in the regulation of 
serotonergic signalling. By taking up 5-HT from the synaptic cleft back into the pre-
synaptic terminal for catabolism/re-utilisation, SERT plays an important role in the 
regulation of the availability of 5-HT to receptors (for review, see De Felice, 2016).  
Regulation of SERT has also been shown to act on feeding behaviour. Sanders 
et al. (2007) demonstrated that inhibition of SERT reduced food intake and operant 
responding for food reward. Selective serotonin reuptake inhibitors (SSRIs) for 




instance, such as sertraline, reduced food intake (Nielsen et al., 1992). The underlying 
mechanism is that by inhibiting 5-HT reuptake, 5-HT becomes increasingly available 
at the synaptic cleft thus increasing stimulation of serotonergic postsynaptic neurons. 
 
As mentioned, the functional and anatomical overlap of homeostatic and 
motivation/behaviour systems suggests effective communication. For instance, LHA 
neurons combine VTA reward-related signals with ARC homeostatic inputs to 
orchestrate an adequate feeding response (Kampe et al., 2009). 
 
In summary, regulation of energy metabolism involves the balance between 
feeding and EE, controlled by complex brain circuits, neurotransmitters, central and 
peripheral peptides. The influences of internal biological factors, as well as external 

















In most general terms, stress can be defined as the sum of physical and mental 
responses that allow living organisms to overcome difficulties caused by certain 
external or internal stressful stimuli (i.e. stressors). Hans Selye, who first introduced 
the concept of stress in his ‘general adaptation syndrome’ paper in 1936, described 
stress as “the non-specific response of the body for any demand for change”. He also 
said that there are so many different situations involving stress that would not be 
possible to measure it, or even define it, thus indicating the complexity of this 
phenomenon (Selye, 1936). 
Interestingly, stress-coping strategies might differ among those who have 
suffered from stressful situations in the past and those who have not. In that sense, 
stress develops from an interplay between external conditions (i.e. stressors) and 
individual variability. Stress is, therefore, a reaction which has physical, 
psychological, hormonal and mental components that can be developed in the face of 
situations that symbolise a challenge to the individual. 
 
1.2.2. Categories 
The current classification of stressors is based on two main categories: 
exteroceptive (e.g. electric shock) or interoceptive (e.g. stimuli through 
pharmacological agents) (Sawchenko et al., 2000). However, it is also critical to take 
into account aspects such as the nature of the stressor (e.g. metabolic, physical, 
psychosocial), the predictability and controllability of the stressor (Koolhaas et al., 




2011), as well as the extent of stressful challenge and the time point for evaluation of 
stress responses (Patchev and Patchev, 2006).   
Stress can be categorised according to its duration. Thus acute stress, a 
physiological response to short-term stimuli (or stressors), often results in reversible 
physical and emotional effects. It is an adaptive response, which Selye referred to as 
“good stress” (Selye, 1976). Chronic stress, on the other hand, affects body and mind 
in a long-lasting and potentially harmful manner – a “bad stress” in Selye’s words. It 
turns the physiological response of “good” stress into a maladaptive pathway that may 
verge towards the development of psychopathologies (Musazzi et al., 2017). Chronic 
stress was shown to be more strongly related to depression than acute stress in humans 
(McGonagle and Kessler, 1990) and rats (Katz et al., 1981).  
 
1.2.3. Neurobiology of stress – HPA axis 
The stress system works through a complex coordinated activation of 
endocrine responses from the hypothalamic-pituitary-adrenal (HPA) axis and the 
cardiorespiratory activity from the locus coeruleus/norepinephrine (LC/NE) 
autonomic sympathetic nervous system (SNS) (Chrousos, 2009). 
Within seconds following stress stimulation, the catecholamines epinephrine 
and norepinephrine are released via activation of sympathetic preganglionic neurons 
in the spinal cord. The signal is then transferred to postganglionic neurons that project 
to peripheral organs in order to prepare the organism for the “fight-or-flight” response; 
it promotes, among other responses, an increase in heart rate and hepatic glucose 
release for enhanced active stress response (for review, see Wehrwein et al., 2016). 
Different from the SNS, activation of the HPA axis occurs within minutes 
following stress initiation, lasting several hours (Herman et al., 2016). The first 




component of the HPA axis is corticotropin-releasing hormone (CRH); dependent on 
neural afferents from the brainstem and limbic system, activation of CRH neurons in 
the parvocellular division of the PVN is followed by synthesis and release of CRH into 
the median eminence (Figure 1.7). Cawley et al. (2016) demonstrated that the release 
of CRH stimulated the transcription of the POMC gene via cAMP/protein kinase A 
and the secretion of POMC-related peptides such as adrenocorticotropic hormone 
(ACTH) from corticotropin cells of the anterior pituitary into the circulation. It is 
generally accepted that the CRH is an essential regulatory hormone of the HPA axis. 
Nevertheless, arginine vasopressin (AVP) is also considered an important regulator of  
ACTH secretion (Aguilera and Rabadan-Diehl, 2000); co-expressed with CRH 
neurons in the PVN, AVP potentiates the activity of CRH in releasing ACTH (Gillies 
et al., 1982). In the adrenal cortex, ACTH binds to melanocortin 2 receptors (MC2R) 
(Margioris and Tsatsanis, 2011), causing an increase in the synthesis of 
glucocorticoids.  
Glucocorticoids are the end product of the HPA axis. Derived from cholesterol, 
GC influences the stress response through activation of the mineralocorticoid receptor 
(MR) and GC receptor (GR) located throughout the body (Oakley and Cidlowski, 
2013). Although MR have a higher binding affinity to GC, a higher concentration of 
GC (e.g. following stressful stimuli) also occupy GR (Sapolsky et al., 2000, 2015); 
anti-inflammation and energy mobilisation are also mediated by this receptor.  
Importantly, control of stress response is mediated via GC negative feedback 
at different levels of the HPA axis (Figure 1.7). Elevated GC acts at the PVN, where a 
high density of GR is found, reducing CRH synthesis and secretion from the 
hypothalamus, and eventually reducing the synthesis of POMC and secretion of ACTH 
in the anterior pituitary. The ceasing of ACTH release promotes a gradual return of 




GC to baseline levels. This negative feedback loop controlled by GC is therefore vital 
to maintain the homeostasis of the stress system (Herman et al., 2016).  
The activity of the HPA axis is also modulated by the time of the day. Under 
basal conditions, GC release follows a pulsatile one-hour ultradian rhythm and a 
predominant circadian pattern with a pronounced peak corresponding to the active 
phase, preparing the organism for daily activities (Fitzsimons et al., 2016). Excessive 
activation of the HPA axis and compromised negative feedback regulation by GC 
promotes a disruption in the circadian rhythm and is often associated with the 
development of endocrine and psychiatric disorders (Koch et al., 2017). 
 
Figure 1.7. The hypothalamus-pituitary-adrenal (HPA) axis. Abbreviations: CNS, central 
nervous system; SCN, suprachiasmatic nucleus; PVN, paraventricular nucleus; CRH, 
corticotropin-releasing hormone; AVP, vasopressin, ACTH, adrenocorticotropic hormone. 
Figure from Lightman (2016), Research and Perspectives in Endocrine Interactions,  p89, © 
Lightman 2016. 




The efficiency of the stress response varies according to the type, intensity and 
duration of the stressor. Studies have suggested that physical and psychological 
categories of stress are recognised differently by the brain, supported by region-
dependent c-fos expression (Dayas et al., 2001). In regards to the intensity, in general, 
the more severe the stressor, the more pronounced is the HPA responsiveness. For 
instance, daily repeated exposure to mild foot shock in rats resulted in higher HPA 
axis adaptation (i.e. reduction in ACTH and corticosterone) when compared to high-
intensity foot shock (Rabasa et al., 2011).  
Duration of stress exposure has also been shown to activate HPA axis 
differently. Acute stress induces a rapid release of CRH into the pituitary and an 
eventual inhibitory mechanism by GC. Conversely, prolonged stress exposure (i.e. 
chronic stress) may lead to impaired HPA axis negative feedback, characterised by GC 
receptor resistance (Cohen et al., 2012), adrenal hypertrophy (Ulrich-Lai et al., 2006) 
and insufficiency in terms of response to an ACTH challenge (Reber et al., 2007), and 
ultimately habituation of HPA axis response. For instance, 1h of immobilisation 
markedly increased ACTH and corticosterone in rats, however, this activation was 
reduced after the seventh immobilisation (Daviu et al., 2014). The initial elevation of 
corticosterone levels followed by its reduction may explain the absence of effect on 
corticosterone levels seen in models of chronic stress (Azzinnari et al., 2014). 
Activation of the HPA axis and the SNS due to stress has also been shown to 
activate the immune system (Segerstrom and Miller, 2004; Chen et al., 2017), 
particularly in the pathophysiology of major depressive disorder (Otte et al., 2016). 
Markers of inflammation, e.g. interleukin-6 (IL-6) and tumour necrosis factor alpha 
(TNF-), were shown to be increased in chronically stressed mice (Azzinnari et al., 
2014). Once stress becomes chronic, enhanced inflammatory response concomitant 




with the hyperactivity of the HPA axis and subsequent glucocorticoid resistance may 
lead to the development of depression (Raison et al., 2006), metabolic diseases 
(Pickup, 2004; Joseph and Golden, 2017) and other disorders. 
In many cases, stressful stimuli can lead to considerable changes in the brain 
and body. Nonetheless, an organism`s adaptive (or maladaptive) response to acute or 
chronic stress is dependent on genetic factors, age, social support or previous stress 
experiences. The individual circumstances will ultimately dictate the possible 

















1.3. Stress-related mood disorders and energy metabolism 
 
Among stress-related disorders, depression is most prevalent, estimated to 
affect 300 million people globally (World Health Organization, 2017). It affects people 
in different ways and with a varied severity. It can cause a wide variety of symptoms, 
such as the presence of continuously low mood or sadness, lack of motivation, feelings 
of anxiety and worthlessness, disturbed appetite, poor sleep, and suicidal tendencies 
(APA, 2013). 
Stressful experiences throughout the life course are among the causes of 
affective disorders such as depression (Hammen, 2005). The etiological relationship 
between the exposure to stressful life events and the emergence of mental disorders 
has not been fully comprehended yet. Numerous studies have been conducted trying 
to elucidate the consequences of stress, within its different categories, on the brain and 
body, and to explain the cross-talk between these two in order to deal with these 
effects.  
 
1.3.1. Stress and energy balance 
1.3.1.1. Stress and feeding behaviour 
 In humans, chronic stress is a major risk factor for depression and related 
psychiatric disorders, in which changes in appetite and body weight are often a major 
symptom or co-occurring feature (Luppino et al., 2010). Many studies link stress with 
alterations in feeding behaviour (Maniam and Morris, 2012) and associations between 
stress and a preference for palatable, energy-rich food have been identified (Gibson, 
2006; Dallman, 2010). There is growing consensus that particularly social stress 




contributes to obesity (Scott, 2012), yet people respond differently to stress, and in 
some people stress leads to weight loss (Adam and Epel, 2007). Under conditions of 
perceived stress, 40% of humans eat more, and this group constitutes those who are at 
the upper range of normal in terms of body mass index (BMI), whilst 40% eat less 
(Oliver and Wardle, 1999). Nonetheless, independent of hyperphagia or hypophagia, 
there is an increase in the intake of highly palatable foods when individuals are 
subjected to stressful situations (Zellner et al., 2006). 
The anatomical overlap of the HPA axis with the regulatory feeding system 
within the hypothalamus, considered the coordinating centre of the endocrine system, 
is a major indication that stress can influence feeding (Maniam and Morris, 2012). For 
instance, NPY/AgRP and POMC/CART neurons, centrally involved in the 
neuroendocrine regulation of feeding, project strongly to the PVN, containing among 
others CRH neurons that initiate the endocrine component of the stress response (Kalra 
et al., 1991; Jhanwar-Uniyal et al., 1993; Millington, 2007). Therefore, the long-lasting 
effects that stress has on feeding behaviour are partly due to the activation of HPA axis 
(Dallman et al., 2004). Secretion of GC has been shown to regulate hypothalamic NPY 
gene expression in rodents (Shimizu et al., 2008, 2010). 
 
1.3.1.2. Stress and energy expenditure 
With regards to EE, GC is also known to modulate BAT thermogenesis, 
nevertheless, there is a marked contrast between rodents and humans (Ramage et al., 
2016). In rats, acute injection of the GR antagonist RU-486 promoted stimulation of 
BAT activity (Hardwick et al., 1989). When subcutaneous corticosterone was given to 
rats, levels of Ucp-1 content and BAT storage of lipid were suppressed in proportion 
to corticosterone increasing (Strack et al., 1995). A comparison between the effects of 




ACTH and corticosterone on WAT browning and Ucp-1 mRNA expression was 
performed; researchers observed that ACTH activated BAT and promoted WAT 
browning, but corticosterone counteracted these effects (Van Den Beukel et al., 2014). 
In humans, the effects of GC on BAT thermogenesis appear to oppose those in rodents 
(Figure 1.8). During hydrocortisone infusion, GC increased BAT temperature 
(Scotney et al., 2017). Further, the GC prednisolone increased the BAT glucose 
uptake, the supraclavicular temperature of the skin and the EE following cold exposure 
(Ramage et al., 2016). These opposing findings demonstrate one of the challenges in 
translating animal studies to humans, especially with regards to the effects of stress on 
EE and overall energy metabolism. 





Figure 1.8. Schematic diagram depicting the different systems involved in the effects of stress 
on energy balance in different organs. Abbreviations: PVN, paraventricular nucleus; BSNT, 
bed nucleus of the stria terminalis; AMY, amygdala; CRH, corticotropin-releasing hormone; 
ACTH, adrenocorticotropic hormone; NPY, neuropeptide Y; BAT, brown adipose tissue; 
WAT, white adipose tissue. Figure from Rabasa and Dickson (2016), Current Opinion in 
Behavioural Sciences, p74. 
 
Factors such as the severity and the duration of stress dictate the personal 
vulnerability on the regulation of feeding systems (Adam and Epel, 2007). For 
instance, acute and chronic stress manifest themselves differently. Perception of 
immediate threats (acute stress) and immediate activation of HPA axis to prepare the 
body for “fight-or-flight” action have often been shown to promote anorexigenic 




effects (for review, see Maniscalco et al., 2012). Chronic stress, however, can have an 
orexigenic effect (Bartolomucci et al., 2009; Rabasa and Dickson, 2016) with 
consequences for body weight, and this can partially be explained by GC release 
(Rabasa and Dickson, 2016). GC receptors are particularly highly concentrated in 
visceral adipose tissue (Maniam and Morris, 2012). In the presence of insulin, cortisol 
promotes the accumulation of triglycerides resulting in an increase of visceral fat 
(Duclos et al., 2005). Chronic stress and, therefore, chronic secretion of GC might 
promote obesity through effects on fat accumulation. In patients with Cushing’s 
syndrome (i.e. high levels of cortisol), obesity is a notable feature (Tiryakioglu et al., 
2010). 
The effects of chronic stress-induced corticosterone on food intake are not 
clear, and recent findings have suggested that stress-related changes in feeding 
behaviour might be glucocorticoid-independent (Patterson et al., 2013) (discussed in 
more details in Chapter 4). Interestingly, not all stress models that have reported an 
effect on food intake also observed elevated GC levels. For example, Pryce and 
colleagues reported an effect of chronic social stress on feeding behaviour (Bergamini 
et al., 2016) but no effect on basal plasma corticosterone (Azzinnari et al., 2014). 
Importantly nevertheless, Azzinnari et al. (2014) and others also reported adrenal 
hypertrophy, suggestive of hyperactivity of the HPA axis. Their findings suggested 
that the adrenal gland became insensitive to ACTH following chronic social stress, 
resulting in adrenal insufficiency. 
It seems evident from an evolutionary point of view that chronic stressors 
promote the activation of mechanisms with obesogenic effects, for the reason that is 
considered advantageous to accumulate visceral fat and to store hepatic glycogen when 
life-threatening conflicts are existent in a long-lasting manner (Rabasa and Dickson, 




2016). Nevertheless, this does not always happen, and it is still unknown what causes 
the absence of fat accumulation despite increased food intake being frequently 
observed. This gap in knowledge is aimed to be elucidated in the present thesis. 
 
1.3.2. Stress and neuroendocrine regulators of feeding 
Peptides such as ghrelin, a gastric hormone involved in meal initiation, and 
leptin, a long-term adiposity signal and also involved in meal termination, have been 
proposed to have a role in stress.  
 
1.3.2.1. Stress and ghrelin 
 It has been proposed the peptide hormone ghrelin has a role in stress responses, 
nevertheless, it is still unknown whether ghrelin has a protective effect against stress-
related symptoms, or, on the contrary, induces anxiogenic- and depressive-related 
symptoms. Ghrelin receptors are found within the PVN, although not co-localised with 
CRH producing neurons (Zigman et al., 2006; Cabral et al., 2012, 2016). When 
administered into the PVN, Wauson et al. (2015) reported that ghrelin exerted an 
anxiogenic effect in rats, attenuated if rats were allowed to eat immediately afterwards. 
A small number of studies reported the effects of different stress models on ghrelin 
levels in the course of the development of stress-related symptoms. Studies observed 
that ghrelin levels rose concurrently with ACTH levels following acute psychological 
stress in rats (Kristenssson et al., 2006). Furthermore, using a rodent model of post-
traumatic stress disorder (PTSD), the stress-related increase in plasma ghrelin was 
necessary to increase Pavlovian fear learning in rats (Meyer et al., 2014). Interestingly, 
by systemically administrating ghrelin receptor agonist, Meyer et al. (2014) showed 
that the increase in fear conditioning was independent of an increase in CRH or 




corticosterone (i.e. HPA activity); moreover, administration of ghrelin receptor 
antagonist prevented the fear learning increase caused by stress without affecting 
stress-related plasma corticosterone. Conversely, other studies suggested the role of 
HPA axis on ghrelin-induced stress-related symptoms. Peripheral administration of 
ghrelin increased Crh mRNA expression (Asakawa et al., 2001). Furthermore, intra-
third-cerebroventricular and intraperitoneal (i.p.) administration of ghrelin increased 
anxiogenic behaviour in the elevated plus maze test in mice. Subsequent 
administration of CRH receptor antagonist was able to attenuate the ghrelin-induced 
anxiogenic effects (Asakawa et al., 2001).  
In contrast to the studies above that describe the role of ghrelin in the 
development of stress-related symptoms, other studies reported an opposite role. Using 
a mouse model of acute restraint stress, Spencer et al. (2012) demonstrated that ghrelin 
receptor knockout (GHS-R KO) mice were more anxious compared to wild-type (WT) 
mice, and exhibited decreased corticosterone response. Contrary to the findings of 
Meyer et al. (2014), this study demonstrated that ghrelin reduced symptoms of anxiety 
(e.g. increased time spent in open arms in the elevated plus maze test) by stimulating 
HPA axis. Moreover, Lutter et al. (2008) showed that subcutaneous injection of ghrelin 
had antidepressant-like effects in mice exposed to social defeat stress (e.g. latency to 
immobility in the forced swim test). Lutter et al. (2008) further showed that 
antidepressant-like effects promoted by ghrelin were not present in mice lacking GHS-
R. 
 
1.3.2.2. Stress and leptin 
Stress has been shown to have a regulatory effect on leptin, and studies have 
been conducted to elucidate the role of leptin in stress-related metabolic disorders 




(Lutter and Elmquist, 2009; Chuang et al., 2010b). The adipokine leptin is thought to 
contribute to stress-related effects on energy metabolism through modulation of 
neuronal populations mostly within hypothalamic nuclei (for review, see Haleem, 
2014). In rats, i.c.v. injection of leptin increased PVN Crh mRNA expression 
(Schwartz et al., 1996). Nonetheless, in mice, i.p. injection of leptin inhibited CRH 
release (Heiman et al., 1997). A more recent study reported that i.v. leptin infusion 
was able to normalise plasma levels of corticosterone in streptozotocin-diabetes 
mellitus rats (Morton et al., 2015). In line with this, following chronic unpredictable 
mild stress (CUMS), a rodent model of depression, rats displayed decreased serum 
leptin and Lepr mRNA expression in the hypothalamus; and Lepr mRNA expression 
was inversely correlated to serum corticosterone (Ge et al., 2013). Interestingly, 
women who had great adiposity and high plasma leptin levels when subjected to acute 
stress had high cardiovascular and inflammatory responsiveness to stress (Brydon, 
2011).  
 As mentioned, stress is a major risk factor for depression and associated 
changes in appetite; leptin has also been associated with depressive states. Following 
chronic unpredictable stress (CUS), a rodent model of stress-induced anhedonia, Lu et 
al. (2006) also observed a reduction in leptin levels in rats; administration of leptin 
was able to reverse sucrose preference impairment promoted by CUS. Furthermore, 
following forced swim test, a rodent antidepressant screening test, administration of 
leptin into the hippocampus had antidepressant-like effects (Lu et al., 2006). 
Conversely, water-immersion restraint stress increased leptin levels in serum and 
adipose tissue (Konishi et al., 2006).  
In humans, early-life stress, frequently accompanied by the development of 
depressive behaviour later in life, has been associated with increased plasma leptin 




(Joung et al., 2014). Leptin has also been negatively associated with depression; 
patients with major depressive disorders were reported with low levels of leptin, 
potentially correlated with the pathogenesis of depression-linked obesity (Jow et al., 
2006). Interestingly, leptin may be associated with depressive symptoms 
independently of body weight. Lawson et al. (2012) applied rating scales for mood 
disorders in order to establish the level of depression and anxiety of a patient, 
correlating that with leptin levels. Particularly in women, levels of leptin were 
inversely associated with Hamilton Rating Scales for Depression (HAM-D) and 
Anxiety (HAM-A), as well as with Perceived Stress scores, persisting significant after 
controlling for body weight or body fat (Lawson et al., 2012). A positive association 
between plasma leptin and DA release was also observed following stress pain 
challenge (Burghardt et al., 2012). Modulation of DA has an important role in the 
development of mood and eating disorders (Nestler and Carlezon, 2006; Johnson and 
Kenny, 2010). 
Both ghrelin and leptin exert their effects on feeding through homeostatic and 
motivation/behaviour pathways. Ghrelin and its receptor GHS-R, similarly to leptin 
and its receptor Lepr, have been widely associated with the hypothalamic regulation 
of energy homeostasis, in both humans and rodents (Cummings et al., 2001; Nakazato 
et al., 2001; Klok et al., 2007). Nevertheless, the role of stress in the regulation of 
ghrelin and leptin and receptors is not fully understood. The present thesis aims to 
address this gap in knowledge. 
 
1.3.2.3. Stress and insulin 
Stress has been shown to alter insulin levels and glucose homeostasis; stress-
induced increase in GC enhances hepatic gluconeogenesis and increases insulin 




secretion (Dallman, 2010). Increased risk of type 2 diabetes is widely associated with 
stress-related human depression (for review, see Knol et al., 2006). For instance, use 
of antidepressant was associated with risk of diabetes (Rubin et al., 2010). Moreover, 
depression in diabetic patients was shown to worsen treatment outcomes and diabetes 
prognosis due to increased non-adherence to medical treatment (Goenzalz et al., 2008). 
Interestingly, the association between depression and impaired glucose homeostasis 
appears to be bidirectional (Mezuk et al., 2008; Bădescu et al., 2016). For instance, in 
limbic structures where insulin receptors are highly expressed (Hill et al., 1986), 
insulin resistance might cause neuronal damage and play a role in neuropsychiatric 
conditions such as depression (Cetinkalp et al., 2014; Kleinridders et al., 2015). 
Furthermore, it has been argued that rather than being the cause or consequence, both 
diabetes and depression are in fact symptoms of the same disease, namely metabolic 
syndrome (Anderson et al., 2001). 
As previously mentioned, under conditions of perceived stress, 40% of people 
increase their caloric intake while 40% decrease their caloric intake (Oliver and 
Wardle, 1999). Those who are overweight appear to be more inclined to increase food 
intake and body weight under stressful periods, and the difference between 
anorexigenic or orexigenic effect during stressful periods may be due to peripheral 
insulin concentrations/functioning (Dallman, 2010). In humans, high BMI is 
associated with increased incidence of insulin resistance (Tatsumi et al., 2015) thus 
increased impaired insulin-induced glucose uptake (Ye, 2013) and, may as a 
consequence, also increase feeding behaviour. The role of stress in the modulation of 
glucose homeostasis by insulin and its implication in stress-related changes in feeding 
behaviour and body weight is not fully understood. The present thesis aims to address 
this gap in knowledge. 




1.3.3. Stress and the serotonergic system 
The monoamine theory of depression, which assumes a reduction in the 
biological activity of brain monoamines such as 5-HT and noradrenaline, facilitated 
the development of SSRI anti-depressant drugs. SSRI drugs are mediated via SERT 
and are meant to correct putatively low levels of 5-HT in depression (Rosenblatt et al., 
1960; Schildkraut, 1965). Such a simplistic theory attracted criticism over the years; 
e.g. not all patients with depression treated with SSRI had their symptoms reversed 
(Bagby et al., 1997). Moreover, antidepressant effects were normally seen after 2 to 4 
weeks of continuous treatment, which created a discrepancy between the immediate 
blockage of 5-HT reuptake and increase in synaptic 5-HT, and clinical improvement 
(Blier, 2001).  
Currently, it is generally accepted that genetic, environmental and biological 
factors are implicated in depression. Although the monoamine theory of depression 
did not gain a long-lasting recognition, the serotonergic system remains at the core of 
recent neuroscience advances in the pathophysiology of depression (Fujita et al., 2017; 
James et al., 2017; Xu et al., 2018), and SSRIs are still widely used as antidepressants. 
For a review of the hypotheses that were proposed to explain the pathophysiology of 
depression, see Yohn et al. (2017). 
Acute and chronic stress have different consequences for the serotonergic 
system. Studies about the effects of CRH on neuronal circuits showed that CRH 
afferent fibres to the DRN have contact with dendrites of both serotonergic neurons 
and GABAergic neurons (Homberg and Contet, 2009; Valentino et al., 2010). Acute 
stress was shown to activate preferably CRH1 receptors, increased the tonic inhibition 
of serotonergic neurons by GABAergic afferent and promoted the appearance of active 
coping strategy (swimming). Conversely, chronic stress (i.e. higher levels of CRH) 




activated CRH2 receptors preferably and stimulated the internalisation of CRH1 
receptors, increasing 5-HT release and promoting the appearance of passive coping 
strategies (floating, freezing) (Homberg and Contet, 2009). 
The effects of stress on 5-HT and 5-HT receptors have been extensively studied 
for the potential involvement in the states of anxiety and depression. However, the 
particular effect of chronic social stress on the serotonergic system is poorly explained 
so far, and some questions remain to be answered. Via 5-HT receptor signalling, 5-HT 
is involved in the regulation of food intake (Voigt and Fink, 2015), and in the aetiology 
of depression (Risch et al., 2009) and anxiety (Lesch et al., 1996). Chronic 
psychosocial stress, an etiological risk factor for depression, causes several different 
alterations in the serotonergic system, with consequences for emotion, appetite, body 
temperature, higher cognitive functions such as memory consolidation, muscle 
contraction and many others (Pryce and Fuchs, 2017). Although 5-HT cell bodies are 
restricted to the discrete regions of the RN, their axonal projections innervate nearly 
every area of the mammalian brain, consequently being able to exert such wide variety 
of responses. The role of the stress in the modulation of the serotonergic system and 
its implication on feeding behaviour is not fully understood. The present thesis aims 
to address this gap in knowledge. 
 
 




1.4. General hypotheses and aims 
 
Animal experimental studies of stress have proved a valuable tool in 
elucidating how stress affects the brain and body (Patchev and Patchev, 2006), and 
have helped to understand how a physiological system can be driven to develop stress-
related pathologies. Both behavioural and metabolic effects of stress have been 
observed in rodent models (Weiss et al., 2004; Pryce et al., 2005; Azzinnari et al., 
2014), and comprehending the causal effects of environmental manipulations relevant 
to human endocrine and psycho-pathologies has the potential to further explain the 
relationship between stress, feeding and metabolism. 
The overall aim of this thesis is to investigate the effects of chronic social stress 
on food intake and energy metabolism, as well as some of the main neural and 
hormonal regulatory systems underlying these fundamental physiological processes, 
in mice. In humans, chronic stress is a major risk factor for depression and related 
psychiatric disorders, in which changes in appetite and body weight are often a major 
symptom or co-occurring feature. Despite the importance of these associations, the 
causal pathways underlying them are complex and currently poorly understood, and 
animal studies are essential to increase the understanding.  
In an established mouse model of chronic social stress, it was shown that stress 
led to increased feeding in the absence of change in body weight (Bergamini et al., 
2016). The causal factors underlying the increase in food consumption and the 
dissociation between feeding and body weight are not well-defined. The present thesis 
aims to investigate some candidate mechanisms underlying these altered states. The 




candidate mechanisms of interest are changes in EE, BAT activity, peripheral and 
central appetite hormone signalling, and peripheral glucose metabolism. 
It is hypothesised that chronic social stress increases signalling of appetite-
enhancing hormones as well as decreases signalling of appetite-suppressing hormones, 
leading to an increase in feeding behaviour. It is hypothesised that stressed animals 
have increased EE and adaptive thermogenesis and that this is associated with the 
previously observed lack of body weight gain. Given that increased food intake can be 
attributed to stress-induced changes in the processing of the reward valuation of food 
in addition to homeostatic appetite control, and given that 5-HT is a modulator of 
homeostatic appetite control, reward processing and stress-related pathologies such as 
depression, it is hypothesised that chronic social stress will affect the binding and 














CHAPTER 2  
 
 


















2.1. Theoretical background 
 
2.1.1. Animal models for translational research into human pathophysiology  
Animal modelling for the translational study of human disease has been proven 
to be a valuable tool in the process of characterisation of pathophysiology (Denayer et 
al., 2014; Vandamme, 2014). In providing a level of environmental and genetic 
manipulation that is not achievable in humans, animal experimental studies have 
become essential for the understanding of the biological basis of several different 
human disorders, including neuropsychiatric illnesses (Snyder et al., 2011; Chesselet 
and Carmichael, 2012). Although it is not possible to fully comprehend human 
physiology by means of laboratory animal research, homology/analogy between 
animal and human are sufficient for translational research; this combined with the 
availability of molecular research tools render the mouse as the foremost mammalian 
model for human health and disease studies (Nguyen and Xu, 2008). 
In Great Britain, according to Home Office figures, in the year of 2016, 72.8% 
of total laboratory procedures involving animals were developed using mouse (Mus 
musculus), with the remaining 27.2% distributed among zebrafish (Danio rerio, 
11.1%), rat (Rattus novergicus, 6.3%), domestic fowl (Galilus domesticus, 3.6%), 
guinea-pig (Cavia porcellus, 0.7%) and others (5.5%) (UK Home Office, 2017). 
Genetic manipulation techniques have developed immensely in the last few decades 
and have allowed geneticists to create a great variability of disease models to be used 
in the research field (Vandamme, 2014), of great importance to scientific progress.  
 




2.1.2. Animal welfare 
According to the Animal Welfare Act of 16 December 2005, Article 3, Section 
C (Appendix 1), an animal experiment is used with the aim of:  
1) testing a scientific assumption 
2) observing the effect of a particular measure in the animal;  
3) testing a substance;  
4) obtaining or testing cells, organs or bodily fluids, except when this is in the context 
of agricultural production, diagnostic or curative operations on the animal or for 
determining the health status of animal populations;  
5) teaching or training. 
  (Swiss Confederation, 2011) 
An experiment that does not meet the above criteria should not be continued.  
 
2.1.3. The principle of 3Rs for animal experimentation ethics 
For the purpose of protecting the dignity and welfare of animals, a Swiss 
Federation Act that prescribes rules of conduct in dealing with and handling animals 
(Appendix 1 – Animal Welfare Act) was established. As part of the national and 
international legislation which regulates animal laboratory experimentation, the 
principle of 3Rs (Replacement, Refinement and Reduction, described below), 
developed in 1959 by Willian Russel and Rex Burch (Russell and Burch, 1959, cited 
by Flecknell, 2002), is taken as synonym of high quality science research; a unifying 
concept and opportunity for achievement of scientific, economic and humanitarian 
benefits (NC3Rs, 2017).   
Replacement – of the use of animals for other methods, such as computer 
models etc, states that animal models for research should be replaced with non-animal 




alternatives whenever possible. Of the 3Rs, although it happens in infrequent 
circumstances, Replacement is the most frequently contemplated, not only 
replacement for in vitro models, but for which animal. In that sense, one of the great 
challenges of animal research still remains in the identification and selection of which 
animal model is the most appropriate for the respective study, hence database searches 
and consultation of literature is exceptionally required for consideration of alternatives 
(Wood and Hart, 2007). 
Refinement – of methodological procedures, which aims at minimising 
unnecessary harm to the animal and improving its welfare, being applied to all aspects 
of experiments, from husbandry until the final sampling acquisition.  
Reduction – of the number of animals used per experiment, either by obtaining 
the same results using less animals or by obtaining more information about the same 
number of animals. Research should employ the minimum suitable sample size, 
calculated using power analysis associated with statistical inferences based on the p-
value and also effect sizes accompanied by confidence intervals (Sneddon et al., 2017). 
The principle of 3Rs establishes the accepted standards for humane 
experimentation on animals, which shall be applied to every aspect of animal 
experimentation for achievement of excellence and distinction in any laboratorial 
research. 
 
2.1.4. Validity criteria of animal models 
Validity criteria have become highly relevant for assessment of animal models 
used in research (Bakshi and Kalin, 2002; Belzung and Lemoine, 2011). Elaborated 
by Willner in 1984, the multidimensional approach of evaluating a model in respect of 
its constructive, face and predictive validity were firstly proposed in relation to animal 




models of depression. The criterion of construct validity sets the theoretical rationale 
behind the model. The criterion of face validity corresponds to observable behaviour 
and biological outcome of a model, looking for similarities between the animal model 
and the condition being modelled. Lastly, the criterion of predictive validity 
contemplates the ability of the animal model to identify therapeutic treatments for the 
disease and, in the case of depression, refers to selective responsiveness to 
antidepressants (Willner, 1984). These criteria have been recently revised and three 
further validity criteria have been added: homological validity, for choice of adequate 
species and strains; pathogenic validity, which takes into consideration the 
manipulation of the organism during developmental and adulthood periods for 
acquisition of pathological characteristics; and mechanistic validity, which identifies 
similarities of cognitive and biological mechanisms in both humans and animals 
(Belzung and Lemoine, 2011). 
In addition to validity criteria, the endophenotype methodology, based on the 
modelling of discrete symptoms rather than the absolute illness, has contributed to the 
advancement in development of animal models for research. The endophenotype 
methodology is based on the study of a set of behavioural and physiological features 
of a basic process that are manifested in a disorder (Bakshi and Kalin, 2002). Such 
methodology has allowed the development of animal models with construct and 
predictive validity.  
 
2.1.5. Animal models of stress 
Experimental animal models of stress are used for the study of behavioural and 
biological reactions to the different forms of environmental threats, exploiting assorted 
circumstances within the laboratory boundaries. Various experimental models have 




been formulated in order to study the associations between stress and its effects on the 
brain and body, by creating sophisticated methods for measuring the many 
components of stress (Lester et al., 1994; Torres and Nowson, 2007).  
For experimental animals, depending on the stressor, a wide variety of 
responses can be generated. The monitoring of these stress responses is based on 
behavioural, physiological, metabolic, neurochemical, endocrine and immunological 
end points promoted by those models. Stress manipulations currently used include 
electric footshock, restraint, tail suspension, or forced swim test, that bear little 
resemblance to the challenges that animals commonly face in a natural environment. 
These stressors are solely physical and offer little validity compared to psychosocial 
stressors of relevance to humans (Tamashiro et al., 2005). Stress paradigms that evolve 
around the establishment of social hierarchy among individuals of a colony/society, 
on the other hand, will evoke behavioural and physiological responses of greater 
similarity to a more naturalistic ecosystem. Comprehending the causal effects of 
environmental manipulations relevant to human pathologies has the potential to help 
us gain a better understanding of the relationship between stress and stress-related 
pathological behaviours. 
 
2.1.5.1. Social stress paradigms – mood and anxiety disorders 
Social stress can be defined as social interactions that threatens an individual’s 
well-being (Lazarus and Folkman, 1984, cited by Schneiderman et al., 2008). It can 
emerge in a number of different circumstances, and since many animal species, 
including humans, spend most of their time interacting with conspecifics (Koolhaas et 
al., 2017) and developing social hierarchies (Ely and Henry, 1978), such conditions 
are recurrent. Among the commonly used animal models of stress, the model of 




psychosocial stress is considered to be one of the most severe stressors in terms of 
neuroendocrine stimulation (Koolhaas et al., 1997); numerous neuropeptide-secreting 
systems are activated by the brain, such as the HPA and the SNS systems (de Kloet et 
al., 2005). 
In humans, stress is the most common risk factor for the development of 
associated numerous psychiatric disorders, such as mood and anxiety disorders (APA, 
2013). With regards to depressive psychopathologies, some models of stress have been 
developed based on the variation of both physical and social environment, such as the 
chronic unpredictable mild stress (CUMS), whilst others are based on the variation of 
the social environment specifically (Razzoli et al., 2014). In the case of CUMS, the 
most widely-used stressor, several physical and social stressors are presented on an 
unpredictable schedule (Willner, 2017). Among the models based on psychosocial 
stressors only, the majority are dyadic-based (e.g. resident-intruder paradigms) and 
result in classification of subjects into dominant or submissive, according to social 
status, and winner or loser, according to the encounter outcome (Koolhaas et al., 2013; 
Razzoli et al., 2014). 
In mice and other rodents, studies based on social stress are often gender-
specific. Aggressive behaviour towards conspecifics and dominance hierarchy in 
dyadic encounters are more visually present in males due to their territorial 
characteristics (Palanza et al., 1993, 2001). Whenever grouped together, they can 
trigger a series of varied behaviours (Blanchard et al., 2001). In contrast, female 
rodents develop very low or no aggression when grouped together with other females, 
and only express detectable social hierarchy when reproductively active (Palanza et 
al., 1993) or during maternal care (i.e. lactation) (Vom Saal et al., 1995). Nevertheless, 
behavioural findings show differential effects of isolation and grouping in both female 




and male rodents (Palanza et al., 2001), with female rats showing higher levels of 
corticosterone when individually-housed than when group-housed (Brown and 
Grunberg, 1995). Clear differentiation between social paradigms is therefore essential. 
 




2.2. The model 
 
2.2.1. Chronic social defeat stress 
2.2.1.1. Rationale 
Chronic social defeat stress, CSDS or simply CSS1 (acronyms varying 
according to duration of stress protocol), is a well-established experimental mouse 
model of prolonged psychosocial stress that involves persistent exposure to social 
stress and results in behavioural and neurobiological changes analogous to those that 
are seen in human stress-related neuropsychiatric disorders, such as reduced social 
interaction and altered expression of genes in pathways of inflammation in the brain 
(Pryce and Seifritz, 2011; Azzinnari et al., 2014; Pryce et al., 2014; Bergamini et al., 
2016). Protecting territory against invaders is a predictable behaviour of animal nature 
and this resident-intruder paradigm of male rodents has been broadly used on stress-
related research as a tool for the better understanding of biological mechanisms and 
pathways of stress-related psychopathologies (Koolhaas et al., 2013; Wei et al., 2014). 
Chronic social stress in combination with relevant readouts can constitute an 
animal model of anxiety/depression. It has been proposed to be distinguished from 
other environmental stressors by its ability to repeatedly activate the HPA axis over 
repeated social confrontations (Golden et al., 2011) and to promote changes in markers 
of anhedonic-like behaviours (e.g. deficit in evaluation of reward as seen by limited 
sucrose-seeking behaviour) (Riga et al., 2015). Moreover, it is also characterised by 
development of adaptive behaviours such as social avoidance that can only be reversed 
                                                 
 
1 CSS applies specifically to the chronic social stress protocol that I applied in my Thesis. 




by chronic antidepressant treatments (Kudryavtseva et al., 1991; Berton et al., 2006; 
Tsankova et al., 2006). 
Chronic social defeat in mice was first described in 1991 by Kudryavtseva and 
colleagues, in which a series of behavioural outcomes, somatic symptoms and effects 
of chronic antidepressant (imipramine) treatment were examined following 20 
consecutive days of social defeat and otherwise permanent sensory contact. 
Development of pathological forms of behaviour similar to depressive state was 
observed in this model, in parallel with development of somatic symptoms (e.g. weight 
loss) coincident with human depression (Kudryavtseva et al., 1991). Although one of 
the first papers published on social defeat stress model in mice was in 1991, social 
conflicts in mice have already been described since 1984. 
A modified paradigm was established by Berton et al. (2006) with an 
abbreviated duration of stress exposure but still with continuous and unavoidable 
psychological stress from 24h of sensory interaction through a perforated divider in a 
shared home cage. In 2011, the standardized protocol was presented in details by 
Golden et al. (2011). The present study is based on a further development of the 
paradigm introduced by Kudryavtseva et al. (1991) (discussed subsequently).  
 
2.2.1.2. Mouse strain 
Regarding mouse strains, C57BL/6 (BL/6) is the most widely used inbred 
strain in social defeat models (Golden et al., 2011; Huang et al., 2013; Iñiguez et al., 
2014, 2016), as well as several others research areas such as developmental biology, 
diabetes and obesity, genetics and immunology. BL/6 was the inbred strain of choice 
for this study, along with outbred CD-1 as the aggressive dominant mice.  
 




2.2.1.3. Housing conditions 
Prior to CSS manipulation, CSS and control (CON) mice were caged in brother 
pairs in standard in-house conditions (20-22°C temperature, 50-60% humidity). Mice 
were provided with tissue bedding and an igloo in the home cage as a retreat and for 
sleeping. Food and water were provided ad libitum, unless required otherwise (i.e. 
glucose tolerance test). Environmental conditions were controlled throughout. 
During the CSS manipulation, CON mice remained in littermate pairs unless 
single caging was absolutely necessary for experimental purposes (i.e. Experiments B 
and C, as described elsewhere) and CSS mice were housed with CD-1 mice in a rota 
system. 
 
2.2.1.4. Prior to CSS manipulation 
A. 5 days prior to day 1 of CSS, BL/6 mice were handled daily for five minutes 
for familiarisation and acclimatisation of animals. Animal handling was carried 
out by taking the entire mouse in the hands and not by picking it up by the tail, 
aiming at reducing/avoiding any non-experimental stress. 
B. Body weight was measured daily for baseline data and for allocation of mice 
to CSS or CON groups, by counterbalancing on this measure. 
C. Motor activity (MA) test was also carried out prior to CSS manipulation for 
allocation of mice to CSS or CON groups. 
D. CD-1 screening was conducted for identification of those that were aggressive, 
with latency to attack < 60s and total duration of attacks > 15s in 5 minutes. 
E. Prior to day 1 of CSS manipulation, the CD-1 mice which were demonstrated 
to be aggressive (Golden et al., 2011) were placed in one compartment of a 
cage (1284L Eurostandard Type II L, Indulab, Gams, Switzerland), containing 




a longitudinal divider made from transparent Plexiglas and perforated with 
multiple holes for sensory interactions. Care was taken to ensure the divider 
was firmly secure in order to prevent mice from escaping their overnight 
compartments. 
 
2.2.1.5. CSS manipulation 
The CSS manipulation used in the present study was adapted from that of 
Golden et al. (2011) (Azzinnari et al., 2014). This standard protocol for CSS was 
conducted by caging together a 10-12 weeks-old BL/6 mouse with a more aggressive 
mouse (CD-1) for a period of 15 consecutive days for a maximum 10 minutes per day 
or until a cumulative total of 60s of physical attack had occurred, subjecting therefore 
BL/6 mice to repeated bouts of social subordination (Figure 2.1). Social stress sessions 
were conducted under reversed light-dark cycle (07:00-19:00 h lights OFF), between 
12:00-15:00 h. 
On day 1, each CSS BL/6 mouse was taken out from its home cage, weighed 
and placed individually in the compartment of a CD-1 mouse. Physical attacks were 
observed and timed throughout. Mice remained together for the period of 10 minutes 
or until physical attacks summed up to 60s. Moreover, it was also scored for each stress 
session whether or not the CSS mouse fought back when attacked by the CD-1 mouse 
and whether or not the CD-1 mouse attacked CSS mouse. Frequency of behaviours 
per session was not scored, simply its presence or absence. Following the stress 
session, the CSS mouse was checked for bite wounds with a tissue paper and returned 
to the compartment where defeat occurred, whilst the CD-1 mouse was transferred to 
the other compartment, allowing continuous olfactory, visual and auditory contact 




during the following 24 h. Resident-intruder pairs with behavioural observation and 
timing of attack durations were conducted with two cages at a time.  
On day 2, a rotation of mice pairings was conducted, so that each CSS mouse 
was confronted with a novel CD-1 mouse and vice versa. This rotation was conducted 
throughout the 15 days of CSS manipulation. Control mice, as stated previously, 
remained in littermate pairs (separated by a divider or not), and were handled and 
weighed daily.  
 
 
Figure 2.1. Mouse chronic social stress (CSS) mouse paradigm. BL/6 mouse is placed in the 
opposite compartment, where aggressor CD-1 is located, for 15 consecutive days (maximum 
10 minutes per day or until a cumulative total of 60s of physical attack had occurred). 
 
2.2.1.6. Protocol refinements 
 In the absence of any observation of the defeat period, there could be several 
minutes of biting, appearance of open bite wounds and eventually indispensable 
removal of animals from experiment, as reported to be common in the standard chronic 
social stress protocol (Golden et al., 2011). These factors somewhat impact on its 
aetiological validity as an emotional psychosocial stressor. Therefore, the protocol 
used in this study aimed to eliminate stress not of a psychosocial or emotional nature, 
including reducing physical injury to an absolute minimum (Azzinnari et al., 2014). 
 




Refinements are described below: 
A. Continuous observation of BL/6 and CD-1 throughout timing of defeat 
(10min/day). It allowed a more in-depth behaviour analysis when in face of the 
defeat; 
B. Timing of attack periods. Mice were immediately separated when the cumulative 
time of attack reached 60s. In this case, attack was defined as chasing, boxing and 
biting; 
C. Trimming of lower CD-1 mice incisors, which grew continuously, to markedly 
reduce surface wounds and completely eliminate deep bite wounds. Every 3 days, 
under brief 3% isoflurane anaesthesia, the lower incisors of CD-1 mice were 
trimmed using rodent tooth-cutting forceps (Precision Surgical International, 
USA) to remove the sharp edges. Food pellets were cut in pieces and provided to 
CD-1 mice so that the teeth blunting did not inhibit their feeding, thus avoiding 
significant weight loss. 
 
Discontinuation of an experiment was established based on the following criteria:  
A. Bite wound in chronic social defeat; 










2.3. Methodological framework 
 
Experiment A (CON=12, CSS=12) investigated the effects of 15-day CSS on 
body weight, glucose tolerance, as well as motor activity test. Physiological valuations 
were also assessed. Experiment B (CON=8, CSS=10) investigated the effects of 15-
day CSS on food intake, body weight and it also aimed at investigating the effects of 
CSS on indirect calorimetry. Physiological valuations were likewise assessed. 
However, due to methodological errors (i.e. inappropriate system calibration), 
metabolic studies in the calorimetry system had to be repeated. Therefore, Experiment 
C (CON=12, CSS=12) also investigated the effects of 15-day CSS on indirect 
calorimetry, in addition to body weight and food intake. Behavioural and physiological 
assessments were also conducted. Physiological samples collected were: plasma, 
interscapular brown adipose tissue (iBAT), epididimal white adipose tissue (eWAT), 
brain, stomach, and pancreas. Experimental designs are summarized in Figure 2.2 



















Figure 2.2. Experimental designs. Three cohorts of mice were exposed to chronic social stress 
(CSS) or control handling (CON) on days 1-15 and studied in three different experiments. 
Mice were handled and a motor activity test (MA) was conducted prior to experiments for 
balanced allocation of mice to CSS or CON groups. Body weight (Experiment A, B and C) 
and food intake (Experiment B and C) were monitored daily. Experiment A: Motor activity 
test was conducted on days 1, 7 and 15. A glucose tolerance test (GTT) was conducted on day 
10 following 14h fasting. Mice were sacrificed and physiological samples (S) were collected 
on day 17. Experiment B: Mice were placed in metabolic cages (MC) for calorimetric data 
collection on day -4 for 5 days for baseline data and on days 16-20 for post-CSS data 
collection. Mice were sacrificed, and physiological samples were collected on day 21. 
Experiment C: Mice were placed in metabolic cages for calorimetric data collection on day -
4 for 5 days for baseline data and on days 16-20 for post-CSS data collection. Behaviours (B) 
were scored on each of CSS/CON days 4, 8 and 12. Mice were sacrificed and physiological 
samples were collected on day 21. Abbreviations: eWAT, epididymal white adipose tissue; 
iBAT, interscapular brown adipose tissue. 




2.4. Research considerations 
 
2.4.1. Animal training 
Animal training was completed (Introductory Course in Laboratory Animal 
Science – LTK Module 1 and Anatomy and Necropsy – Module 7E) according to the 
requirements of the Federation of Swiss Cantonal Veterinary Officers at Vetsuisse-
Faculty, University of Zurich. 
 
2.4.2. Health and safety 
The majority of the risks to this project were related to laboratory procedures. 
For that purpose, detailed risk assessment forms for each experimental procedure were 
filled out to ensure fully understanding and management of the risks. The in vivo work 
carried out in Zurich presented some risks associated with animal handling. To ensure 
a safe working environment, personal protective equipment was used when 
appropriate, both at the University of Zurich and University of Roehampton. 
 
2.4.3 Transport of samples 
Import of non-infectious murine laboratory research samples from Switzerland 
to United Kingdom did not require any permit. Samples were sent via Dangerous 
Goods International (DGI) courier, authorised to transport and comply with packaging 
and health and safety regulations (Federal Express, FE) from Zurich to London, under 
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3.1.1. Stress and feeding behaviour 
Energy metabolism is essential for the maintenance of cell and organ 
functioning and individual survival. An organism’s energy needs are subject to 
environmental factors, including social stress, which is known to affect body energy 
metabolism and more specifically feeding behaviour, body weight and EE. Previous 
studies on the effects of chronic social stress on feeding and EE have been conducted. 
Interestingly, the effects of stress on feeding behaviour appear to be different between 
mice and rats. Most of the studies performed in rats report decreases in food intake 
and body weight gain (Meerlo et al., 1996; Haller et al., 1999; Becker et al., 2008; 
Razzoli et al., 2009; Iio et al., 2012, 2014; Olivares et al., 2012; Ahnaou and 
Drinkenburg, 2016; Liu et al., 2017). In mice, the effects of stress on feeding behaviour 
are less consistent. Several studies report increased feeding without effects on body 
weight (Moles et al., 2006; Lutter et al., 2008; Sanghez et al., 2013; Bergamini et al., 
2016), but increased feeding concomitant with increased body weight gain was also 
frequently observed (Chuang, et al., 2010a,b; Razzoli et al., 2010; Razzoli et al., 
2011a,b; Patterson et al., 2013; Goto et al., 2014). The stress protocols associated with 
a HFD appears to play an essential role in determining body weight gain and fat 
content of mice under stressful circumstances. Chuang et al. (2010a) observed that 
control mice given HFD had higher body weight gain and more body fat than mice 
given a standard diet, as anticipated. Interestingly, stressed mice given HFD had 
significantly less body fat compared to control mice on HFD diet. Similarly, Balsevich 




et al. (2014) reported significantly decreased body weight and body fat in stressed mice 
on HFD diet than control on HFD.  
In mouse models of social stress similar to the one studied in this thesis, studies 
have observed increased calorie intake and increased body weight gain in stressed 
mice (Patterson et al., 2013). In the chronic social stress model (from Pryce laboratory) 
used in this thesis, increased calorie intake in the absence of an effect on body weight 
was observed (Bergamini et al., 2016). This is in agreement with several other studies 
previously mentioned. 
 
3.1.2. Stress and energy expenditure 
 There is limited understanding of the neurobiological mechanisms that 
underpin the relationship between stress and energy balance. The reason for the 
absence of an effect on body weight despite an increase in calorie intake seen in this 
stress model is yet to be determined. A potential explanation could be due to changes 
in energy metabolism, more specifically, increased EE induced by chronic social 
stress. 
 Although present, studies on the effects of stress on EE using indirect 
calorimetry are scarce. Moles et al. (2006) reported increased food intake in stressed 
mice compared to the control mice, and higher body weight in subordinate mice 
compared with dominant mice. Increased EE was only observed in dominant mice, 
confirming the lack of body weight gain (Moles et al., 2006). Sanghez et al. (2013) 
observed increased feeding behaviour and similar body weight gain in subordinate 
mice compared to control mice, and a combination of increased feeding behaviour, 
decreased body weight gain and increased EE in dominant mice. More recently, 
Coccurello et al. (2017) reported decreased calorie intake and body weight at the end 




of the stress period compared to the beginning of the stress period in stressed mice fed 
a standard diet; control mice maintained calorie intake and body weight over time. 
Compared to control mice, stressed mice had increased EE and respiratory quotient 
(i.e. increased usage of carbohydrate as energy fuel). Decreased body weight despite 
increased calorie intake over time was observed in stressed mice fed a high palatable 
diet compared to control mice, in combination with increased EE but decreased 
respiratory quotient (Coccurello et al., 2017). The increase in EE observed in the 
studies mentioned above indicates that stress leads to an increase in energy demand in 
comparison to control animals. Respiratory quotients appear to change according to 
dietary fat content, as observed by Coccurello et al. (2017). Further calorimetry studies 
are necessary to obtain a clear understanding of the energetic demands of a system 
under stressful conditions.  
 As previously mentioned, EE is also determined by BAT activity and its 
thermogenic uncoupling protein 1 (Ucp-1) located in the BAT. Since the discovery of 
Ucp-1 in adult humans in 2009 (Cypess et al., 2009), it has received considerable 
attention as a potential target to treat obesity, given its ability to increase EE when 
activated. Under physiological conditions of low adaptive thermogenesis, it was 
reported that chronic social stress stimulated BAT activation and thermogenesis in 
mice, associated with increased resistance to diet-induced obesity despite the existence 
of hyperphagia (Razzoli et al., 2016). Stress responding in terms of activation of the 
SNS and acute increase in glucocorticoids levels were shown to suppress both Ucp-1 
and respiration in rodents but to enhance Ucp-1 in humans (Ramage et al., 2016). In 
contrast, chronic increase in glucocorticoid levels were shown to suppress BAT 
activity and result in obesity (Ramage et al., 2016; Leitner et al., 2017). 
  




 Measuring body weight and food intake changes in this study was the first stage 
for a better understanding of the metabolic effects of CSS. Feeding efficiency was 
calculated as the ratio of body weight to energy intake. Assessment of EE through 
indirect calorimetry and evaluation of BAT thermogenesis was followed. Calorimetric 
techniques for assessment of EE and fuel selection are described below.  
 As previously mentioned, TEE could also be increased by physical activity; 
this could have been measured through beam breaks in the same indirect calorimetry 
system. Nevertheless, since the calorimetry system we used could not do such analysis, 
measurements of activity were performed in the home cage. 
 
3.1.2.1. Calorimetry 
 Calorimetry is the discipline in which the energy of a system (i.e. organism) in 
terms of the heat exchange of this system with its surroundings is measured. 
Assessment of energy demands using calorimetry originates back to the research of 
Lavoisier and Laplace in the 1700s (Lavoisier 1783, cited by Schoffelen and Plasqui, 
2018). There are currently two different calorimetric approaches commonly used for 
measuring EE in mammals: direct versus indirect calorimetry (Levine, 2005; Tschöp 
et al., 2011) (Figure 3.1).  
 





Figure 3.1. Diagram of direct calorimetry and closed-circuit indirect respirometry systems. 
Rodent is placed inside the calorimeter chamber for direct or indirect measurement of heat 
production. Humidity and temperature regulator systems calculate body metabolism directly 
through changes in the water temperature. Figure from Grobe Lab U Iowa, n.d. 
 
 Direct calorimetry is based on the direct measurement of body heat production 
in a water-enclosed calorimeter chamber. In addition to the technical difficulties of 
direct calorimetry in terms of measuring small amounts of heat and the requirement 
for numerous control steps to ensure appropriate system functioning, commercial 
equipment is not currently available for rodent experiments. Furthermore, it does not 
take into account the organism’s heat storage throughout the test period; consequently, 
if body temperature would increase, the system would not compute for that increase 
and would, therefore, lead to a rather large error in the calculation of metabolic rate 
(Tschöp et al., 2011; Speakman, 2013; Lam and Ravussin, 2016).  
 Indirect calorimetry estimates the heat energy used by an organism based on 
gas exchange measurements – oxygen (O2) consumption and carbon dioxide (CO2) 
production. Relative to direct calorimetry, it requires a simple and inexpensive system, 




and can be performed using different approaches. Doubly-labelled water (DLW), for 
instance, calculates EE by labelling the body with isotopes of oxygen (18O) and 
hydrogen (2H) and by evaluating elimination rate of these isotopes via water excretion 
(through the sampling of saliva, urine and blood) and respiration (Westerterp, 2017). 
The challenges from this method include the difficulty of injecting the isotopes into 
small animals, the washout speed from animals with high metabolic rate, and the 
limited body water for analysis with isotope ratio mass spectrometry (Speakman, 
2013). Furthermore, a significant drawback is the inevitable stress caused by blood 
sampling. Open-circuit system, the most commonly used method for analysis of EE 
and the method of choice for this study, consists of placing the animal inside a 
metabolic cage that is connected to a flow of fresh air for measurements of the amount 
of O2 consumed and CO2 produced. Respiratory Exchange Ratio (RER) and Energy 
Expenditure (EE) are subsequently calculated by the values obtained (Tschöp et al., 
2011; Gupta et al., 2017).  
 
3.1.2.2. Assessment of energy expenditure and fuel selection 
 Oxidation of the three major energy substrates, namely carbohydrates, lipids 
and proteins, requires consumption of O2 and production of CO2 and water, with 
energy release in the form of ATP and/or heat (Jéquier et al., 1987), according to the 
functions below: 












(3) 1g protein + 966ml O
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O + 0.5g urea + 16.7kJ  
 




 The efficiency of oxidation in a living organism is reflected by the amount of 
ATP (representative of useful energy) retained for the performance of biological 
processes. For oxidation of glucose, for instance, 60% of the energy produced is 
wasted in the form of heat (Fine and Feinman, 2004). Any reduction in calorie 
efficiency, and consequent reduced ATP production, increases the likelihood that body 
stores of fat will be enlisted to yield the additionally required ATP, as represented in 
Figure 3.2. below.  
 
Figure 3.2. Representation of glucose oxidation efficiency in calorimetric and living systems 
with body weight outcomes. Figure from Fine and Feinman, 2004, Nutrition and Metabolism. 
 




 From O2 and CO2 measurements, it is possible to evaluate substrate utilisation 





   
(1) 1g 𝐜𝐚𝐫𝐛𝐨𝐡𝐲𝐝𝐫𝐚𝐭𝐞 =
756𝑚𝑙
746𝑚𝑙
 = 𝟏. 𝟎 
 
(2) 1g 𝐥𝐢𝐩𝐢𝐝 =  
1430𝑚𝑙
2029𝑚𝑙
 = 𝟎. 𝟕 
 
(3) 1g 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 =  
782𝑚𝑙
966𝑚𝑙

















Weir equation for Energy Expenditure estimation 
  
 Stress can also influence behaviour (Blanchard 2001, Beery 2015). 
Characterisation of behavioural phenotypes, to model certain aspects of psychiatric 
disorders, is an essential tool in the study of animal models relevant to stress-related 














Chronic social stress in mice: 
3.2.1. Increases calorie intake 
3.2.2. Increases total energy expenditure 
3.2.3. Increases Ucp-1 mRNA expression 





To investigate the effects of chronic social stress on: 
3.3.1. Food intake, body weight and energy expenditure based on indirect calorimetry, 
in a comparison of CSS and control mice 
3.3.2. mRNA expression of the heat generation protein, uncoupling protein 1 (Ucp-1), 
in brown adipose tissue, in a comparison of CSS and control mice 











 Experiment B (CSS=10, CON=8) investigated the effects of 15-day CSS on 
food intake, body weight and it was used as a pilot study for calorimetry studies. 
Physiological samples of blood, brain, epididymal WAT (eWAT), interscapular BAT 
(iBAT) and stomach were also collected. Experiment C (CSS=12, CON=12) 
investigated the effects of 15-day CSS on indirect calorimetry, in addition to body 
weight and food intake. Behavioural and physiological assessments were also 

























Figure 3.3. Study day of experimental designs. Mouse cohorts were exposed to chronic social 
stress (CSS) or control handling (CON) on days 1-15. Mice were handled, and a motor activity 
test (MA) was conducted before experiments for a balanced allocation of mice to CSS or CON 
groups. Body weight and food intake were monitored daily. Experiment B: Mice were placed 
in metabolic cages (MC) for calorimetric data collection on day -4 for 5 days for baseline data 
collection and on days 16-20 for post-CSS data collection. Mice were sacrificed and 
physiological samples were collected on day 21. Experiment C: Mice were placed in metabolic 
cages for calorimetric data collection on day -4 for 5 days for baseline data and on days 16-20 
for post-CSS data collection. Behaviours (B) were scored on each of CSS/CON days 4, 8 and 
12. Mice were sacrificed, and physiological samples were collected on day 21. Abbreviations: 
eWAT, epididymal white adipose tissue; iBAT, interscapular brown adipose tissue. 
 
 
3.4.1. Food intake and body weight 
 Experiments B and C (please refer to Chapter 2 for ‘Methodological 
framework’). 
 Prior to, during and after CSS/CON, body weight and food intake were 
measured on a daily basis. Food intake was measured by weighing three food pellets 
in individual containers, placing inside the home cage and weighing the pellets again 




24 hours later, using a 1 decimal place scale (Model XS6002SDR, Mettler Toledo). 
Mean value per 5-day block was calculated per mouse. 
 
3.4.2. Indirect calorimetry 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
 The indirect calorimetry study was carried out at the Institute of Veterinary 
Physiology, Vetsuisse, Zurich. Mice were transferred from the Department of 
Psychiatry 10 days before study onset. At both facilities, mice were maintained under 
a reversed light:dark cycle. During the 5-day pre-CSS/CON period (baseline) and the 
5-day post-CSS/CON period, mice were single-housed in gas-tight metabolic cages of 
an automated open-circuit indirect calorimetry system (Type III, PhenoMaster Home 
Cage, TSE Systems, Inc.). Food and water were available ad libitum. The temperature 
and humidity of the room were kept at 23.4 ± 0.2°C and 54.7 ± 6%, respectively. Each 
cage was connected to a fresh air supply, which was also the sample switch unit for 
drawing air samples and measuring the flow rate from each cage. During the baseline 
period, the first 3 days (days -4 to -2) were used to acclimatise mice to the metabolic 
cages and baseline data were collected on days -1 and 0. In the post-manipulation 
period, day 16 was used to re-acclimatise mice to the cages and the data collected on 
days 17-20 were used for analysis. Each 20 min, measurements were obtained for each 
of the following parameters: O2 consumption, CO2 production, RER and EE, and the 
hourly average was then calculated. Following completion of calorimetry data 
collection on day 20, mice were fasted for 14 h and sacrificed at day 21. 
   
3.4.3. Epididymal white adipose tissue dissection 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 




 Following completion of in vivo experiments on day 20 (Experiment C) mice 
were fasted overnight and sacrificed by decapitation for the collection of eWAT. The 
mouse was placed on its back and the pelage was rinsed with 70% ethanol to avoid 
tissue contamination with hair. The skin was lifted with tweezers and an incision was 
made along the abdomen, from the groin and towards the thorax. The eWAT was 
carefully detached from connective tissue, corresponding lymph nodes and blood 
vessels. Following dissection, eWAT was weighed for group comparison (in 
Experiment C) and stored at -80°C until subsequent steps. 
 
3.4.4. Interscapular brown adipose tissue dissection 
 Following completion of in vivo experiments on day 20 (Experiments B and 
C) mice were fasted overnight and sacrificed for collection of iBAT. Dissection of 
iBAT was adapted from Mann et al. (2014) and performed as follows: the mouse was 
placed on its abdomen and the pelage was rinsed with 70% ethanol to avoid tissue 
contamination with hair. The skin was lifted with tweezers and an incision was made 
along the upper half of the spine and toward the shoulders, revealing the butterfly-
shaped iBAT. The iBAT was carefully removed and separated from surrounding 
connective tissues, avoiding collection of muscular tissue closely associated with 
iBAT. Following dissection, iBAT was weighed for group comparison (in Experiment 
C) and stored at -80°C until subsequent steps. 
 
3.4.5. Brown adipose tissue activity – Ucp-1 mRNA expression 
 Experiments B and C (please refer to Chapter 2 for ‘Methodological 
framework’). 




Expression of Ucp-1 was measured as a marker of BAT activity, using the 
reverse transcription quantitative polymerase chain reaction (RT-qPCR) method. 
 
3.4.5.1. RNA extraction  
 The RNA was extracted from iBAT using an RNeasy Lipid Tissue Mini Kit 
(Qiagen®), designed to purify RNA from small amounts of starting material. Tissue 
disruption was performed as follows: QIAzol Lysis Reagent (1mL/30mg) was added 
to each tube containing two stainless steel beads (ø 5mm, QIAgen®) and placed in a 
TissueLyser LT (QIAgen®) for 7 min at 50 Hz. The lysate was transferred to a new 
tube for an incubation period of 5 min at room temperature (RT). For phase separation, 
200µL of chloroform was added, the tube was agitated vigorously for 15 sec, left for 
incubation for 3 min at RT, and centrifuged at 10000rpm for 15 min at 4°C. The upper 
aqueous phase (approx. 600µL) was transferred to a new tube, one volume of 70% 
ethanol was added to induce RNA precipitation and the tube vortexed. The solution 
was loaded onto a RNeasy Mini spin column placed in a collection tube and 
centrifuged at 12000rpm for 15 sec at RT. The flow-through was discarded. This 
procedure was performed twice until all tube content had been transferred. Washing 
Buffer RW1 (350µL) was added to the RNeasy MinElute spin column, centrifuged at 
12000rpm for 15 sec at RT and flow-through was discarded. DNase I solution (80µL) 
diluted in RDD buffer (RNase-Free DNase Set, QIAgen®) was added directly to spin 
column membrane. The membrane was left for 15 min at RT to allow DNase digestion 
and genomic DNA (gDNA) removal. Washing buffer RW1 (350µL) was added to an 
Rneasy spin column, centrifuged at 12000rpm for 15 sec at RT. Flow-through was 
discarded, 500µL of washing buffer RPE were added to the RNeasy spin column for 
removal of salt traces, and it was centrifuged again at 12000rpm for 15 sec at RT. A 




second centrifugation with buffer RPE was carried out for a more extended period (2 
min) to ensure no ethanol was carried over during RNA elution. The RNeasy spin 
column was placed in a new collection tube and centrifuged at full speed (14800rpm) 
for 1 min. The RNeasy spin column was again placed in a new tube, 40µL of RNase-
free water were added directly to the membrane, and centrifuged at 12000rpm for 1 
min. A second centrifugation was performed using eluate for higher RNA yield 
concentration.  
 
3.4.5.1.1. RNA purity and quantity 
 Assessment of RNA purity and quantity was performed using NanoVue™ Plus 
Spectrophotometer (GE Healthcare). 
Two criteria were used for verification of RNA purity:  
1. Ratio A260/280: 1.9 – 2.2. Ratios below 1.9 would be indicative of protein or 
phenol contamination; 
2. Ratio A260/230: 2.0 – 2.2. Ratios below 2.0 would be indicative of 
contaminants which absorb at 230nm.  
 
3.4.5.1.2. RNA integrity 
 Visual assessment of RNA integrity was conducted using 1% agarose gel 
electrophoresis (ThermoScientific™). RNA samples were stained with ethidium 
bromide (RNA Gel Loading Dye 2x, ThermoScientific™) and minimum 1µg of 
extracted RNA was loaded to the gel. The ratio of ribosomal RNA (rRNA) 28S and 
18S bands (28S:18S) was checked. Smeared bands and a 28:18S rRNA ratio less than 
2:1 are indicative of degradation and were therefore avoided. RNA was kept at -80°C 
with minimal freeze-thaw cycles, until further use. 




3.4.5.2. Reverse transcription 
 For synthesis of complementary DNA (cDNA) from the RNA template, 1µg 
RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems), as follows: thawed RNA and reagents were briefly vortexed 
and centrifuged. 2x Reverse Transcription Master Mix (RT Buffer, RT Random 
Primers, 100mM dNTP Mix and 50U/µL MultiScribe® Reverse Transcriptase) were 
prepared according to the manufacturer’s instructions. Total RNA samples were added 
to the master mix, carefully homogenised and briefly centrifuged. Negative RT 
(absence of reverse transcriptase enzyme) was also prepared for identification of 
gDNA in downstream reactions. Samples were loaded into a thermal cycler (T100™, 
Bio-Rad Laboratories, Inc.) and optimum conditions were programmed (Table 3.1). 
cDNA was kept at -20°C until further use. 
 
Table 3.1. Details of the 4-step cycling protocol for RNA reverse transcription 
1. Primer annealing 10 min 25°C 
2. DNA polymerisation 120 min 37°C 
3. Enzyme deactivation 5 min 85°C 
  Infinite hold 4°C 
 
Please refer to Appendix 2 for reagents and solutions. 
 
3.4.5.3. Quantitative polymerase chain reaction 
 By means of qPCR, specific quantification of cDNA targets was performed 
using the QuantiFast SYBR Green PCR Kit (QIAgen®) in the presence of ROX 
passive reference dye, according to the manufacturer’s instructions. Briefly, 2x SYBR 
Green PCR Master Mix, 500nM forward and reverse primers and RNase-free water, 




were mixed with 50ng/µL cDNA and prepared in duplicates. No template control 
(NTC) containing RNase-free water instead of cDNA was also prepared for analysis 
of quality primer pairs. Samples were loaded onto a MicroAmp™ Fast Optical 96-
Well Reaction Plate (Applied Biosystems™). Care was taken to avoid the formation 
of air bubbles in the wells. The plate was placed in the StepOnePlus™ Real-Time PCR 
System (Applied Biosystems™) according to the cycling protocol shown in Table 3.2 
below: 
 
Table 3.2. Details of the 2-step cycling protocol for qPCR 
1. Pre-incubation 5 min 95°C denaturation   
2. PCR (40 cycles) 10 sec 95°C 
 
  
  30 sec 60°C* annealing/extension 
* specific temperature of primer pairs described in Section ‘PCR efficiency’. 
 
Please refer to Appendix 2 for reagents and solutions. 
 
3.4.5.3.1. Primer design 
 Primer pairs for Ucp-1 were designed using NCBI Primer-BLAST, with the 
parameters set to create a product of 70-200bp and primer melting temperature ranging 
from 57°C to 63°C. BLAT (BLAST-Like Alignment Tool) from UCSC Genome 
Browser was used to check for primer sequence alignment. Primers were synthesised 
by Invitrogen (ThermoScientific™) and working stocks containing both forward (FW) 
and reverse (RV) primers at a concentration of 10μM were prepared. Two genes, 
Gapdh (Matoušková et al., 2014) and Actb, were used as housekeeping genes, for 
increased accuracy of the results (Kozera and Rapacz, 2013).  
 
 




3.4.5.3.2. PCR efficiency 
 Presence of PCR inhibitors, inaccurate reagent pipetting and poor quality 
oligos/primers were some of the several parameters that could have affected the 
efficiency of the PCR reaction and were therefore avoided. Optimisation of PCR 
efficiency was achieved by performing a 5-fold cDNA dilution series for each target 
and each tissue. According to the length and composition of the primers, modifications 
of annealing temperature and extension time were necessary to achieve PCR efficiency 
of 90-110% (Table 3.3). A standard curve was generated for each primer pair setting 
and the slope of the curve was calculated.  
 
Table 3.3. Gene description, primer sequences, qPCR parameters and primer efficiency 









Ucp-1 FW: CTGCCAGGACAGTACCCAAG 110 63 40 100 
  RV: GACCCGAGTCGCAGAAAAGA         
Actb FW: GGCTGTATTCCCCTCCATCG 154 63 30 103 
 
RV: CCAGTTGGTAACAATGCCATGT 
    
Gapdh FW: AGGTCGGTGTGAACGGATTTG 123 63 40 94 
 
RV: TGTAGACCATGTAGTTGAGGTCA 
    
 
 
3.4.6. Behavioural observation  
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
To measure spontaneous behaviours in the home cage, the method of 
‘instantaneous scan sampling’ was applied, in which each mouse was observed in turn 
for 10 sec every 2 min, and the most prominent behaviour during each 10 sec sample 
was scored (Dawkins et al., 1994). An ethogram comprising 10 behaviours was used, 
namely eating, drinking, self-grooming, foraging, sitting upright, resting, “at divider”, 
locomoting, climbing and rearing. On each of CSS/CON days 4, 8 and 12, a 1-hour 




observation was conducted at 8-9 h, 11-12 h, 16-17 h and 19-20 h (30 sample points 
per hour per mouse). The definition of each behaviour was as described below: 
 
 Eating – holding and biting food pellet  
 Drinking  
 Self-grooming – washing with front paws and licking of neck, trunk, abdomen 
or anogenital region; scratching coat 
 Foraging – burying nose into cage bedding, and also including moving of 
tissue paper in the mouth  
 Sitting upright – stationary with body weight supported by hind legs only, 
including some periods with head movement  
 Resting – stationary with body weight supported by front and hind legs and 
with abdomen resting on the ground. Includes periods of sleeping. 
 At divider – on front and hind legs or hind legs only and investigating with the 
nose either into the divider holes or at the divider base 
 Locomoting – walking or running on front and hind legs  
 Climbing – clinging with front and/or hind legs either vertically on the 
divider or upside down on the food grid  
 Rearing – standing on hind legs only with body and neck elongated and head 
oriented towards the top or corner of the cage 
 
3.4.7. Statistical analysis 
 Statistical analysis of CSS effects on feeding, body weight, adipose tissue 
mass, calorimetry measures and home-cage behaviours was conducted using SPSS 
(version 24, SPSS Inc., Chicago IL, USA). In Experiment B, for food intake, repeated 




measures analysis of covariance (ANCOVA) was conducted, with pre-CSS/CON body 
weight as a covariate. For body weight and food intake adjusted to body weight, 
repeated measures analysis of variance (ANOVA) was conducted. In Experiment C, 
for food intake and body weight, repeated measures ANCOVA was conducted, with 
pre-CSS/CON body weight as a covariate. For food intake adjusted to body weight, 
ANCOVA was conducted with pre-CSS/CON value as a covariate. Independent 
Student’s t-test was conducted for feeding efficiency and adipose tissue mass. For 
calorimetric data, the linear mixed model (LMM) with baseline body weight as a 
covariate was used to study the effects of CSS on EE, O2 production and CO2 and the 
LMM was used to study the effects of CSS on RER. Significant main or interaction 
effects were analysed using post hoc testing with Bonferroni correction for multiple 
comparisons. For home-cage behaviours, ANOVA was conducted with group 
(CSS/CON) as between-subject factor and CSS/CON day and time as within-subject 
factors. Significant main or interaction effects were analysed using the least significant 
difference (LSD) post hoc test. For those behaviours that demonstrated a significant 
effect of group (CSS, CON) on a specific day and at a specific time point, additional 
non-parametric analysis of these specific effects was performed using the Mann-
Whitney U test. Furthermore, to compensate for multiple testing, the level of 
significance was set at p≤0.01 for the Mann-Whitney U tests conducted. Data are given 
as means and the estimate of variance used is 1 standard deviation (SD). Analysis of 
iBAT Ucp-1 expression was carried out using the 2-∆∆Ct method and 𝛽-Actin was used 
as a control gene for normalisation; the independent Student’s t-test was conducted. 
Data are given as fold change + standard error of the mean (SEM). Statistical 
significance was set at p≤0.05. 






3.5.1. Food intake and body weight 
3.5.1.1. Experiment B 
 Please refer to Chapter 2 for ‘Methodological framework’. 
For the body weight and food intake parameters, measurements were averaged 
across 5-day blocks. There was no effect of Group on body weight (ANOVA: F(1, 
16)=0.193, p=0.67, Figure 3.4A). Food intake was measured across the same time 
period: there was a Group x Day block interaction (ANCOVA with pre-CSS/CON 
body weight as covariate: F(4, 56)=3.4, p=0.015); post hoc tests demonstrated that 
CSS mice had increased food intake at days 16-20 post-CSS (Figure 3.4B). When food 
intake was adjusted for body weight, there was a Group x Day block interaction 
(ANOVA: F(4, 52)=6.7, p<0.001); at days 11-15 of CSS and 16-20 of post-CSS, food 
intake was increased in CSS mice compared to controls (Figure 3.4C). No difference 
in feeding efficiency was found between CSS and CON mice (t(16)=-0.36, p=0.74, 
Figure 3.4D). The increase in food intake and the absence of body weight gain 
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Figure 3.4. Effects of 15-day chronic social stress (CSS=10), versus control handling 
(CON=8) on body weight and food intake. (A) Absolute body weight. (B) Daily food intake. 
(C) Daily food intake adjusted for body weight. (D) Feeding efficiency. Values are overall 
means per 5-day block +/- standard deviation (SD). *p<0.05, **p<0.01, ***p<0.001 for CSS 
versus CON mice in day block indicated, using Group x Day block ANCOVA (Daily food 
intake) or Group x Day ANOVA (Absolute body weight and daily food intake adjusted for 
body weight), and in the case of significant interaction, day block-specific post hoc testing 















































3.5.1.2. Experiment C 
 Please refer to Chapter 2 for ‘Methodological framework’. 
 There was a Group x Day block interaction effect on body weight (ANCOVA 
with pre-CSS/CON body weight as covariate: F(2, 43)=11.9, p<0.0001); post hoc tests 
demonstrated that CSS mice weighed less than CON mice at days 11-15 of CSS and 
16-20 post-CSS (Figure 3.5A). Food intake was measured across the same time period: 
there was no effect of CSS on mean food intake per 5-day block (ANCOVA with pre-
CSS/CON body weight as covariate: F(1, 21)=1.92, p=0.18, Figure 3.5B). When food 
intake was adjusted for body weight, there was no effect of Group (ANOVA: F(1, 
22)=2.8, p=0.11) or Group x Day block interaction (ANOVA: F(3, 73)=0.66, Figure 
3.5C). Therefore, although CSS mice failed to gain weight across the study whereas 
CON mice did gain weight, the two groups were consuming a similar amount of food. 
In regards to feeding efficiency, CSS mice showed lower feeding efficiency compared 
























Figure 3.5. Effects of 15-day chronic social stress (CSS=12), versus control handling 
(CON=12) on body weight and food intake. (A) Absolute body weight. (B) Daily food intake. 
(C) Daily food intake adjusted for body weight. (D) Feeding efficiency. Values are overall 
means per 5-day block +/- standard deviation (SD). *p<0.05, **p<0.01 for CSS versus CON 
mice in day block indicated, using Group x Day block ANCOVA (Absolute body weight and 
daily food intake) or Group x Day block ANOVA (Daily food intake adjusted for body 
weight), and in the case of significant interaction, day block-specific post hoc testing using 
LSD test. 
 
3.5.1.3. Adipose tissue weight  
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
 The BAT weight difference was found to be borderline significant: CSS mice 
had a lower BAT weight than CON mice (t(22)=4.11, p=0.054, Figure 3.6A). With 
regards to WAT weight, this was lower in CSS mice than CON mice (t(22)=2.03, 





















































A.           B. 
 
Figure 3.6. Effects of 15-day chronic social stress (CSS=12), versus control handling 
(CON=12) on BAT and WAT weight. (A) BAT. (B) WAT. ***p<0.001 for CSS versus CON 
mice following an Independent sample t-test. 
 
3.5.2. Indirect calorimetry 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
 As previously mentioned, the hourly average of parameters was calculated 
from the regular (every 20 min) measurements obtained on the indirect calorimetry 
system. As an illustration, the hourly data obtained for RER on day 19 of the 
experiment are presented in Figure 3.7. From these hourly data, the mean values were 
calculated for each 12-h dark phase (07-19:00 h) and each 12-h light phase (19-07:00 



































Figure 3.7. Data for respiratory exchange ratio obtained with CSS (N=12) and CON (N=12) 
mice for each hour on study day 19. One value was obtained each 20 min, and the mean hourly 
value per mouse was calculated. Values are overall group mean RER per hour +/- standard 
deviation for CSS and CON mice. 
 
 There is a general concern about the different approaches for measuring and 
calculating EE following an intervention. Since lean body mass was not measured and 
since variability in the metabolism of different adipose tissues might also generate 
inconsistency of analysis, for the present study pure values of O2 consumption and 
CO2 production were used followed by body weight correction when needed. Simple 
linear regression was performed to determine the association between parameters 
obtained from indirect calorimetry (O2, CO2, EE and RER) and body weight. For O2 
consumption, CO2 production and EE, there was a clear positive association with body 
weight. There was no Group x BW interaction but a main effect of body weight. Body 
weight was used as a covariate in these cases and mixed model ANCOVA was 
conducted. Regarding RER, there was no relationship between RER and body weight; 
therefore, mixed model analysis was performed without body weight as a covariate 
(Figure 3.8).  




      
 
      
 
      
 
Figure 3.8. Simple linear regression analysis of O2 consumption, CO2 production, Energy 
Expenditure and Respiratory Exchange Ratio with body weight for both dark (left) and light 
(right) phases. CON (empty circle; dotted line), CSS (filled circle; continuous line). 
 




 For O2 consumption, there was no effect of Group in either the dark or light 
phase. There was a main effect of Day during the light phase, indicating higher O2 
consumption at days 18-20 versus days -1/0 (Figure 3.9A).  
 For CO2 production, there was a main effect of Group in the dark phase with 
CSS mice producing more CO2 than CON mice; there was no effect of Group in the 
light phase. There was a main effect of Day during the light phase indicating higher 
CO2 production at days 18-20 versus days -1/0. Furthermore, during the light phase, 
there was a Group x Day interaction effect; CSS mice produced more CO2 than CON 
mice at days 19 and 20 (Figure 3.9B).  
 With regard to EE, there was no significant effect of Group (interaction or main 
effect) in either dark or light phases. There was a main effect of Day during the light 
phase, indicating higher EE at days 18-20 versus days -1/0 (Figure 3.9C). Despite the 
absence of a statistical effect, there was a clear positive association of EE with body 
weight, as shown previously in Figure 3.8; in mice of the same body weight, EE is 
typically higher in CSS than CON mice.  
 Lastly, regarding RER (Figure 3.9D), during the dark phase, there was a main 
effect of Group, with CSS mice showing higher RER values than CON mice. There 
was also a main effect of Day during the dark phase, indicating higher RER at day 17 
versus day -1. There was a Group x Day interaction effect; CSS mice showed higher 
RER than CON mice at days 17-20. During the light phase, there was a main effect of 
Day indicating higher RER at day 17 versus day -1. There was a Group x Day 
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Figure 3.9. Effects of 15-day chronic social stress (CSS=12), versus control handling 
(CON=12) on indirect calorimetry. (A) O2 consumption. (B) CO2 production. (C) Energy 
Expenditure. (D) Respiratory Exchange Ratio. For each parameter, the left panel gives values 
during the dark phase and the right panel the values during the light phase. Values are overall 
mean +/- standard deviation. For statistical analysis, data were used for days -1, 0, 17, 18, 19, 
20. *p<0.05, **p<0.01, ***p<0.001, for CSS versus CON mice following a main effect of 
Group in the mixed model ANCOVA (O2, CO2, EE) or ANOVA (RER), or in day-specific 
post hoc Bonferroni testing following a significant Group x Day interaction in ANCOVA or 
ANOVA. 
 




3.5.3. Brown adipose tissue activity – Ucp-1 mRNA expression  
 Experiments B and C (please refer to Chapter 2 for ‘Methodological 
framework’). 
 No difference in Ucp-1 mRNA expression was found in iBAT of mice from 
Experiment B. For Experiment C, Ucp-1 mRNA expression was increased in CSS 
mice when normalised to the housekeeping gene Actb (p=0.009, left Figure 3.10B), 
but no difference in expression was found when normalised to Gapdh.  
 
Table 3.4. iBAT Ucp-1 mRNA expression normalised to Actb and Gapdh, for Experiment B 
and Experiment C (specified in brackets). Values of ∆Ct expressed as mean values ± SEM.  
Gene CON ∆Ct CSS ∆Ct Difference (%) Fold change p value  
Ucp-1_Actb(B) -2.17 ± 0.27 -2.12 ± 0.35 5 1.39 0.924  
Ucp-1_Gapdh(B) 0.01 ± 0.32 -0.51 ± 0.37 52 1.20 0.330  
Ucp-1_Actb(C) -1.62 ± 0.13 -2.11 ± 0.11 49 1.39 0.009 ** 
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Figure 3.10. Effects of 15-day chronic social stress (CSS), versus control handling (CON) on 
iBAT Ucp-1 mRNA expression. (A) Experiment B (CSS=10, CON=8). (B) Experiment C 
(CSS=12, CON=12). Values are in terms of fold change relative to Actb (left) and Gapdh 
(right) housekeeping genes + SE. *p<0.05 for CSS versus CON mice following an 
independent Student’s t-test. 
 
3.5.4. Behaviour 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
For self-grooming, there was a main effect of Group (F(1, 22)=30.16, 
p<0.0001), with CSS mice self-grooming more than CON mice (Figure 3.12A). The 
Mann-Whitney test indicated that the self-grooming behaviour was greater for CSS 
mice (Mdn = 4.08) than for CON mice (Mdn=2.79), U=8, p<0.01. For sitting upright, 
there was a main effect of Group (F(1, 22)=9.30, p<0.006), with CSS mice sitting 




















































































































sitting upright was greater for CSS mice (Mdn=1.04) than for CON mice (Mdn = 0.75), 
U=21.5, p<0.01. No main or interaction effect of Group was found for any of the other 
behaviours measured. 
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Figure 3.11. Comparison of CSS and CON mice in terms of behaviour on three days and at 
different time points, during the manipulation phase. (A) Self-grooming. (B) Sitting upright. 
(C) Resting. (D) Locomoting. (E) Climbing. (F) Eating. (G) Drinking. (H) At divider. (I) 
Rearing. (J) Foraging. Values are mean + standard deviation, N=12 per group. P values are for 
Group x Day x Time ANOVA. 






 Changes in patterns of feeding behaviour and body weight are commonly 
observed as symptoms in depressive disorders (WHO, 2016) and are often seen in 
models of chronic social stress. Therefore, body weight and food intake were 
investigated in the current CSS model. An effect of CSS on energy metabolism was 
observed, in which stressed animals had either increased food intake with no change 
in body weight (Experiment B) or similar food intake with decreased body weight gain 
associated with lower eWAT (Experiment C) when compared to control animals. 
Calorimetric parameters were evaluated for a greater understanding regarding 
regulation of energy balance and fuel selection for homeostatic requirements, and Ucp-
1 mRNA expression analysed for evaluation of iBAT thermogenic activity. Indirect 
calorimetry revealed that EE was similar between stressed and control mice despite 
the reduced weight gain in the former. The RER was increased in stressed compared 
to control mice, indicating increased carbohydrate utilisation in the former, associated 
with lower eWAT. Gene expression of Ucp-1 in iBAT was not significantly different 
between stressed and control mice. Additionally, the effect of CSS on individual 
home-cage behaviour was also studied. Stressed mice showed increased self-grooming 
behaviour as well as sitting upright behaviour when compared to control animals.  
 
3.6.1. Food intake and body weight  
 For Experiment B, it was observed that CSS led to increased food intake, 
especially on the 5 last days of social stress and the post-CSS period. Previous studies 
also showed an increased feeding in chronically stressed mice (Moles et al., 2006; 




Lutter et al., 2008; Chuang et al., 2010a,b; Razzoli et al., 2011a,b; Kumar et al., 2013; 
Goto et al., 2014; Bergamini et al., 2016). Moreover, there was no effect on body 
weight, in accord with some previous studies (Moles et al., 2006; Lutter et al., 2008; 
Savignac et al., 2011; Kumar et al., 2013; Sanghez et al., 2013; Azzinnari et al., 2014; 
Bergamini et al., 2016; Koch et al., 2016), suggesting a possible effect on EE. In 
contrast with the present findings, other studies observed increased body weight gain 
(Chuang et al., 2010a,b; Razzoli et al., 2010, 2011a,b; Patterson et al., 2013; Goto et 
al., 2014). Interestingly, the studies which demonstrated increased body weight 
performed slightly different stress protocol to the one presented here. For instance, 
Goto et al. (2014) performed a milder stress protocol of reduced social defeat duration 
(0.5 min versus 10 min in this study). Patterson et al. (2013) performed a stress 
protocol of 21 days, versus 15 days in this study. Chuang et al. (2010a) reported body 
weight gain at day 40, following 30 days of the 10-day stress protocol; it was not clear 
at which point the effects were seen.  
 For Experiment C, no change in feeding behaviour was found between CSS 
and CON mice, and CSS mice failed to gain weight across the study, in contrast to 
CON mice, which gained weight across the study period. This co-occurred with a 
decrease in eWAT. Absence of the effect of social stress on food intake was previously 
reported (Bartolomucci et al., 2004; Koch et al., 2016) as well as a decreased body 
weight gain (Bartolomucci et al., 2004; Balsevich et al., 2014). Of note, body weight 
loss was recently reported, but this was likely a consequence of the decreased food 
intake observed in the study (Coccurello et al., 2017). Interestingly, the effect of social 
stress on body weight may be dependent on various factors such as mouse strain 
(Razzoli et al., 2011b, c) and the time of the day in which the stress protocol is 
implemented (Koch et al., 2016). Razzoli et al. (2011c) observed that C57BL6/J 




stressed mice did not exhibit altered body weight compared to control mice, whereas 
stressed Balb/c mice gained significantly less body weight than controls. Savignac et 
al. (2011) observed decreased body weight gain in stressed Balb/c mice compared to 
controls, but also increased body weight gain in C57BL6/J stressed mice. Most of the 
studies using social stress protocols were performed using the C57BL6/J strain, in 
which increased body weight gain, lack of body weight change (Lutter et al., 2008; 
Azzinnari et al., 2014; Bergamini et al., 2016) and decreased body weight gain were 
observed (Balsevich et al., 2014). Therefore, a clear comparison between Balb/c and 
C57BL6/J or other strains in terms of body weight change is not available. With 
respect to the time of the day, Koch and et al. (2016) observed that mice had greater 
body weight loss when the stress protocol was performed during the light phase, when 
animals are less active (Koch et al., 2016), which was not the case for the current study. 
Stress protocols performed during the light phase were linked with altered diurnal 
activity patterns and increased body temperature (Bartlang et al., 2015). 
 On the other hand, in contrast to mouse studies, various studies in socially 
stressed rats showed decreased body weight gain versus controls (Meerlo et al., 1996; 
Haller et al., 1999; Becker et al., 2008; Razzoli et al., 2009; Iio et al., 2012, 2014; 
Olivares et al., 2012; Ahnaou and Drinkenburg, 2016; Liu et al., 2017) and body 
weight loss (Albonetti and Farabollini, 1994), concomitant with anorexic behaviour 
(Meerlo et al., 1996; Becker et al., 2008; Iio et al., 2014). Repeated social stress seems 
to produce different effects between rats and mice as far as feeding behaviour and body 
weight gain are concerned. 
 Although Experiments B and C were performed under similar circumstances, 
results on food intake and body weight gain were different. We also measured body 
weight in a further study focused on glucose homeostasis, described in Chapter 4. In 




this study, metabolic cages were not used, but otherwise the protocol was very similar. 
In this study, similar to Experiment B, no difference in body weight was observed. 
Furthermore, a previous study performed in the Pryce laboratory with the same CSS 
model again reported results similar to Experiment B (Bergamini et al., 2016). Our 
data suggest there can be some variance in the effects on feeding between experiments 
for yet unknown reasons. Nonetheless, despite differences in feeding results, in all 
these studies CSS mice displayed less weight gain per gram of food eaten, versus 
control mice, which suggests a less efficient use of food as energy or greater energy 
demand. 
 
3.6.2. Indirect calorimetry 
 With regards to the effects of CSS on the regulation of EE, animals of 
Experiment C were placed in metabolic cages for measurements of O2 consumption 
and CO2 production, at baseline and post-CSS period. In the present study, we did not 
observe a significant effect of stress on EE. Nonetheless, these CSS mice displayed 
less weight gain than CON mice and had less WAT mass. The similar EE with a 
relatively low BW in stressed mice indicates reduced energy efficiency and/or higher 
energy requirement in CSS mice for metabolic processes. A recent study performed 
by Zhao et al. (2017) reported increased hippocampal levels of glycogen 
phosphorylase (glycogenolysis catalyser) in a mouse model of chronic unpredictable 
stress, an indication of rapid glycogen breakdown and brain energy demand (Zhao et 
al., 2017). A relatively novel angle of understanding of the effect of social stress on 
energy balance emerges.  
 Although inefficiency of body weight gain in socially stressed mice was 
previously shown (Moles et al., 2006; Lutter et al., 2008; Bergamini et al., 2016), the 




usage of metabolic cages for the purpose of evaluating the effects of chronic social 
stress on regulation of energy metabolism is scarce. Moles et al. (2006) described the 
metabolic effects of social stress using indirect calorimetry; the period of 1 hour 
acclimatisation used was short for single-housing conditions (Stechman et al., 2010). 
Other studies performed similar experiments, with 6 hours of acclimatisation (Sanghez 
et al., 2013; Coccurello et al., 2017). Our experiment had a period of 3 days of 
acclimatisation and evaluated EE and RER in the course of 2 days instead of 17 hours 
(Moles et al., 2006), 20 hours (Coccurello et al., 2017) or 24 hours (Sanghez et al., 
2013). 
 As previously stated, EE in humans is determined by four main factors: body 
size (i.e. the bigger the body the greater the RMR), body composition (i.e. RMR is 
greater when there is more free-fat mass), environment (i.e. ambient temperature) and 
behaviour (i.e. food intake and physical activity) (Westerterp, 2017). Body 
composition might wield influence on EE in both groups; however, since it was not 
determined in the current study, this limitation is present. Additionally, since 
calorimetric studies were performed at the same temperature, the environment had 
little to no influence on the regulation of EE in this case.  
 The previous study by Moles et al. (2006) that reported increased food intake 
with no change in body weight has also reported increased EE. Nevertheless, such 
increase was mostly observed when comparing dominant to submissive and control 
mice; dominant mice showed greater EE versus submissive mice, both at baseline and 
post-stress period and greater EE versus control mice at post-stress period. 
Furthermore, as previously stated, measurements in this study were performed for a 
total of about 17 hours only (Moles et al., 2006). A similar outcome was reported by 
Sanchez et al. (2013); however, dominant mice showed decreased body weight gain 




in comparison to control mice in this case. The effect of social stress on metabolic rate 
appears to be dependent on social status (Moles et al., 2006; Sanghez et al., 2013). The 
recent study performed by Coccurello et al. (2017), using the same obesity-prone 
C57BL/6 mice strain used in our studies, found an increase of EE from socially 
stressed mice fed either a standard chow diet or high-fat/high-sugar diet, along with 
increased iBAT mass, but decreased overall body weight.  
 In comparison to our findings, these different outcomes could have been the 
result of fundamental methodological differences of maintaining control animals in 
brother pairs in the study performed by Coccurello et al. (2017), which was not applied 
in our case. The reasoning behind not housing together brother pairs of CON mice was 
that mice interaction following separation at the calorimetry stage might elicit 
undesired stress-related physiological and/or behavioural changes in the controlled 
group. Furthermore, physical contact between animals were showed to exert an effect 
on the physiology and behaviour of animals (Yamada et al., 2015), for the lack of 
social thermoregulation otherwise present. Group-housed animals can huddle, which 
reduces their thermoregulatory requirements. Comparison of EE between control 
animals housed in brother pairs (with lower thermoregulatory needs) and stressed 
animals single-housed throughout the stress period might exacerbates their difference 
in energy requirements. Nevertheless, a pilot study comparing CON mice pairs 
maintained together or separated from each other by a divider demonstrated no effects 
in tests of motor activity or fear acquisition (Azzinnari et al., 2014).  Furthermore, the 
recent study by Coccurelo was performed following a 24-day stress protocol with 10-
min social encounters twice a day, which could have had a prolonged impact on 
subjects’ metabolism. Additionally, measurements of EE and RER were performed for 
20 hours, at day 18 of social stress, following 6 hours of adaptation. The present study 




instead performed indirect calorimetry prior and after stress protocol, for a period of 2 
days and following 3 days of acclimatisation. This novel design allowed for a better 
longitudinal view on the effects of social stress on EE. 
 Studies using rats showed that EE increases during repeated restraint (Harris 
et al., 2006) or chronic mild stress (García-Díaz et al., 2007) and that it was combined 
to increased BAT temperature and psychosocial stress-induced body hyperthermia 
(Lkhagvasuren et al., 2011; Kataoka et al., 2014). This was likely mediated by the SNS 
and activation of 𝛽3 adrenoceptors, which are abundantly expressed in BAT. This 
study found no consistent effect of stress in BAT activity, regarding Ucp-1 mRNA 
expression (discussion addressed in the next section). 
 With regards to the effects of CSS on RER and fuel selection, the present study 
has shown that CSS mice have increased RER in comparison to CON mice during the 
dark phase. Increased RER is an indication of increased utilisation of carbohydrate as 
the energy source and as a consequence can lead to increase of fat tissue. While 
increased fat mass in social stress mice was previously reported (Patterson et al., 
2013), our study instead observed reduced WAT weight. This may be explained by 
previous studies that showed enhanced lipid oxidation following social stress 
(Coccurello et al., 2017). In accord with our results, other studies reported decreased 
body fat in mice (Chuang et al., 2010b) and rats (Iio et al., 2014). An increase in 
carbohydrate oxidation observed through RER analysis could be a consequence of 
increased energy demand by the brain, which processes primarily glucose 
(Mergenthaler et al., 2013). Therefore, it is necessary to scrutinise the different fuel 
demands and metabolic profiles across different organs to better comprehend the 
effects of psychosocial stress on the maintenance of cerebral and peripheral energy 
homeostasis. The different forms of central and peripheral activation of energy balance 




regulators were recently reviewed (Razzoli and Bartolomucci, 2016). Essentially, 
Razzoli and Bartolomucci (2016) described the three major neuroendocrine systems 
mediating the components of stress: HPA axis acting on adrenal cortex to stimulate 
release of glucocorticoids, sympatho-adrenomedullary axis innervating every organ in 
the body in a specific manner, and peptides, such as ghrelin, leptin and insulin, 
regulating feeding under different fat content conditions. Moreover, it described the 
molecular mechanisms of stress-induced positive and negative energy balance as well 
as the role of adaptive thermogenesis on energy homeostasis.  
Research using modulatory neuroendocrine approaches for the investigation of 
stress-related diseases have increased continuously, despite the diverse metabolic 
effects of chronic social stress between rodents and humans. Nonetheless, studies 
using activation of BAT by a sympathetic purinergic system, independently of 
noradrenaline-dependent 𝛽-AR activation, have recently pointed out neuromodulation 
of adipose tissue in rodents for targeting metabolic disorders in humans. Studies on 
the effects of CSS on EE in the long-term are also required, for analysing the duration 
of psychosocial encounters on the regulation of energy balance. 
 
3.6.3. Brown adipose tissue activity – Ucp-1 mRNA expression 
For this study, it was hypothesised that CSS increases Ucp-1 mRNA 
expression and EE, which would enlighten the possible lack of calorie efficiency found 
in our results on food intake and body weight regulation. Activation of BAT were 
shown to increase energy utilisation for heat production rather than ATP formation 
(Morrison et al., 2014). Such an increase would subsequently result in less ATP 
production from fuel sources and would require greater triglycerides lipolysis and 
release of fatty acids from WAT for adaptive thermogenesis (Blondin et al., 2017), a 




mechanism with consequent fat loss.  
In order to evaluate the impact of BAT activation on energy metabolism, 
assessment of BAT depots and BAT Ucp-1 mRNA expression were performed. In our 
studies, no difference in BAT mass was found between stress and control mice. 
Moreover, no significant change in Ucp-1 mRNA expression was found in socially 
stressed mice compared to control when using Gapdh as the reference gene. When 
using Actb as the reference gene, however, Ucp-1 was upregulated in stressed mice 
compared to controls; however that was only seen in Experiment C. Although no 
significant change was seen in the majority of cohorts, a tendency towards 
upregulation in stressed mice can be pictured. Overall, since our results have shown 
no substantial upregulation of mRNA Ucp-1, changes in BAT mass or regulation are 
unlikely to explain the calorie efficiency observed. 
 A potential explanation for the lack of calorie efficiency observed in this mouse 
model would be the altered nutrient absorption from the GI tract. The brain's response 
to stress has a direct effect on the gut; previous studies showed that stressed animals 
had altered levels of nutrient absorption (Toyoda et al., 2015), gut permeability 
(Yarandi et al., 2016) and gut microbiota (Bailey et al., 2011). Further studies on the 
role of CSS on GI nutrient absorption are required. 
 
3.6.4. Behaviour 
As previously mentioned, characterisation of behavioural phenotypes is an 
essential tool in the study of stress-related disorders. The aim of home-cage behaviour 
analysis performed in Experiment C was to investigate the behavioural frequency of 
mice subjected to CSS as well as evaluating advancement in the development of such 
behaviours by analysis of the 3 blocks of stress (CSS days 4, 8 and 12). CSS mice were 




more often engaged in self-grooming and sitting upright behaviours, while no effect 
was found for the remaining behaviours (eating, drinking, foraging, resting, “at 
divider”, locomoting, climbing and rearing).  
Self-grooming (licking and scratching of body and head), beyond the primary 
purpose of hygiene and body care, were shown to act on the stimulation of skin, 
thermoregulation (Almeida et al., 2015) and also on stress reduction in rodents, with 
potential translational validity (Roth et al., 2013). Previous studies showed that i.c.v. 
injection of CRH in rats induced an increase in self-grooming behaviour (Sutton et al., 
1982; Gargiufo and Donoso, 1996). Furthermore, a single episode of stress (i.e. acute 
stress) were also shown to significantly increase grooming behaviour (Füzesi et al., 
2016). Nonetheless, chronic social stress seems to exert an opposite effect; a previous 
study had suggested a pronounced effect of chronic social stress on self-grooming 
frequency, time and patterning in mice (Denmark et al., 2010), in which a decrease in 
the percentage of grooming body transitions was observed. Moreover, decreased self-
grooming behaviour were also observed in chronically stressed rats (Razzoli et al., 
2007; Denmark et al., 2010; Ahnaou and Drinkenburg, 2016). Our study, in contrast, 
showed that CSS increases self-grooming frequency. Interestingly, an absence of 
effect on corticosterone were observed in the same animal model of stress (Azzinnari 
et al., 2014). Since stress paradigms such as the one used in the present study can 
include biting, one explanation for the increase in self-grooming behaviour would be 
intensification in wound licking. Nonetheless, since the frequency of bite wounds was 
low to none in this study due to CD-1 teeth-trimming, it is unlikely to have caused this 
increase. These conflicting results are possibly due to methodological differences in 
analysing self-grooming behaviour. The cumulative scores showed here provide little-




detailed analysis of this rather complex behaviour and therefore further observations 
should be made in the future. 






In summary, the present experiments suggest that CSS in mice leads to reduced 
energy efficiency and/or increased energy requirements for metabolic processes. This 
is evident in both experiments despite the variation in the feeding and bodyweight 
results observed between the experiments. A change in metabolism following CSS is 
further supported by our observation of an increased respiratory exchange ratio as an 
indication of increased carbohydrate utilisation. It is plausible to speculate that the 
body adapts to chronic stress by making glucose preferentially available as a fuel. This 
is explored further in Chapter 4. However, this effect on fuel utilisation does not fully 
explain the metabolic inefficiency observed in the present model, and additional 
factors such as the potential effects of stress on GI absorption may play a role and 
should be investigated in further studies.  
 The variation in the feeding and body weight results observed between the two 
studies in this chapter highlights how groups of mice, like humans, can vary in their 
responses to social stress. It is possible that subtle undetected differences in the 
experimental environment may lead to substantial changes in the response to social 
stress or indeed, to the status of the mice in the control group. Indeed, these differences 
to the evidence that similar models of stress in different laboratories report varying 








CHAPTER 4  
 
 
Effects of chronic social stress on neuroendocrine 



















The brain receives short-term and long-term satiety signals from peripheral 
organs important for the regulation of feeding behaviour and EE (Morton et al., 2014). 
The effects of CSS on the hormone ghrelin, a proposed appetite signal derived from 
the stomach, and leptin, a satiety signal derived from fat stores, are investigated in the 
current chapter. In addition, the effect of CSS on glucose homeostasis is examined.  
 
4.1.1. Stress and neuroendocrine regulators of feeding 
4.1.1.1. Ghrelin 
 Elevated ghrelin levels were previously reported in mouse models of chronic 
social stress (Lutter et al., 2008; Chuang et al., 2011; Patterson et al., 2013). There is 
evidence that this increase in ghrelin levels has anti-depressive effects including 
increased latency to immobility in the forced swim test, and that it acts as a defence 
mechanism in chronic social stress (Lutter et al., 2008) as well as in other models, e.g. 
chronic unpredictable mild stress (Huang et al., 2017).  
 Stress-related symptoms appear to be directly linked to the ghrelin receptor; 
for instance, following acute stress, GHS-R KO mice developed more anxiolytic 
behaviours compared to WT mice (Spencer et al., 2012). In chronic social stress, GHS-
R KO mice displayed increased social avoidance (i.e. depression-like behaviour) 
(Lutter et al., 2008; Chuang et al., 2011). In regards to the effects of chronic social 
stress on ghrelin-associated feeding, a study reported an attenuated effect of chronic 
social stress on food intake and body weight gain in GHS-R KO mice (Patterson et al., 
2013). Similar findings were reported in mice subjected to chronic unpredictable stress 




(Patterson et al., 2010). Interestingly, corticosterone levels increased similarly in WT 
and GHS-R KO mice, suggesting that effects on feeding and body weight were due to 
the increase in ghrelin rather than the increase in corticosterone (Patterson et al., 2013).  
 The effect of chronic social stress on ghrelin appears to be consistent (Lutter 
et al., 2008; Kumar et al., 2013; Patterson et al., 2013), and interestingly it was 
observed in both models/studies that reported body weight increase (Patterson et al., 
2013) and those which did not (Lutter et al., 2008). 
 Whilst it is clear that ghrelin levels are initially elevated after chronic social 
stress, the duration of this effect is unclear. Lutter et al. (2008) reported that plasma 
ghrelin concentrations remained elevated 4 weeks after the stress period. Nonetheless, 
Patterson et al. (2013) showed that effects were lost after a period of 3-weeks recovery. 
Recently, using a model of PTSD in rats with a history of stress exposure, a study 
reported elevation in acyl ghrelin for a period of 130 days following tail 
immobilisation stress (Yousufzai et al., 2018). 
 Also in humans, stress has been shown to increase plasma ghrelin levels; acute 
psychological stressors in the form of speech delivery and other mental challenges 
increased ghrelin in humans of normal weight (Rouach et al., 2007). Following 
exposure to a severe stressor, i.e. traumatised children affected by terrorist activities, 
adolescent humans also displayed increased ghrelin, for a minimum of 4 years 
(Yousufzai et al., 2018). Furthermore, in response to stressor anticipation, women 
displayed increased ghrelin in comparison to women in control conditions (Raspopow 
et al., 2014).  
 




4.1.1.2. Leptin  
Altered levels of leptin have also been frequently described in animal models 
of chronic social stress. Some studies reported that chronically stressed mice on both 
chow and HFD had decreased adipose tissue and decreased serum leptin (Chuang et 
al., 2010b; Balsevich et al., 2014), whereas another study reported decreased plasma 
leptin despite increased body weight (Finger et al., 2012). Decreased leptin levels were 
also reported in the absence of an effect on body weight (Kumar et al., 2013; 
Bergamini et al., 2016). As discussed in the Chapter 1, body fat exerts influence on 
leptin levels; nonetheless, the effect of chronic stress on leptin observed for various 
body weight outcomes suggests the altered leptin is independent of changes in adipose 
tissue mass.  
No effect on plasma leptin was also reported in stressed mice (Razzoli et al., 
2011a, b, c; Patterson et al., 2013). Equally in rats, in a protocol consisting of 3 daily 
social defeat experiences, Razzoli et al. (2009) reported similar levels of plasma leptin 
following one day of social stress; nevertheless, an increase in leptin was reported 21 
days after the last defeat, despite body weight loss.  
Dietary fat-content was reported to exert influence on the duration of stress-
related changes in leptin levels (Finger et al., 2011, 2012); leptin levels were found to 
be decreased up to three weeks after chronic psychosocial stress (mix of social defeat 
and overcrowding) in mice on a low-fat diet, however this effect was prolonged to six 
weeks when on an HFD (Finger et al., 2012). Moreover, effects of time of the day on 
plasma leptin were also observed: mice under chronic social stress showed decreased 
leptin compared with control mice during the late light phase and early dark phase but 
not during the early light phase and late dark phase (Kumar et al., 2013). 




While various studies described alterations in plasma concentrations of ghrelin 
and leptin in response to stress, the effects of chronic social stress on the brain-region 
expression of Ghs-r1a and the Lepr and their respective genes were not yet 
investigated. Such data are essential for the understanding of the effects of chronic 
social stress on ghrelin and leptin systems.  
 
4.1.1.3. Insulin 
 Stress has been reported to exert both positive and negative effects on glucose 
homeostasis. For instance, chronic social stress were shown to promote the impairment 
of glucose tolerance (Tsuneki et al., 2013); it was associated with increased fasting 
glucose levels in both standard and HFD, accompanied by elevated insulin levels, 
which suggested a degree of insulin resistance, in the presence of body weight 
difference (Chuang et al., 2010a). Nonetheless, hypophagia and weight loss associated 
with chronic stress were shown to improve the obesity features of impaired glucose 
tolerance as well as insulin and leptin resistance (Balsevich et al., 2014); mice under 
HFD presented increased glucose and insulin levels, and hypophagia and weight loss 
induced by chronic social stress were able to counteract these effects (Balsevich et al., 
2014). In line with that, Finger et al. (2011) observed that diet-induced obese mice 
were resistant to stress-induced depressive-like behaviour such as increased 
immobility in the forced swim test. Moreover, a recent study reported that subordinate 
mice which showed signs of metabolic syndrome and type 2 diabetes (e.g. 
hyperphagia, high leptin and dyslipidemia) were euglycemic when fed a standard diet; 
these results led to the hypothesis that stress might predispose mice to develop type 2 
diabetes when combined with risk factors such as an HFD (Sanghez et al., 2013).  




 Preliminary studies from our laboratory reported increased food intake coupled 
with unchanged body weight (Bergamini et al., 2016), suggesting increased energy 
need and/or impaired calorie efficiency. Studies reviewed in Chapter 3 showed either 
no change in body weight or a decrease in body weight gain. The current CSS model 
therefore represents a good opportunity to study the effects of chronic social stress on 
glucose homeostasis in the absence of obesity. In order to assess the metabolic 
phenotype of this mouse model of chronic social stress, an intraperitoneal glucose 
tolerance test (GTT) was performed. 






Chronic social stress in mice: 
4.2.1. Up-regulates the ghrelin system and down-regulates the leptin system 




To investigate the effects of chronic social stress on: 
4.3.1. Plasma ghrelin and leptin levels 
4.3.2. Ghrelin system 
4.3.2.1. GHS-R1a-positive cells number in mouse arcuate nucleus (ARC), 
ventromedial hypothalamus (VMH) and ventral tegmental area (VTA) 
4.3.2.2. Ghs-r1a gene expression in mouse paraventricular hypothalamic 
nucleus (PVN), arcuate nucleus (ARC), ventromedial nucleus (VMH) and 
ventral tegmental area (VTA) 
4.3.3. Leptin system 
4.3.1.1 Lep and Lepr gene expression in mouse eWAT 
4.3.1.2. Lepr gene expression in mouse medial prefrontal cortex (mPFC), 
nucleus accumbens (NAcc), paraventricular hypothalamic nucleus (PVN), 
arcuate nucleus (ARC), ventromedial nucleus (VMH) and ventral tegmental 
area (VTA) 
4.3.4. Glucose homeostasis, through evaluation of blood glucose and plasma insulin 
levels, following a glucose tolerance test 






4.4.1. Blood collection 
 Collection of blood followed the same procedure for all experiments. 
Following CSS on days 1-15, on day 16 (in Experiment A) or day 20 (Experiment C) 
mice were fasted overnight. On the following day mice were decapitated and the trunk 
blood (300-500µL) was collected into EDTA-coated tubes (Microvette 500 K3E, 
Sarstedt) and placed on ice. For plasma active ghrelin, 100µL blood was subsequently 
transferred into a second tube (Microvette 300 Z, Sarstedt) containing esterase 
inhibitor AEBSF (A8456, Sigma) to a final concentration of 1mg/mL. Blood was 
centrifuged at 3000 rpm and 4˚C for 10 min, plasma aliquots were transferred to 
cryotubes (Protein LoBind, Eppendorf) and, in the case of the sample for ghrelin 
determination, followed by HCl acidification (Merck Millipore) to a final 
concentration of 0.05N, to prevent catabolism of active ghrelin. For plasma leptin 
measurements, the trunk blood collected into EDTA-coated tubes was directly 
centrifuged for plasma separation. Plasma samples were stored at -80°C. Blood 
collection for the glucose tolerance test is explained later in this chapter. 
 
4.4.2. Plasma active ghrelin – Enzyme immunoassay 
 Experiment A (please refer to Chapter 2, ‘Methodological framework’). 
 Analysis of plasma active ghrelin (acyl ghrelin) was performed using 
Rat/Mouse Sandwich ELISA (#EZRGRA-90K, Merck Millipore), according to the 
manufacturer’s instructions. The sensitivity of the assay based on 20μL is 8pg/mL. All 
reagents were brought to room temperature prior to use. Assembled well strips were 




washed three times using wash buffer (300μL/well), followed by the addition of 
Matrix solution (20μL) to blank, standards and quality control wells. Assay buffer was 
added to each of the blank and sample wells (20μL), as well as to each of the standard 
and quality control wells (10μL). Ghrelin standards, QC 1 and 2 and unknown samples 
were added in duplicate (20μL). Antibody solution mixture (1:1 capture and detection 
antibody) was added to each well (50μL) and left for incubation for 2 hours at RT on 
an orbital plate shaker, set at moderate speed. This first reaction consisted of the 
capture of ghrelin molecules in the sample by anti-ghrelin antibody and immobilisation 
of the resulting complex to plate wells, followed by binding of a second, biotinylated 
antibody to ghrelin. Well contents were aspirated and washed three times using wash 
buffer (300μL/well). The enzyme solution (100μL) was dispensed into wells and the 
plate was left for incubation for 30 mins at RT. This second reaction consisted of 
binding of horseradish peroxidase (POD) to the immobilised biotinylated antibodies. 
3,3’,5,5’-tetramethylbenzidine (TMB) substrate solution (100μL) was immediately 
dispensed into wells and left for 5 to 20 mins, depending on the colour development, 
for detection of the POD conjugate. The enzyme reaction was stopped by adding 100μl 
of the enzyme reaction stop solution. Absorbance (A490/A620) was measured within 5 
min and ghrelin concentration was determined via interpolation using the standard 
curve generated by plotting absorbance versus the corresponding concentration of 
ghrelin standards.  
Please refer to Appendix 3 for the standard curve of plasma ghrelin. 
 
4.4.3. Plasma leptin – Enzyme immunoassay 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 




 Analysis of plasma leptin was performed using Mouse Sandwich ELISA 
(CrystalChem, #90030), according to the manufacturer’s instructions. Sensitivity 
range of the assay based on 5μL is 0.2 – 12.8ng/mL. All reagents were brought to RT 
prior to use. Assembled well strips were washed two times using wash buffer 
(300μL/well), followed by addition of sample diluent (45μL) and guinea pig anti-
mouse leptin serum (50μL). Standards and samples (5μL) were added to the wells, 
followed by overnight (16 – 20 hours) incubation at 4°C. This first reaction consisted 
of simultaneous binding of the mouse leptin in the sample to the rabbit anti-leptin 
antibody coated on the microplate well and the anti-leptin IgG of the guinea pig anti-
mouse leptin serum added to each well. On the second day, well contents were 
aspirated and washed five times using wash buffer (300μL/well). The anti-guinea pig 
IgG enzyme conjugate (100μL) was dispensed into wells and the plate was left for 
incubation for 3 hours at 4°C. This second reaction consisted of binding of horseradish 
POD-conjugated anti-guinea pig IgG antibody to the guinea pig anti-leptin IgG of the 
complex immobilised to the microplate well. Well contents were aspirated, washed 
seven times using wash buffer (300μL/well), and the TMB substrate solution (100μL) 
was immediately dispensed into wells and left to react for 30 min at RT, for detection 
of the POD conjugate. The enzyme reaction was stopped by adding 100μl of the 
enzyme reaction stop solution. Absorbance (A490/A620) was measured within 30 min 
and leptin concentration was determined via interpolation using the standard curve 
generated by plotting absorbance versus the corresponding concentration of leptin 
standards. 
Please refer to Appendix 3 for the standard curve of plasma leptin. 
 




4.4.4. White adipose tissue – Lep and Lepr mRNA expression 
Expression of Lep and Lepr was measured in eWAT by RT-qPCR. 
 
4.4.4.1. Epididymal white adipose tissue dissection 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
 As described in Chapter 3. 
 
4.4.4.2. RNA extraction 
 Similar to the RNA extraction from iBAT tissue described in Chapter 3, the 
RNA from frozen eWAT was also extracted using RNeasy Lipid Tissue Mini Kit 
(Qiagen®). However, instead of disrupting tissue in TissueLyser LT (QIAgen®) for 7 
min at 50 Hz, eWAT was disrupted for 5 min at 50 Hz, due to its softer consistency.  
  ‘RNA purity and quantity’ and ‘RNA integrity’ steps were performed as 
shown in Chapter 3 for Ucp-1 mRNA expression. 
 
4.4.4.3. Reverse transcription 
As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
4.4.4.4. Quantitative polymerase chain reaction 
As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
4.4.4.4.1. Primer design 
 Primer pairs for Lep were designed using NCBI Primer-BLAST, with the 
parameters set similarly to Ucp-1 and synthesised by Invitrogen (ThermoScientific™). 
Predesigned KiCqStart® primer pair for mouse Lepr was purchased from Sigma-




Aldrich. Two genes, Gapdh (Matoušková et al., 2014) and Actb, were used as 
housekeeping genes, for increased accuracy of the results (Kozera and Rapacz, 2013). 
 
4.4.4.4.2. PCR efficiency 
As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
Table 4.1. Gene description, primer sequences, qPCR parameters and primer efficiency 









Lep FW: TTTCACACACGCAGTCGGTA 150 63 40 96 
 
RV: GCACATTTTGGGAAGGCAGG 
    
Lepr FW: TTTCACACACGCAGTCGGTA 138 60 30 109 
  RV: GCACATTTTGGGAAGGCAGG         
Actb FW: GGCTGTATTCCCCTCCATCG 154 63 30 103 
 RV: CCAGTTGGTAACAATGCCATGT     
Gapdh FW: AGGTCGGTGTGAACGGATTTG 123 63 40 96 
 RV: TGTAGACCATGTAGTTGAGGTCA     
 
4.4.5. Brain region-specific – Ghs-r1a immunopositive cell number 
 Using stereological methodology, effects of CSS on the total GHS-R1a 
immunopositive cell number was also investigated. Areas of interest included arcuate 
nucleus (ARC) and ventromedial hypothalamus (VMH) within the hypothalamus and 
the ventral tegmental area (VTA) located in the midbrain. The brain samples used for 
this study were obtained from a previous experiment conducted in the same laboratory. 
 
4.4.5.1. Brain tissue dissection and cryosectioning 
 On day 19, in a cohort of mice (CSS N=6, CON N=7) that had not been fasted 
overnight, brains were perfused with 4% paraformaldehyde, removed, post-fixed, 
cryopreserved in 30% sucrose solution and stored at -80C prior to cryostat sectioning. 




Frozen brains were placed in a cryostat set at -19˚C (Bright, model 11122/EX) and 
sectioned coronally at 25µm. Using a mouse brain atlas (Paxinos and Franklin, 2004), 
the following regions were harvested: arcuate nucleus, ventromedial hypothalamus 
and ventral tegmental area (Figure 4.1 and Table 4.2). Collected brain sections were 
stored in sucrose and anti-freezing solution at -20˚C for preservation prior to 
immunohistochemistry. 
 
Figure 4.1. Representative coronal mouse brain sections depicting regions of interest for the 
investigation into effects of 15-day chronic social stress on GHS-R1a cell number, by 
immunohistochemistry. On the left, representative figures (from Paxinos and Franklin, 2004) 
depicting the target region for (A) ARC. (B) VMH. (C) VTA. On the right, representative 
images (from Allen Mouse Brain Atlas) illustrating regions of interest (dark purple). 




Table 4.2. Fundamental details of brain region sectioning, according to The Mouse Brain in 
Stereotaxic Coordinates (Paxinos and Franklin, 2004) 
Brain/region Bregma interval 
ARC, VMH -1.34      –     -1.70 
VTA -2.48      –     -3.68 
Abbreviations: ARC, arcuate nucleus; VMH, ventromedial hypothalamus; VTA, ventral 
tegmental area. 
 
4.4.5.2. Immunohistochemistry incubation 
 The procedure was adapted from Abizaid et al. (2006). Optimisation of 1st Ab 
concentration was performed (1:2000, 1:1000, 1:500 and 1:250) for best staining 
result.  
On day 1, brain sections from CSS and CON mice were 
taken out from the freezer and placed in a 4-well petri-dish (5-7 
sections/well). Petri-dish wells were divided for CSS, CON and BLANK samples. In 
order to wash out storage sucrose solution, samples were washed 5x10min in 10mM 
phosphate buffered saline (PBS) on the vibrant shaker (200rpm/min, RT). Afterwards, 
sections were treated with 1% hydrogen peroxide (H2O2) (Sigma-Aldrich) in 10mM 
PBS for 15 min (200rpm/min, RT) in order to inhibit endogenous peroxidase, followed 
by additional rinsing steps in 10mM PBS (3x10min, 200rpm/min, RT). Blocking 
solution of 10% normal goat serum (VECTASTAIN® Elite® ABC System, Vector 
Laboratories) was added to each well and left for 1h incubation on the vibrant shaker 
(200rpm/min, RT). The blocking solution was then rinsed off with 10mM PBS on the 
vibrant shaker for 5x10min, followed by addition of the 1:250 1st Ab (Rabbit Anti-
GHS-R1a, CYS0 330 336, Phoenix Pharmaceuticals) or vehicle solution (blank). The 
dish was left for 30 min on the vibrant shaker at RT, followed by overnight (20h) 
incubation in ice (200rpm/min). 




On day 2, 1st Ab solution was rinsed off with 10mM PBS for 10 min and in 
0.01% PBST for 5 min on the vibrant shaker, followed by additional rinsing steps in 
10mM PBS (3x10min, 200rpm/min, RT) to remove any excess of unbound 1stAb. The 
second antibody (Goat anti-rabbit IgG, VECTASTAIN® Elite® ABC System, Vector 
Laboratories) was applied and left to incubate for 30 min on the vibrant shaker 
(150rpm/min). During the incubation period, ABC complex (Vectastain Elite 
streptavidin-avidin-peroxidase ABC Kit, PK 6100 Series, Vector Laboratories) was 
prepared and left standing for 30 min. The second Ab was rinsed off with 10mM PBS 
on the vibrant shaker (3x5min, 150/min, RT) followed by the addition of the ABC 
complex (30min, 150rpm/min, RT). This complex has a large protein avidin with a 
high affinity for biotin, a low molecular weight vitamin that can be conjugated with 
antibodies. Avidin can be labelled with peroxidase developed with 3’3 
diaminobenzidine DAB (Sigma-Aldrich) to produce a coloured label. In this case, 
DAB was mixed with ammonium-nickel-sulphate (Sigma-Aldrich) solution to bring 
out details of immunoreactive structures in immunostained preparations, resulting in a 
black reaction production. For the removal of the ABC complex, sections were rinsed 
with 10mM PBS on the vibrant shaker (3x10min, 150/min, RT). The DAB solution 
was applied into wells, incubated for 2 min and the reaction was stopped by application 
of 1% H2O2 in PBS. The solution was aspirated quickly to avoid tissue damage and 
rinsed with 10mM PBS on the vibrant shaker (3x10min, 150/min, RT) to remove the 
excess of DAB. Sections were then gently mounted onto slides with a small brush and 
left to air-dry. Sections were dehydrated with a series of ethanol gradients (50%, 70%, 
90% and 100%), for 5min each and left to air-dry for 10 min. Sections were protected 
with glass cover slips (22x22mm) using mounting media (Histomount®, National 
Diagnostics) and left to air-dry overnight.  




Please refer to Appendix 2 for reagents and solutions. 
 
4.4.5.3. Image analysis 
 GHS-R1a immunoreactive cells in the ARC, VMH and VTA were counted 
using the optical fractionator (Stereo Investigator®, Version 10, Microbrightfield 
Bioscience, Inc.). The neuroanatomical regions of interest were traced based on a 
mouse brain atlas (Paxinos and Franklin, 2004). Unbiased estimation of the total 
number of cells was achieved by choosing every 5th section yielding 5 to 7 sections 
per animal. Average mounted section thickness of 25µm was firstly manually entered 
in the analysis. Top and bottom guard regions of 4µm were used to compensate for 
cell post-processing section damage, and dissector height of 12µm was used for 
counting frame depth. Regions of interested were visualised and traced using a low 
magnification lens (2x); cell counting was performed under higher lens magnification 
(40x). Sampling frame and grid size (X: 100µm, Y: 100µm) were applied (Figure 4.2), 
comprising two inclusion lines (green) and two exclusion lines (red). An object (i.e. 
cell) was not included in the counting if it crossed or was outside the exclusion lines.  
 
Figure 4.2. A representative example of a brain section depicting GHS-R1a positive 
immunoreactive cells and the visualisation of their clearly-defined nuclei (white arrows). 
 




4.4.6. Brain region-specific – Ghs-r1a and Lepr mRNA expression 
 Experiment C (please refer to Chapter 2 for ‘Methodological framework’). 
Expression of genes was measured in selected brain regions by RT-qPCR. 
 
4.4.6.1. Brain tissue dissection, cryosectioning and micro-punching 
 Following completion of in vivo experiments on day 20 (Experiment C) mice 
were fasted overnight and sacrificed for brain collection by decapitation. Brains were 
quickly dissected from the skull, rinsed with ice-cold saline solution, snap-frozen at -
40C in 2-methylbutane (Sigma-Aldrich) and stored at -80˚C until analysis. Prior to 
brain sectioning and punching, all materials including cryostat chambers were 
decontaminated for removal of nucleic acid contaminants (DNA-ExitusPlus™, 
AppliChem). Frozen brains were embedded in optimal cutting temperature (OCT) 
compound, vertically mounted onto the cryostat chuck, placed in the cryostat which 
was previously set at -18˚C (Bright, model 5040 OTF/AS) and cut coronally into 
300µm sections (Figure 4.3). 
 
 
Figure 4.3. Brain mounting onto steel chuck followed by cryostat sectioning. 
 




 Using brain punches (Ø=0.5 and 1 mm, model 57397, Stoelting Europe) and a 
mouse brain atlas (Paxinos and Franklin, 2004), the following regions represented in 
Figure 4.4 and Table 4.3 were microdissected (model OTF5000, Bright) and 
transferred into 2 ml cryotubes (Protein LoBind, Eppendorf). The microdissection was 
conducted at -24˚C chamber temperature. Punches were stored at -80˚C until analysis.  





Figure 4.4. Neuroanatomical regions used for investigation into effects of 15-day chronic 
social stress on region-specific gene expression at day 21, using quantitative PCR with mRNA 
obtained from CSS mice (N=12) and CON mice (N=12). On the left, representative figures 
(from Paxinos and Franklin, 2004) depicting the target region for  (A) mPFC. (B) NAcc. (C) 
PVN. (D) ARC and VMH. (E) VTA. On the right, representative computer-enhanced 
photographs of brain sections taken subsequently to the punch. 




Table 4.3. Anatomical details of brain region microdissection, according to The Mouse Brain 
in Stereotaxic Coordinates (Paxinos and Franklin, 2004) 
Brain/region Bregma interval Ø (mm) 
mPFC 1.98      –     1.42 1 
NAcc 1.42      –     0.74 1 
PVN 0.02      –     -1.94 0.5 
ARC -1.34     –     -1.94 0.5 
VMH -1.34     –     -1.94 0.5 
VTA -2.92     –     -3.80 0.5 
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus (including periventricular nucleus); ARC, arcuate nucleus; VMH, 
ventromedial hypothalamus; VTA, ventral tegmental area. 
 
Initially, Ghs-r1a mRNA analysis was aimed to be completed for all the 
regions mentioned in the table above; nevertheless, due to limitations in the process of 
the RNA extraction, the amount of RNA extracted was not sufficient for investigation 
of the expression of Ghs-r1a mRNA in the mPFC and NAcc. 
 
4.4.6.2. RNA extraction 
 The RNA was extracted from the brain using a RNeasy Micro Kit (Qiagen®), 
designed to purify RNA from small amounts of starting material (up to 5mg). Tissue 
disruption was performed as follows: QIAzol Lysis Buffer RLT (500µL mixed with 
10 µL/ml of 𝛽-mercaptoethanol) was added to each tube containing two stainless steel 
beads (ø 5mm, QIAgen®) and placed in a TissueLyser LT (QIAgen®) for 3 min at 40 
Hz. The lysate was transferred to a new tube and centrifuged for 3 min at full speed 
(14800rpm). The supernatant was then transferred to a new tube, one volume of 70% 
ethanol was added to induce RNA precipitation and the tube vortexed. The solution 
was loaded onto a RNeasy Mini spin column placed in a collection tube and 
centrifuged at 10000rpm for 15 sec at RT. The flow-through was discarded. This 




procedure was performed twice until all tube content had been transferred. Washing 
buffer RW1 (350µL) was added to the RNeasy MinElute spin column, centrifuged at 
10000rpm for 15 sec at RT and flow-through was discarded. DNase I solution (80µL) 
diluted in RDD buffer (RNase-Free DNase Set, QIAgen®) was added directly to the 
spin column membrane. The membrane was left for 15 min at RT to allow DNase 
digestion and gDNA removal. Washing buffer RW1 (350µL) was added to the RNeasy 
MinElute spin column, centrifuged at 10000rpm for 15 sec at RT. Flow-through and 
collection tube were discarded. With a new collection tube, 500µL of washing buffer 
RPE was added to the RNeasy MinElute spin column for removal of salt traces, and it 
was centrifuged again at 10000rpm for 15 sec at RT. 80% ethanol (500 µL) was added 
to the RNeasy MinElute spin column; flow-through and collection tube were 
discarded. The RNeasy spin column was placed in a new collection tube and 
centrifuged at full speed (14800rpm) for 5 min with the lid opened, in order to dry the 
spin membrane and ensure no ethanol was carried over during RNA elution. The 
RNeasy spin column was again placed in a new tube, 14µL of RNase-Free water were 
added directly to the membrane and centrifuged at full speed for 1 min.  
 
4.4.6.2.1. RNA purity and quantity 
As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
4.4.6.2.2. Quality control of RNA extraction 
 Assessment of quality control for RNA extraction was performed using a series 
of 6 punches (0.5-5) from the same brain region (e.g. cortex). Pearson’s Correlation 
Coefficient (r) was calculated. 






Figure 4.5. Linear correlation between the number of cortex punches and RNA yield achieved 
from RNA extraction. Coefficient of correlation r=0.92. 
 
4.4.6.2.3. RNA integrity 
 Visual assessment of RNA integrity could not be performed as a minimum of 
1µg of RNA is generally required in order to successfully run agarose gel 
electrophoresis. 
 
4.4.6.3. Reverse transcription 
 Synthesis of cDNA from the RNA template was performed. Depending on the 
RNA yielded from each brain region punched, different amounts of RNA were used 
per region, but always the same amount was used for all the subjects within the same 
region (Table 4.4). The RNA was then reverse transcribed as performed for Ucp-1 











Table 4.4. Amount of RNA (ng) used for reverse transcription according to brain region 







Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial hypothalamus; VTA, ventral tegmental area; RN, raphe nuclei. 
 
4.4.6.4. Quantitative polymerase chain reaction 
 As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
Table 4.5. Details of the 2-step cycling protocol for qPCR 
1. Pre-incubation 5 min 95°C denaturation   
2. PCR (40 cycles) 10 sec 95°C 
 
  
  30 sec 60°C* annealing/extension 
* specific temperature of primer pairs is described in Section ‘PCR efficiency’. 
 
4.4.6.4.1. Primer design 
 Predesigned primer pairs for Ghs-r1a and Lepr were purchased from 
KiCqStart® (Sigma-Aldrich). The Actb primer pair was designed using NCBI Primer-
BLAST, with the parameters set to create a product of 70-200bp and primer melting 
temperature ranging from 57°C to 63°C. BLAT (BLAST-Like Alignment Tool) from 
UCSC Genome Browser was used to check for primer sequence alignment. Primers 
were synthesised by Invitrogen (ThermoScientific™) and working stocks containing 
both FW and RV primers at a concentration of 10μM were prepared. 




4.4.6.4.2. PCR efficiency 
 As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
Table 4.6. Gene description, primer sequences, qPCR parameters and primer efficiency 









Lepr FW: TTTCACACACGCAGTCGGTA 138 60 30 106 
  RV: GCACATTTTGGGAAGGCAGG         
Ghs-r1a FW: ACAAACAGACAGTGAAGATG 197 60 30 102 
 
RV: TGTAGAGAATGGGGTTGATG 
    
Actb FW: GGCTGTATTCCCCTCCATCG 154 63 30 103 
 RV: CCAGTTGGTAACAATGCCATGT     
 
4.4.7. Glucose tolerance test 
 Experiment A (please refer to Chapter 2 for ‘Methodological framework’). 
 Mice were fasted for 14 hours on CSS day 9. On CSS day 10, between 8-10am, 
a 20% β-D-glucose solution (Sigma-Aldrich) was administered intraperitoneally 
(10μL/g body weight), according to Bowe et al. (2014). Blood samples were drawn 
from the lateral tail vein (50μl/sample) immediately prior to (-1 min) and at 15, 30, 45, 
60 and 120 min after glucose administration (total blood volume 6 x 50 = 300μl). For 
blood collection, the tail of the mouse was warmed with an infra-red lamp to cause 
vasodilatation and the mouse was then placed inside a restraint tube that allowed 
access to the tail (as shown in Figure 4.6). 
 
Figure 4.6. Mouse restrainer, 2’’ diameter tube with sliding nose 
restraint lock knob, ports and tail access for blood collection.  
 




 At the first blood sampling a 1-2mm incision was made on the lateral surface 
of the tail, approximately 15mm from the tip. The tail was then massaged gently, and 
50μL of blood was collected into a capillary tube (Microvette® CB300µl, K2 EDTA, 
Sarstedt) and then placed on ice for analysis of plasma insulin levels. All subsequent 
samples were collected from the same incision site. Immediately after each blood 
draw, a small amount of blood was collected on a blood glucose test strip for 
immediate estimation of the blood glucose level using a hand-held blood glucose meter 
(ACCU-CHEK Aviva, Roche Diabetes Care Limited). Following blood sampling, 
capillary tubes were centrifuged at 3000 rpm and 4˚C for 10 min, plasma aliquots were 
transferred to cryotubes (Protein LoBind, Eppendorf) and stored at -80˚C. 
Please refer to Appendix 2 for the detailed preparation of glucose solution. 
 
4.4.8. Plasma insulin – Enzyme immunoassay 
 Analysis of plasma insulin was performed using Ultra-Sensitive Sandwich 
ELISA Assay for mouse samples (CrystalChem, #90080), according to the 
manufacturer’s instructions. Sensitivity range of assay based on 5μL is 0.1 – 6.4ng/mL. 
The assay had 100% reactivity to mouse insulin but did not cross react with related 
peptides or degradation products. All reagents were brought to RT prior to use. In each 
well of the antibody-coated microplate, 95μL of sample diluent were dispensed, 
followed by 5μL of sample or mouse insulin working standards. This first reaction 
consisted of incubating the plasma with the guinea pig anti-insulin antibody that coated 
the wells of the plates, to allow the binding of insulin. The plate was left for incubation 
for 2 hours at 4˚C. Well contents were aspirated, and wells were washed five times 
using wash buffer (300μL/well). The anti-insulin enzyme conjugate (100μL) was 
dispensed into wells and the plate was left for incubation for 30 min at RT. This second 




reaction consisted of incubating horseradish POD-conjugated anti-insulin antibody to 
the guinea pig anti-insulin antibody/mouse insulin complex immobilised to the 
microplate well. Well contents were aspirated and washed seven times using wash 
buffer (300μL/well). The TMB substrate solution (100μL) was immediately dispensed 
into wells and left to react for 40 min at RT, for detection of POD conjugate. During 
the enzyme reaction, exposing the microplate to light was avoided. The enzyme 
reaction was stopped by adding 100μl of the enzyme reaction stop solution. 
Absorbance (A490/A620) was measured within 30 min, and insulin concentration was 
determined via interpolation using the standard curve generated by plotting absorbance 
versus the corresponding concentration of mouse insulin standards. 
Please refer to Appendix 3 for standard curves of plasma insulin. 
 
4.4.9. Statistical analysis 
 Statistical analysis of the CSS effects on blood glucose, plasma ghrelin, leptin 
and insulin, central GHS-R1a cell number, central Ghs-r1a mRNA expression, eWAT 
Lep and Lepr mRNA expression and central Lepr mRNA expression, was conducted 
using SPSS (version 24, SPSS Inc., Chicago IL, USA). Independent Student’s t-tests 
were conducted for plasma ghrelin and plasma leptin and central GHS-R1a cell 
number. Repeated measures analysis of variance (ANOVA) was conducted in cases of 
a between-subject factor of group (CSS, CON) and a within-subject factor of CSS day 
block (e.g. blood glucose). For the body weight of Experiment A and plasma insulin, 
repeated measures ANCOVA was conducted, with time -1 (i.e. baseline) insulin as the 
covariate. ANOVA and ANCOVA post hoc testing were conducted using Fisher’s 
least significant difference (LSD). Gene expression analysis was carried out using 2-
∆∆Ct method and 𝛽-actin and GAPDH were used as the control genes for normalisation; 




data are given as fold change + standard error of the mean (SEM). Independent 
Student’s t-tests were conducted for each region within each gene study. Statistical 
significance was set at p≤0.05. 






4.5.1. Plasma active ghrelin (Experiment A) 
 There was an effect of Group with higher plasma acyl ghrelin levels in CSS 
compared with CON mice (t(12.25)=-2.229, p≤0.05, Figure 4.7). 
 
Figure 4.7. Effects of 15-day chronic social stress (CSS, N=10), versus control handling 
(CON, N=11) on levels of plasma ghrelin at day 17. *p≤0.05 for CSS versus CON mice 
following an independent Student`s t-test. 
 
4.5.2. Plasma leptin (Experiment C) 
 There was an effect of Group with lower plasma leptin levels in CSS mice 





































Figure 4.8. Effects of 15-day chronic social stress (CSS, N=10), versus control handling 
(CON, N=12) on levels of plasma leptin at day 21. ***p≤0.001 for CSS versus CON mice 
following an independent Student’s t-test. 
 
4.5.3. White adipose tissue – Lep and Lepr mRNA expression (Experiment C) 
There was a significant decrease in eWAT Lep expression in CSS mice 
compared with CON mice, both when using either Actb (t(20)=-3.06, p≤0.01) or 
Gapdh (t(22)=-5.81, p≤0.001) as reference genes. There was no CSS effect on eWAT 
Lepr expression, neither when using Actb (t(22)=0.0095, p=0.92) nor Gapdh (t(22)=-









































Figure 4.9. Effects of 15-day chronic social defeat stress (CSS, N=12), versus control handling 
(CON, N=12) on eWAT Lep and Lepr mRNA expression at day 21. Values are in terms of 
fold change + SEM. **p≤0.01, ***p≤0.001 for CSS versus CON mice following an 
independent Student’s t-test. 
 
 
Table 4.7. Lep and Lepr mRNA expression relative to Actb and Gapdh in eWAT.  




p value  
Lep_Actb 1.16 ± 0.22 2.04 ± 0.18 76.31 0.54 0.006 ** 
Lep_Gapdh 0.60 ± 0.18 2.45 ± 0.26 310.85 0.27 0.0001 *** 
Lepr_Actb 8.27 ± 0.21 8.24 ± 0.28 -0.39 1.02 0.927  
Lepr_Gapdh 7.71 ± 0.28 8.33 ± 0.29 8.13 0.64 0.133  















































































































4.5.4. Brain region-specific – GHS-R1a immunopositive cell number 
 There was no CSS effect on the number of GHS-R1a positive cells on ARC 
(t(12)=-0.9, p=0.38, Figure 4.10A), VMH (t(12)=-0.18, p=0.86) or VTA (t(10)=0.54, 
p=0.59), following an independent Student’s t-test. 
A.                         B.               C. 
  
 
Figure 4.10. Effects of 15-day chronic social stress (CSS) versus control handling (CON) on 
number of GHS-R1a-positive cells in specific brain regions measured using 
immunohistochemistry and stereology at day 19. Individual and mean values are given for (A) 
ARC (CSS=6; CON=8). (B) VMH (CSS=6; CON=8). (C) VTA (CSS=6; CON=6). 
 
4.5.5. Brain region-specific – Lepr and Ghs-r1a mRNA expression  
4.5.5.1. Ghs-r1a mRNA expression (Experiment C) 
There was a significant increase in Ghs-r1a expression in the VMH of CSS 
mice compared with CON mice (t(19)=2.92, p≤0.05) (Figure 4.11, Table 4.8). There 
was no significant difference in Ghs-r1a expression between the CSS and CON groups 
in any other region of the brain investigated. 
 





Figure 4.11. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on region-specific Ghr-r1a mRNA expression at day 21. Values presented as 
mean fold change + SEM. **p≤0.01 for CSS versus CON mice following an independent 
Student’s t-test. Abbreviations: PVN, paraventricular nucleus; ARC, arcuate nucleus; VMH, 
ventromedial nucleus; VTA, ventral tegmental area. 
 
Table 4.8. Ghs-r1a mRNA expression in selected brain regions.  
Brain/region CON ∆Ct CSS ∆Ct Difference 
(%) 
Fold change p value  
PVN 4.15 ± 0.16 4.11 ± 0.14 -0.81 1.02 0.559  
ARC 4.17 ± 0.32 4.54 ± 0.22 2.97 0.91 0.717  
VMH 9.92 ± 0.14 9.35 ± 0.13 -5.70 1.48 0.009 ** 
VTA 6.39 ± 0.15 6.57 ± 0.19 2.83 0.88 0.779  
Abbreviations: PVN, paraventricular nucleus; ARC, arcuate nucleus; VMH, ventromedial 
nucleus; VTA, ventral tegmental area. **p≤0.01. Values of ∆Ct expressed as mean ± SEM. 
n=12 per group. 
 
4.5.5.2. Lepr mRNA expression (Experiment C) 
There was no significant difference in Lepr expression between the CSS and 
















































Figure 4.12. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on region-specific Lepr mRNA expression at day 21. Values presented as fold 
change + SEM. Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; 
PVN, paraventricular nucleus; ARC, arcuate nucleus; VMH, ventromedial nucleus; VTA, 
ventral tegmental area. 
 
Table 4.9. Lepr mRNA expression in selected brain regions.  
Brain/region CON ∆Ct CSS ∆Ct Difference 
(%) 
Fold change p value  
mPFC 9.18 ± 0.14 9.22 ± 0.13 0.45 0.97 0.830  
NAcc 8.28 ± 0.12 8.47 ± 0.17 2.38 0.87 0.379  
PVN 6.15 ± 0.06 6.20 ± 0.11 0.77 0.97 0.744  
ARC 4.59 ± 0.23 3.94 ± 0.07 -8.48 1.28 0.202  
VMH 8.61 ± 0.11 8.76 ± 0.15 1.65 0.91 0.458  
VTA 6.20 ± 0.13 6.47 ± 0.11 4.27 0.83 0.115  
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; ARC, arcuate nucleus; VMH, ventromedial nucleus; VTA, ventral 




















































4.5.6. Glucose tolerance test (Experiment A) 
The GTT was performed on day 10 at which point there was no significant 
difference in body weight between CSS and CON mice (ANCOVA with pre-
CSS/CON body weight as covariate: F(1, 21)=0.005, p=0.94). There was a Group x 
Day block interaction effect on body weight (F(2, 42)=0.468, p≤0.05; however post 
hoc analysis demonstrated that CSS mice did not differ to CON mice in body weight 
at any time point) (Figure 4.13). 
 
 
Figure 4.13. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on absolute body weight. Values are overall means per 5-day block +/- standard 
deviation (SD). P values are for repeated measures ANCOVA. No significant interaction was 
found at any specific day block following LSD post hoc testing. 
 
 
For blood glucose, there was a Group x Sampling time interaction effect: 
F(3.23, 67.91)=3.05, p≤0.05; post hoc analysis demonstrated that at time 30 min, blood 
glucose was higher in CSS than CON mice (p≤0.05) (Figure 4.14A). In terms of blood 
glucose area under the curve (AUC), there was no difference between groups for either 
periods Min -1 to 60 (t(22)=-1.32, p=0.20) or Min -1 to 120 (t(22)=-0.63, p=0.53) 
(Figure 4.14B).  




A.   
 
 
B.   
       
 
 
Figure 4.14. Effects of chronic social stress (CSS, N=12) versus control handling (CON, 
N=12) on levels of blood glucose at CSS day 10 following 14 h fasting. (A) Blood glucose of 
CON and CSS mice across the sampling period. (B) Total area under the curve for glucose at 
Min -1 to 60 and Min -1 to 120. (A) *p≤0.05 following Group x sampling time ANOVA and 
specific post hoc testing using LSD test. 
 
4.5.7. Plasma insulin (Experiment A) 
For plasma insulin, there was a Group x Sampling time interaction effect in 
ANCOVA with baseline insulin as covariate: F(3.27, 62.16)=3.15, p≤0.05. Post hoc 
analysis demonstrated that plasma insulin was lower in CSS than CON mice at times 













































15 min (p<0.01) and 30 min (p<0.05) after glucose administration (Figure 4.15A). In 
terms of plasma insulin AUC, CSS mice had lower plasma insulin levels than CON 
mice at Min -1 to 60 (t(22)=4.32, p≤0.001) and Min -1 to 120 (t(22)=2.69, p≤0.05) 
(Figure 4.15B). When baseline insulin values were compared between groups, CSS 
mice had lower plasma insulin levels than CON mice (t(21)=2.86)=0.009, data not 
shown). Insulin AUC was also calculated after removing baseline values for each 
group, to determine whether there is a group effect for the insulin response to glucose 
injection; here also, CSS mice had lower plasma insulin levels than CON mice at Min 
-1 to 60 (t(18)=2.67, p≤0.05) and Min -1 to 120 (t(17)=2.49, 0.023) (Figure 4.15C). 
Therefore, CSS led to a decrease in baseline insulin as well as a reduced plasma insulin 
response to glucose challenge compared with CON mice. 
 
  


















































C.   
 
 
Figure 4.15. Effects of chronic social stress (CSS, N=12) versus control handling (CON, 
N=12) on levels of plasma insulin at CSS day 10 following 14 h fasting. (A) Plasma insulin 
of CON and CSS mice across the sampling period. (B) Total area under the curve for insulin 
at Min -1 to 60 and Min -1 to 120. (C) Total area under the curve for insulin at Min -1 to 60 
and Min -1 to 120 after removing baseline values. (A) *p≤0.05, **p≤0.01 for CSS versus CON 
mice following Group x sampling time ANCOVA and specific post hoc testing using LSD 
test. (B) and (C) *p≤0.05, ***p≤0.001 for CSS versus CON mice following an independent 
Student’s t-test. 







































 Neuroendocrine regulators of feeding, such as ghrelin and leptin, as well as 
glucose homeostasis, were evaluated for a better understanding of CSS effects on 
peripheral and central systems in the regulation of energy metabolism. Plasma 
concentration of ghrelin was increased in CSS mice compared with CON mice. 
Furthermore, there was a pronounced decrease in plasma levels of leptin, 
concomitantly with a decrease in eWAT mass. With regards to leptin (Lep) and leptin 
receptor (Lepr) gene expression in eWAT, CSS mice showed decreased eWAT Lep 
mRNA expression and no change in eWAT Lepr mRNA expression, compared with 
CON mice. In terms of hypothalamic levels of receptor expression, there was no effect 
of CSS on Lepr mRNA expression in any sub-region investigated, whilst Ghs-r1a 
expression was increased in VMH specifically. With respect to the number of GHS-
R1a immunopositive cells, there was no CSS effect in the ARC, VMH or VTA. In 
fasted mice, the GTT revealed an increased blood concentration of glucose at time 30 
min in CSS mice specifically. Plasma levels of insulin were consistently lower in CSS 
mice than in CON mice.  
  
4.6.1. Ghrelin system 
 Assessment of plasma acyl ghrelin was performed on CSS day 17 of 
Experiment A. CSS mice had higher plasma ghrelin levels than CON mice. Similar 
studies using chronic social stress also observed an increase in plasma levels of ghrelin 
(Chuang et al., 2011; Kumar et al., 2013; Patterson et al., 2013) and at least up to four 
weeks post-stress (Lutter et al., 2008). Chronic stress studies using different protocols, 




for example a study where rats were placed in a cage filled with water to a height of 2 
cm, also reported increased plasma active ghrelin levels (Ochi et al., 2008). Moreover, 
Ochi et al. (2008) also reported an increase in the number of ghrelin-immunoreactive 
cells in the gastric body, as well as an increase in preproghrelin mRNA expression 
(Ochi et al., 2008). Effects of water avoidance stress (i.e. acute psychosocial stress) on 
circulating ghrelin levels were investigated in anxiety-associated rat strains; ghrelin 
levels were found to be increased by 80% in a low-anxiety rat strain and by 40% in a 
high-anxiety rat strain (Kristenssson et al., 2006). These results show consistent effects 
of stress on plasma ghrelin across protocols of different chronicity and methodologies.  
 In parallel to the evaluation of peripheral levels of acyl ghrelin, effects of CSS 
on central ghrelin receptor expression was also performed. As previously mentioned, 
some amelioration of stress-related symptoms appears to be mediated by the ghrelin 
receptor. Thus, Lutter et al. (2008) demonstrated that mice lacking ghrelin receptor 
exhibited increased depressive-like symptoms. Furthermore, Patterson et al. (2013) 
demonstrated that stress-induced increase in body weight gain and a tendency to 
increase in food intake was ablated in GHS-R KO mice. Although previous studies 
showed that the effects of chronic social stress on body weight and food intake were 
linked to central GHS-R1a (Patterson et al., 2013), effects of CSS on central GHS-R1a 
were not investigated. The GHS-R1a is found prominently in hypothalamic nuclei 
such as ARC and VMH, and in the VTA, implicated in food reward and addition (Guan 
et al., 1997; Zigman et al., 2006; Chuang et al., 2011). Therefore, we examined the 
mRNA expression of Ghs-r1a by qPCR in discrete hypothalamic sub-regions 
associated with regulation of feeding, and the number of GHS-R1a positive cells in 
these sub-regions.  




  There was a significant increase in Ghs-r1a mRNA expression in the VMH of 
CSS mice compared with CON mice. There was no significant difference in Ghs-r1a 
mRNA expression between the CSS and CON groups in any other region of the brain 
investigated. There was no effect of CSS on GHS-R1a positive cell number in the 
ARC, VMH or VTA.   
 Increased levels of ghrelin and enhanced ghrelin signalling through activation 
of central GHS-R1a have been shown to play an important role in protecting 
chronically stressed rodents from the development of depressive-like symptoms 
(Kanehisa et al., 2006; Lutter et al., 2008; Chuang et al., 2011). Furthermore, another 
recent study reported that chronic peripheral treatment with ghrelin was able to 
alleviate anxiety- and depression-like symptoms promoted by CUMS (Huang et al., 
2017). Nevertheless, the mechanisms by which ghrelin modulates depressive-related 
behaviour is yet unclear; the well-defined influence of ghrelin on food intake indicates 
that ghrelin may exert a role as anxiolytic and antidepressant at the cost of increased 
food intake, as suggested by Lutter et al. (2008). The majority of neuroendocrine 
systems are regulated by a process of negative feedback, in which increased levels of 
hormones induce downregulation of central receptors, counterbalancing hormonal 
signalling. Therefore, it is particularly striking that an increase in Ghs-r1a mRNA 
expression in a hypothalamic nucleus is co-occurred with an increase in plasma acyl 
ghrelin levels. Of note, mRNA levels of both stomach ghrelin and hypothalamic Ghs-
r1a were upregulated together after fasting (Kim et al., 2003).  
 
4.6.2. Leptin system 
 Stress is known to affect regulation of energy balance through changes in body 
fat storage and metabolism. With regards to the effects of CSS on fat tissue mass, 




eWAT mass was evaluated. A decrease in eWAT in CSS mice in comparison to CON 
mice was observed. This is in accord with previous studies (Bartolomucci et al., 2004; 
Chuang et al., 2010b; Balsevich et al., 2014). Nevertheless, an increase in the visceral 
fat pad in stressed mice following chronic social stress protocol was also observed in 
other studies (Patterson et al., 2013; Coccurello et al., 2017).  
 With regards to the effects of CSS on leptin levels, a previous study from the 
same laboratory reported a decrease in plasma leptin (-60%) in non-fasted CSS mice 
relative to CON mice (Bergamini et al., 2016). Consistent with this finding, CSS mice 
again had lower (-90%) leptin levels compared with CON mice. The larger decrease 
in plasma leptin observed in the present study is likely due to decreased body weight 
gain and fat pads in CSS mice, compared to no change in body weight observed by 
Bergamini et al. (2016). Findings with the current CSS model are in accord with other 
studies that observed a decrease in plasma leptin in various rodents models of stress 
(Lu et al., 2006; Chuang et al., 2010b; Finger et al., 2011, 2012; Ge et al., 2013; 
Balsevich et al., 2014; Iio et al., 2014). In mice, decreases in plasma leptin have been 
observed up to several weeks after chronic social stress. A decrease in plasma leptin 
was observed 30 days after the 10-day stress period in mice under chow or HFD by 
Chuang et al. (2010b), as well as following 21 days of chronic social stress by 
Balsevich et al. (2014). Moreover, reduced plasma leptin following chronic social 
stress in mice on both low and HFD was observed, but interestingly the effect was 
more pronounced in mice on an HFD (Finger et al., 2011, 2012). As previously 
mentioned, a decrease in plasma leptin following 10-day stress period was also 
observed by Kumar et al. (2013) specifically during the late night/early dark phase. 
Interestingly, an absence of the stress effect on plasma leptin was also observed: 
despite a decrease in abdominal fat mass (Razzoli et al., 2011a, b, c), with an increase 




in body weight gain (Razzoli et al., 2011a, b), and without a change in body weight 
(Razzoli et al., 2011c). The protocol developed by Razzoli and colleagues comprised 
four weeks of single housing in addition to the 10-day chronic social stress. A previous 
study in isolated rats reported increased plasma leptin levels (Perelló et al., 2006), thus 
the included single housing period in Razzoli studies might have exerted 
counterbalancing effect on the leptin lowering often observed in stressed animals. A 
recent meta-analysis conducted on the effects of single housing on visceral fat mass in 
rodents reported a significant increase in fat mass in individually housed compared 
with socially housed animals (Schipper et al., 2018); this would be expected to co-
occur with an increase in plasma leptin levels. Chronic social stress and social isolation 
may influence fat metabolism and leptin signalling in different manners, possibly 
explaining the leptin findings observed by Razzoli et al. (2011a, b, c).  
 Furthermore, in order to consider the genetic expression of leptin in WAT and 
therefore evaluate the self-regulatory function of adipocytes in protein synthesis, 
assessment of Lep mRNA expression was performed. In the same cohort used for 
plasma leptin analysis, a significant decrease in expression of eWAT Lep mRNA in 
CSS mice compared with CON mice was observed. This demonstrates that the 
reduction in plasma leptin observed is related not only to the decrease in eWAT mass 
but also to the reduced eWAT Lep mRNA expression, the latter possibly being 
associated with adipocyte size (Guo et al., 2004) and not necessarily with WAT mass. 
To my knowledge, this is the first study to assess the effects of CSS on Lep mRNA 
expression in eWAT in mice. In rats, Iio et al. (2014) observed a decrease in Lep 
mRNA expression in eWAT, concomitant with a decrease in plasma leptin and fat 
tissue, following five weeks of daily social defeat.  




 Therefore, in this experiment, CSS led to no change in food intake despite a 
decrease in plasma leptin, a decrease in eWAT mass and a decrease in eWAT Lep 
mRNA expression, and, as would be predicted, there was a decrease in body weight 
gain. Assessment of Lepr mRNA expression by qPCR, in brain regions associated with 
homeostatic regulation of feeding, was performed, however the present study did not 
show any significant difference in Lepr in any of the brain regions investigated. To my 
knowledge, assessment of Lepr mRNA expression within the brain, in animal models 
of depression has not been conducted until the present moment.  
 
4.6.3. Glucose homeostasis 
 In rodents, stress is known to affect glucose metabolism (Black, 2006; Chuang 
et al., 2010a; Kanarik et al., 2011). For evaluation of the effects of CSS on glucose 
homeostasis, a fasted GTT was performed at day 10. CSS mice had a higher blood 
concentration of glucose at 30 min following i.p. administration of glucose compared 
with CON mice. This increase in blood glucose at time point 30 min indicates a mild 
impairment in glucose processing/homeostasis in CSS mice. This might be attributable 
to reduced insulin release/secretion from the pancreas into the bloodstream. Indeed, 
lower plasma insulin levels were observed in these CSS mice compared with CON 
mice. A decrease in plasma insulin was observed in a previous chronic stress study in 
mice, by Balsevich et al. (2014), and under conditions of both normal chow diet and 
HFD. It will be important to investigate whether plasma insulin is also reduced in non-
fasting mice. A possible cause of the decrease in insulin may be the enhanced plasma 
ghrelin found in CSS mice compared with CON mice. Previous studies showed that 
mice overexpressing the active form of ghrelin had attenuated glucose-stimulated 
insulin release (Bewick et al., 2009). In line with this, blockade of endogenous ghrelin 




were shown to increase levels of insulin, likely by preventing Ca2+ signalling in -cells 
(Dezaki et al., 2004). The majority of studies of chronic social stress observed the 
development of insulin resistance. For instance, Chuang et al. (2010a) observed 
increased fasting glucose levels accompanied by elevated insulin levels. Increased 
insulin levels and insulin resistance have been mostly observed in chronically stressed 
mice on a HFD (Finger et al., 2012; Sanghez et al., 2013). Indeed, when observed 
under a chow diet, no change in insulin levels was observed in chronically stressed 
mice (Sanghez et al., 2013; Tsuneki et al., 2013).  
 Interestingly, glucose homeostasis is regulated not only by insulin but also by 
the fasting hormone leptin, both acting in the central nervous system to regulate food 
intake and adiposity (Benoit et al., 2004). Previous studies showed that insulin 
enhanced leptin synthesis and secretion, in order to promote a decrease in food intake 
and therefore to regulate body weight gain (Inui et al., 2012). A decrease in levels of 
insulin in CSS mice might lead to reduced leptin secretion from adipose tissue, 
resulting in the observed lower leptin levels. Conversely, an increase in leptin levels 
was reported to promote a reduction in glucose-stimulated pancreatic insulin secretion, 
insulin delivery and lipogenesis (Paz-Filho et al., 2012); thus low levels of leptin 
observed here could be expected to enhance insulin secretion; nevertheless, this is not 
the situation.  
 In addition, ghrelin has also been shown to regulate glucose homeostasis and 
insulin secretion in both rodents and humans. In mice, ghrelin inhibited glucose-
stimulated insulin secretion in a dose-dependent manner (Reimer et al., 2003). In rats, 
ghrelin did not significantly alter basal insulin, but it inhibited insulin secretion in 
response to increased blood glucose (Egido et al., 2002). In humans, administration of 
ghrelin promoted hyperglycemia and suppressed insulin secretion (Broglio et al., 




2001; Arosio et al., 2003). Moreover, low levels of ghrelin were associated with 
increased insulin and insulin resistance in mice (Pöykkö et al., 2003). Conversely, 
insulin infusion decreased plasma ghrelin (Saad et al., 2002). Therefore, an increase 
in ghrelin levels observed in the present study might explain the low levels of insulin 
in CSS mice. 
 The decreased levels of insulin found in this study suggest that CSS in mice 
might be leading to reduced efficiency in the use of glucose or increasing glucose 
demand for metabolic processes such as for brain function and execution of stress-
coping tasks. The brain does not require insulin in a direct manner; therefore it can be 
speculated that decreased insulin levels correspond to lower (or slower) peripheral 
glucose storage thus increased likelihood of brain glucose uptake. The speculation that 
CSS mice might be using up available glucose for metabolic processes is reinforced 
by the increased RER and the decreased accumulation of eWAT observed here, 
suggesting that great energy requirements by stressed animals limit fat storage. 
Increased fat mass is not observed in CSS mice in the present study, and CSS mice 
might be using the available glucose at an increased rate, not allowing sufficient time 
for fat storage and usage. The great energy demand for brain function, believed to be 
occurring in this case, has limited glucose availability to peripheral organs, making 










 In summary, the results presented in this chapter demonstrated that CSS in 
mice led to peripheral metabolic changes consistent with increased energetic 
requirements; CSS induced changes in the neuroendocrine regulators of energy 
metabolism and feeding, leptin and ghrelin in a pattern associated with increased 
appetite. CSS also led to a decrease in plasma insulin co-occurring with impaired 
glucose metabolism. We can speculate that stress induces changes in areas including 
the brain, which leads to increased demand for glucose for energy metabolism. This 
may lead to neuroendocrine changes consistent with increasing the drive to eat, 














CHAPTER 5  
 
 




















The emergence of psychopathology in humans is widely associated with 
stressful events experienced throughout life. Recent neuroscience research advances 
in the pathophysiology of mood-related disorders, e.g. depression, have been focused 
on the regulatory mechanisms of the serotonergic system (Fujita et al., 2017; James et 
al., 2017; Xu et al., 2018). Anatomical and molecular similarities of the human and 
rodent serotonergic systems facilitate translational research; it makes experimental 
studies of 5-HT and its receptors in mice relevant to answering research questions 
which also refer to human physiology and neurobiology (Figure 5.1). 
 
 
A.       B. 
 
Figure 5.1. Schematic sagittal view of serotonergic projections in human and mouse brains, 
depicting 5-HT neuron clusters allocated within the raphe nuclei. (A) Serotonergic pathway 
of the human brain. Figure adapted from Kalat (1998), Biological Psychology 6th edition. (B) 
Serotonergic pathway of the mouse brain. Figure adapted from Murphy and Lesch (2008), 
Nature Reviews Neuroscience, p91, ©2008 Springer Nature. Abbreviations: B1, raphe 
pallidus nucleus; B2, raphe obscurus nucleus; B3, raphe magnus nucleus; B4, dorsolateral 
raphe obscurus; (B5, B8) MRN, medial raphe nucleus; (B6, B7) DRN, dorsal raphe nucleus; 
B9, pontis oralis nucleus; MFB, medial frontal bundle. 
 




The serotonergic system not only plays a role in the development of stress-
related depressive symptoms, as addressed below, but it also modulates reward 
processing and feeding regulation (Kranz et al., 2010). Anticipatory reward of and 
gratification through food consumption can activate a range of brain regions, e.g. 
nucleus accumbens, ventral tegmental area, prefrontal and cingulate cortices, some of 
the hypothalamic nuclei, and amygdala (Yager et al., 2015), which triggers a repetitive 
behaviour in order to keep experiencing this positive sensation. Brain reward signals 
can override signals of satiety, leading to overeating and, as a result, obesity (Yu et al., 
2015). Mice subjected to chronic social stress in adulthood showed an increased food 
intake, for at least one month after the defeat period, in the absence of weight gain, but 
with reduced effortful motivation to obtain the gustatory reward (Chuang et al., 2011; 
Pryce and Fuchs, 2017). An increased intake of highly palatable foods was reported in 
socially stressed mice, independent of signs of hyperphagia or hypophagia (Chuang et 
al., 2011). There is growing evidence that brain reward activation can buffer stress 
effects and there are plausible links between reward and resilience to stress, as recently 
reviewed (Dutcher and Creswell, 2018).  
The role of stress in the modulation of the serotonergic system, including 5-
HT receptors and transporter, and its implication in feeding behaviour is not fully 
understood. This chapter is therefore focused on the effects of stress on the three 
selected 5-HT receptors known to modulate mood-related and eating behaviours: 5-
HT1A, 5-HT2A and 5-HT2C, and the serotonin transporter, SERT. 
 




5.1.1. Stress and serotonin receptors 
5.1.1.1. Stress and serotonin 5-HT1A receptor 
5-HT1A receptor is involved in the stress-related regulation of the HPA axis 
with the limbic system and modulation of depressive-like symptoms in humans and 
rodents, as explained below. Thus in depressed and chronically psychosocially 
stressed subjects, PET studies showed reduced 5-HT1A binding potential (BP) in the 
limbic brain regions such as the hippocampus, insular cortex, anterior cingulate and 
RN (Sargent et al., 2000; Jovanovic et al., 2011). In regards to the role of 5-HT1A in 
the HPA axis regulation, the 5-HT1A agonist 8-OH-DPAT administered into the PVN 
was shown to activate PVN CRH neurons (Bovetto et al., 1996), increase  plasma 
ACTH (Pan and Gilbert, 1993; Petrunich-Rutherford et al., 2018) and corticosterone 
release (Bovetto et al., 1996). It was also able to relieve depressive symptoms in rats 
(Jiang et al., 2014). In the hippocampus, however, activation of 5-HT1A appears to 
have an opposing role. In hippocampal cell cultures, stimulation of 5-HT1A by 
application of 5-HT increased GR density (McAllister-Williams et al., 1998). The role 
of hippocampal GR in the HPA axis regulation is to inhibit CRH release via the 
inhibitory feedback to PVN CRH neurons (Herman et al., 2016). The involvement of 
glucocorticoid resistance in depression, due to impaired GR function, has been 
considered (Anacker et al., 2011).  
In mice, chronic mild stress (CMS) led to a reduced sensitivity of DRN 5-
HT1A autoreceptors, likely in response to their overactivation (property displayed by 
many GPCRs), but not in GR-impaired mice (i.e. mice bearing GR antisense RNA) 
with a deficit in the HPA negative feedback (Froger, 2004). A slow increase in the 
inhibition of DRN following 5-HT1A agonist (i.e. reduced sensitivity) and a reduced 
serotonergic firing activity was also reported in rats following chronic unpredictable 




stress, co-occurring with anhedonic-like symptoms (Bambico et al., 2009). Acute 
suppression of RN 5-HT1A autoreceptors by administration of small interference 
RNA (siRNA) enhanced 5-HT release and promoted antidepressant-like effects in 
mice under stressful conditions (Ferrés-Coy et al., 2013). 
In the context of feeding regulation, as mentioned in Chapter 1, 5-HT1A 
agonists were shown to stimulate feeding in rats (Williams and Dourish, 1992; Voigt 
et al., 2002). It is plausible that stress causes an increase in food intake through the 
modulation of the 5-HT1A receptor and decreasing availability of extracellular 5-HT 
in animal models of stress such as the chronic mild stress and chronic unpredictable 
stress (Froger, 2004; Bambico et al., 2009). 
 
5.1.1.2. Stress and serotonin 5-HT2A receptor 
In regards to the 5-HT2A receptor, its modulation seems to play an essential 
role in depressive-like symptoms, however, studies are divergent. A downregulation 
of Htr2a was reported in BLA of rats under learned helplessness stress (Jiang et al., 
2009) and mice following chronic social stress and co-occurring with increased 
acquisition of fear and helplessness (Azzinnari et al., 2014). As previously mentioned, 
5-HT2A receptors are highly expressed in GABAergic interneurons in various regions 
of the brain, e.g. amygdala and VTA (Guiard and Di Giovanni, 2015); administration 
of 5-HT2A agonist in the BLA increased the frequency and amplitude of inhibitory 
postsynaptic currents (Jiang et al., 2009). In rats, acute injection of 5-HT2A agonist 
into the mPFC, a region with extensive neural connectivity with the limbic structures 
e.g. amygdala (Arco and Mora, 2009; Park et al., 2018), was able to block depression-
like behaviours, such as a deficit in perseveration and shorter latency of immobility, 
following chronic mild stress (Natarajan et al., 2017).  




The 5-HT2A receptor agonist DOI can cause an up-regulation of the BDNF in 
selected brain regions, including the hippocampus, prefrontal cortex, amygdala and 
nucleus accumbens in a rat model of acute psychosocial stress (Jiang et al., 2016). 
BDNF is widely associated with neuronal differentiation and development, and is 
essential for the molecular mechanisms of synaptic plasticity; the survival of 5-HT 
neurons depends on trophic factors such as BDNF (Martinowich and Lu, 2008). 
Interestingly, rats exposed to acute swim stress produced rapid transcriptional changes 
in BNDF isoforms and chronic treatment with the serotonin-noradrenaline reuptake 
inhibitor antidepressant duloxetine was able to modulate these effects (Molteni et al., 
2009). 
In contrast, inactivation of this receptor was also shown to be beneficial in 
animal models of depression. For instance, the 5-HT2A antagonist BIP-1 decreased 
duration of immobility in mice during a forced swim test (Pandey et al., 2010). 
Furthermore, i.p. administration of the 5-HT2A antagonist SR-46349B in mice 
partially reverted the delayed nesting (i.e. motivation behaviour) promoted by acute 
social stress (Otabi et al., 2017).  
5-HT2A receptors are also thought to be implicated in the modulation of 
feeding, however, studies are limited. For instance, 5-HT2A gene polymorphism of 
the promoter region was associated with eating disorders such as anorexia nervosa 
(Collier et al., 1997; Ricca et al., 2002). Further studies on the role of 5-HT2A in 
feeding behaviour are required. 
 
5.1.1.3. Stress and serotonin 5-HT2C receptor 
 5-HT2C receptors appear to be involved in the response to stress, as 5-HT2C-
KO mice are more responsive to repeated stress than WT mice, displaying increased 




levels of ACTH and corticosterone (Chou-Green et al., 2003). However, the role of 
stress in the modulation of 5-HT2C receptors and the relevance of this to stress-related 
depressive symptoms are not well established.  
 5-HT2C receptors are also implicated in the regulation of mood and anxiety 
disorders. Thus 5-HT2C agonists increased anxiety in a social interaction test in mice 
(Mongeau et al., 2010), whereas 5-HT2C antagonists were anxiolytic in both mice 
(Rainer et al., 2012) and humans (Demyttenaere, 2014). It was recently shown that the 
5-HT2C antagonist SB242,084 works in parallel to SSRIs, potentiating antidepressant 
effects in patients (Demireva et al., 2018). 
 In the context of feeding regulation, as previously mentioned, 5-HT2C 
receptors are thought to be necessary for the control of eating behaviour. 5-HT2C 
agonists were shown to decrease food intake (De Vry and Schreiber, 2000) whereas 
the 5-HT2C antagonist risperidone increased food intake and body weight (Kursungoz 
et al., 2015). Effects of CSS on the modulation of 5-HT2C receptors with implications 
in feeding behaviour are not yet established. 
 
5.1.2. Stress and serotonin transporter 
 Stress is known to exert effects not only on the 5-HT receptors but also on 
SERT. In response to social stress in rodents, Sert mRNA and SERT protein 
expression were found to be upregulated in DRN (Filipenko et al., 2002; Zhang et al., 
2012) and amygdala (Azzinnari et al., 2014). However, a decrease in SERT binding in 
RN was also found in chronically stressed rats (McKittrick et al., 2000). In primates, 
the gene encoding SERT contains a regulatory variation that contributes to individual 
differences in anxiety-related traits and susceptibility for depression (Canli and Lesch, 
2007). In line with that, SERT became a recognised target for treating stress-related 




disorders such as depression; by functionally blocking SERT activity in the 
presynaptic neurons, SSRIs increase the availability of 5-HT at the synaptic cleft (for 
review, see Otte et al., 2016). SSRI drugs such as fluoxetine and citalopram were 
shown to revert stress-induced decrease in the locomotor activity and rearing 
behaviour in rats submitted to a chronic social stress regimen (Rygula et al., 2006a, b). 
The inhibitory effect of SSRIs on 5-HT signalling is linked to the overactivation of 5-
HT1A autoreceptors in the DRN. The SSRI-promoted increase in 5-HT activates 
presynaptic inhibitory 5-HT1A autoreceptors and leads to a subsequent decrease in 
serotonergic firing rate (Celada et al., 2013). It was shown that 5-HT1A antagonists 
did not reverse these inhibitory effects in the DRN, but 5-HT2A antagonist 
(MDL100,907) reversed the signal response, an indication that inhibition of both 
receptors was required for the prevention of these inhibitory effects (Quesseveur et al., 
2013) and effective treatment of depression. 
 In humans, PET imaging and postmortem studies also demonstrated reduced 
SERT binding and expression in the brains of individuals with depression (Arango et 
al., 1995; Malison et al., 1998; Willeit et al., 2000; Parsey et al., 2006). Although 
effects of stress on SERT have been widely investigated in RN, amygdala and other 
brain areas, the results are somewhat controversial and stressor-dependent. Further 
investigation into the effects of stress on the regulation of SERT and expression of its 
gene Slc6a4 is required.  
 
In the present study, complementary to the experiments on the effects of CSS 
on homeostatic regulators of feeding presented in Chapter 4, the ligand-binding 
activity of the 5-HT1A, 5-HT2A, 5-HT2C receptors in mouse brain regions implicated 
in the central regulation of food intake or reward evaluation was investigated using 




quantitative autoradiography. Moreover, the effects of CSS on the gene expression of 
the aforementioned 5-HT receptors as well as Sert were investigated using quantitative 
polymerase chain reaction. Quantification of 5-HT receptors and Sert in such regions 
provides a better understanding of the effects of CSS on the central regulatory 










Chronic social stress in mice: 
5.2.1. Alters ligand-binding activity of the 5-HT receptors in mouse brain regions that 
are implicated in the central regulation of food intake or reward evaluation.  
5.2.2. Alters mRNA expression of the 5-HT receptors and serotonin transporter in 
mouse brain regions that are implicated in the central regulation of food intake or 





To investigate the effects of chronic social stress on: 
5.3.1. 5-HT1A, 5-HT2A and 5-HT2C receptor binding in mouse medial prefrontal 
cortex (mPFC), nucleus accumbens (NAcc), ventral tegmental area (VTA), amygdala 
(Amy), hypothalamus (Hyp), dorsal raphe nucleus (DRN), hippocampus (Hipp) and 
locus coeruleus (LC), by means of quantitative autoradiography. 
5.3.2. Htr1a, Htr2a, Htr2c and Slc6a4 (Sert) mRNA expression in mouse medial 
prefrontal cortex (mPFC), nucleus accumbens (NAcc), paraventricular nucleus of 
hypothalamus (PVN), basolateral amygdala (BLA), arcuate nucleus (ARC), 
ventromedial hypothalamus (VMH), ventral tegmental area (VTA) and raphe nuclei 
(RN), by means of quantitative PCR. 
 






5.4.1. 5-HT1A, 2A and 2C receptor binding – quantitative autoradiography 
Quantitative autoradiography is a highly specific method that uses radioactive 
biochemical substances for detection of pharmacologically characterised receptors in 
biological tissue. This technique requires radioligands of high affinity, high receptor 
specificity and low non-specific binding. Elimination of non-specific binding and 
appropriate system calibration provides an anatomically discrete, reproducible 
quantification of specific binding of the binding sites of interest. 
 
5.4.1.1. Study design 
 In a cohort of mice exposed to CSS or control handling (CSS N=8, CON N=8), 
quantitative autoradiography of 5-HT1A, 5-HT2A and 5-HT2C receptors was 
performed in brain sections of medial prefrontal cortex (mPFC), nucleus accumbens 
(NAcc), ventral tegmental area (VTA), amygdala (Amy), hypothalamus (Hyp), dorsal 
raphe nucleus (DRN), hippocampus (Hipp) and locus coeruleus (LC). 
 
5.4.1.2. Brain tissue dissection and cryosectioning 
 On day 17 after CSS, animals were sacrificed by means of decapitation. Brains 
were quickly dissected from the skull, rinsed with ice-cold saline solution, snap-frozen 
at -40C in 2-methylbutane (Sigma-Aldrich) and stored at -80˚C. Coronal 25µm brain 
sections were cut and stored at -80°C prior to autoradiography. Sections from a total 
of 16 mouse brains were used per radioligand assay. Performed by Michaela Buerge 
(2016). 




5.4.1.3. Material for autoradiography 
The following radioligands were used: [O-methyl-3H]WAY 100635 as 
selective 5-HT1A receptor antagonist, [3H]ketanserin as 5-HT2A receptor antagonist 
and [125I]DOI as 5-HT2C receptor agonist. Due to the absence of high specificity of 
the last two radioligands, masking drugs were used to exclude interfering activities. 
 The radioligands for 5-HT1A and 5-HT2C receptors, [O-methyl-3H]WAY 
100635 (specific activity 80 Ci/mmol) and [125I]DOI (specific activity 2200 Ci/mmol) 
were purchased from American Radiolabelled Chemical Ltd. The radioligand for 5-
HT2A, ketanserin hydrochloride [ethylene-³H] (specific activity 43 Ci/mmol), 
methysergide, MDL 100907 and RS-102221, were purchased from Tocris/Biotechne 
Biosciences UK; tritium microscales were purchased from Amersham UK. Tritium 
sensitive Hyperfilm was purchased from GE Healthcare Life Sciences. All other 
chemicals were purchased from Sigma-Aldrich (Poole, UK).  
 For each radioligand, a range of 32 to 48 slides was used, according to the 
number of regions examined, with 2-3 sections per region per subject. Two slides per 
cassette were selected as the block for non-specific binding. 0.5M Tris buffer was 
prepared for stock in advance; pH was adjusted to 7.5 by adding HCl to the stock 
solution. On the day of the experiment, (0.5M) Tris-HCl stock was diluted 10x and its 
pH was re-adjusted to 7.5. 
Please refer to Appendix 2 for reagents and solutions. 
 
5.4.1.4. Serotonin 5-HT1A receptor binding 
 The procedure was based on Leventopoulos et al. (2009). Frozen brain sections 
were left to thaw for 3 hours before the incubation procedure. Brain sections were pre-
incubated in 0.05M Tris-HCl buffer pH 7.5 for 30 min at room temperature. This step 




ensured that endogenous 5-HT was removed from the brain sections. After the period 
of pre-incubation, Tris-HCl buffer was poured from slides into a glass beaker, and the 
surplus buffer was blotted off the slides with absorbent paper. Brain sections were then 
incubated with 2nM [O-methyl-3H]WAY 100635 (specific activity 80 Ci/mmol) with 
10μM pargyline, a monoamine oxidase inhibitor, for 2h at RT. Non-specific binding 
was determined using 10μM unlabelled 5-HT. A paraffin pen was used to ensure block 
solution did not slip to the other half of sections. Slides were then washed in ice-cold 
Tris-HCl buffer for 2 min and rinsed 3x in cold deionised water, very briefly each time. 
Slides were removed from the racks and placed on plastic trays covered with paper 
tissue. They were left to air dry for 24 hours. 
 
5.4.1.5. Serotonin 5-HT2A receptor binding 
The procedure was based on Dawson et al., (2014). Brain sections were 
preincubated in 0.05M Tris-HCl buffer with pH 7.5 for 5 min at room temperature and 
incubated with 1nM [3H]ketanserin (specific activity 43 Ci/mmol) in 0.05M Tris-HCl 
buffer pH 7.5 with 1μM prazosin (to block binding to adrenergic receptors) and 100nM 
tetrabenazine (to block binding to the vesicular transporter) for 60 min at RT. Non-
specific binding was assessed in the presence of 200μM methysergide (block solution). 
Slides were then washed twice for 30 min in ice-cold Tris-HCl buffer, replacing buffer 
after the first wash and rinsed in cold deionised water for 10 sec.   
 
5.4.1.6. Serotonin 5-HT2C receptor binding 
 The procedure was based on Li et al., 2003. Brain sections were preincubated 
in assay buffer (0.05M Tris-HCl buffer pH 7.5, 0.5mM EDTA, 10mM MgSO4, 0.1% 
ascorbic acid, 0.1% bovine serum albumin, 10uM pargyline) for 30 min at room 




temperature and incubated in 0.2nM [125I]DOI (specific activity 2200 Ci/mmol) with 
100nM MDL 100907 for 1h at room temperature. Non-specific binding was assessed 
using 10μM RS-102221. Sections were washed in ice-cold assay buffer for 2x10min 
and rinsed 3x with cold deionised water. 
 
5.4.1.7. Film exposure 
 Once dried, radiolabelled slides were placed inside cassettes (RPN13642 
18x24cm, Amersham Biosciences). Tritium standard strips were put in the centre. 2-3 
layers of heavy paper (160g/m2) were cut at the same size as the Amersham™ 
Biosciences [3H]Hyperfilm, with a small notch cut on the upper right-hand side, and 
placed at the bottom of the cassette. Autoradiography films were placed on the top of 
the emulsion facing the slides and then 3-4 layers of heavy paper on top to provide 
more pressure and light protection. Cassettes were closed, sealed with silver foil and 
placed at 4°C for the required period of exposure. The same procedure was carried out 
for [3H]ketanserin, [O-methyl-3H]WAY 100635 and [125I]DOI, with 8 weeks, 6 weeks 
and 2 days of exposure, respectively.  
 
5.4.1.8. Film development 
After the appropriate time, the cassettes were opened in a dark room, 
completely isolated from any light source. Films were placed glossy-side down into a 
tray filled with the developing solution: this fluid contains reducing agents in alkaline 
solution that enable the conversion of the remaining silver ions within a crystal to 
metallic silver and the formation of a “negative visual image”. Ensuring that the films 
remained immersed in Kodak™ D19 developer solution, they were gently agitated for 
1 min. Using tweezers, films were removed from the developing tray and placed into 




another tray filled with stop solution, for another minute. Next, they were submerged 
into a fixer solution for 3 min, in order to remove any remaining silver bromide/halide. 
The contact with the fixing solution lasted for a long enough period to remove all silver 
ions. Once fixed, films were transferred into an empty tray and washed with running 
filtered water for a minimum of 30 min. Lastly, developed films were hung up in a 
fume cupboard to air dry overnight. The same procedure was carried out for all the 
films. 
Please refer to Appendix 2 for reagents and solutions. 
 
5.4.1.9. Calibration and image grabbing 
For quantification of radiolabelled tissue sections, MCIDTM Image Analysis 
Software (MCID Basic 7.0, Imaging Research In., Interfocus Ltd, UK) was used. A 
Northern Light desktop illuminator B95 with a Nikon 50mm, f2.8 lens was used to 
capture images. Prior software calibrations were required for reliable image 
acquisition and analysis: Magnification and Focus, Flat Field Correction, Distance and 
Density Calibration.  
Magnification and Focus calibration was performed by adjusting the distance 
between the objective lens of the microscope and the light box until a focused image 
was achieved. In order to do so, the autoradiography film sheet was placed on the light 
box and image was digitalised. Camera height was adjusted until the coronal brain 
section occupied most of the field of view (FOV). As camera images can display some 
intensity variation due to uneven illumination, a Flat Field Correction was made for 
compensation of shading error. The film sheet was removed, and light box intensity 
illumination was adjusted until a blank FOV appeared bluish-pink. A new image was 
acquired, and the flat field correction was completed pixel by pixel. From then on, 




MCID Basic scanned the blank field and was able to determine how much each pixel 
deviated from the mean grey level value. Once established, this correction became part 
of the camera’s default configuration and images acquired were then automatically 
corrected for uneven illumination, providing standardised regulated images. Flat field 
correction was established whenever there was a change in the illumination pattern 
and when a new autoradiography film was used. Distance Calibration was then 
conducted. It established the pixel definition according to FOV distance in centimetres, 
by placing a glass scale in FOV and calibrating horizontal and vertical distances. 
Density Calibration was the last step before the image grabbing. In order to express 
autoradiography data in units of isotope or ligand concentration, a standard curve was 
constructed from the set of standards (RPA510 – RPA506 + RPA507, AmershamTM 
MicroscalesTM) co-exposed with the tissue sections and their related value. Pre-
existing standard values were used for that purpose (Amersham Biosciences, Inc., [3H] 
Microscales RPA506 and RPA507). As each standard was digitalised and sampled, 
MCID Basic plotted the standard curve (density vs. standard values). The system’s 
internal density measurement unit for the standard values was ROD (Relative Optical 
Density). From the constructed curve, a ROD value corresponded to the concentration 
of ligand bound to the tissue area, in nCi/mg. Tritium standards were used for [O-
methyl-3H]WAY 100635 (5-HT1A), [3H]ketanserin (5-HT2A). For [125I]DOI, the 
results were kept expressed as ROD and receptor binding was averaged among the 
three films; density calibration was not applied in that case. After following the 
calibration steps, an image of each section was acquired and saved. The above steps 
were completed whenever a new film was placed on the light box.  
 




5.4.1.10. Image analysis and quantification 
Prior to image analysis, blank sections were sampled for the establishment of 
non-specific binding. On each image, ROI around the specific areas of interest (mPFC, 
NAcc, VTA, Hipp, Hyp, Amy, LC and DRN) were traced freehand for quantification, 
based on a mouse brain atlas (Paxinos and Franklin, 2004) (as shown in Figure 5.2, 
left column). Neuroanatomical images on the left side of Figure 5.2 were taken from 
the Allen Mouse Brain Atlas (Brain Explorer 2.3.2, Allen Institute from Brain 
Science), a digital high-resolution anatomic reference atlas accompanied by a 
systematic, hierarchically organised taxonomy of mouse brain structures. Specific 
binding of each neuroanatomical region was calculated automatically by subtraction 
of non-specific binding from total binding.  
Measurements of standards of each cassette were used for the establishment of 
standard curves, which correlated ROD values with its specific binding in nCi/mg. As 
no reliable iodine standards were available, specific binding of films developed for 5-
HT2C remained shown as ROD.  





Figure 5.2. Neuroanatomical regions used for specific-binding quantification of 5-HT 
receptors. (A) mPFC (green) and NAcc (blue): bregma 1.98. (B) Amy (green and blue): 
bregma -1.06. (C) Hipp (green), VTA (pink), Hyp (red): bregma -2.50. (D) DRN (green): 
bregma -4.16. (E) LC (green): bregma -5.34. Figures on the left were taken from The Mouse 
Brain in Stereotaxic Coordinates (Paxinos and Franklin, 2004). Figures on the right were taken 
from Allen Mouse Brain Atlas software (Brain Explorer 2.3.2, Allen Institute from Brain 
Science). 




5.4.2. Brain-region specific – Htr1a, 2a, 2c, Slc6a4 mRNA expression 
 Experiment A (please refer to Chapter 2 for ‘Methodological framework’). 
Expression of genes was measured in selected brain regions by RT-qPCR. 
 
5.4.2.1. Brain tissue dissection, cryosectioning and micro-punching 
Performed as shown in Chapter 4 for Ghs-r1a and Lepr mRNA expression. 










Figure 5.3. Neuroanatomical regions used for investigation into effects of 15-day chronic 
social stress on region-specific gene expression at day 16, using quantitative PCR with mRNA 
obtained from CSS mice (N=12) and CON mice (N=12). On the left, representative figures 
from Paxinos and Franklin (2004) depicting the target region for (A) mPFC. (B) NAcc. (C) 
PVN. (D) Amy. (E) ARC and VMH. (F) VTA. (G) RN. On the right, representative computer-
enhanced photographs of brain sections taken after micro-punching. 
 




Table 5.1. Anatomical details of brain region microdissection, according to The Mouse Brain 
in Stereotaxic Coordinates (Paxinos and Franklin, 2004) 
Brain/region Bregma interval Ø (mm) 
mPFC 1.98     –     1.42 1 
NAcc 1.42     –     0.74 1 
PVN 0.02     –     -1.94 0.5 
BLA -0.82    –     -1.94 1 
ARC -1.34    –     -1.94 0.5 
VMH -1.34    –     -1.94 0.5 
VTA -2.92    –     -3.80 0.5 
RN -4.36    –     -4.84  1 
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial hypothalamus; VTA, ventral tegmental area; RN, raphe nuclei. 
 
5.4.2.2. RNA extraction 
Performed as shown in Chapter 4 for Ghs-r1a and Lepr mRNA expression.  
 Visual assessment of RNA integrity (ratio 2:1 for 28S/18S RNA bands) could 
not be performed since a minimum of 1µg of RNA is generally required to run agarose 
gel electrophoresis. 
 
5.4.2.3. Reverse transcription 
 Synthesis of cDNA from RNA template was performed. Depending on the 
RNA yield for each brain region, different amounts of RNA were used (Table 5.2). 
RNA was then reverse transcribed, as performed for Ucp-1 mRNA expression, 








Table 5.2. Amount of RNA (ng) used for reverse transcription according to the brain region. 









Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial hypothalamus; VTA, ventral tegmental area; RN, raphe nuclei. 
 
 
5.4.2.4. Quantitative polymerase chain reaction 
 As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
5.4.2.4.1. Primer design 
 Predesigned KiCqStart® primer pairs for mouse Htr1a, Htr2a and Htr2c were 
purchased from Sigma-Aldrich. Slc6a4 primer pair sequence was obtained from 
Filipenko (2002) and synthesised by Invitrogen (ThermoScientific™). Actb primer 
pair was designed using NCBI Primer-BLAST, with the parameters set to create a 
product of 70-210bp and primer melting temperature ranging from 57°C to 63°C. 
BLAT (BLAST-Like Alignment Tool) from UCSC Genome Browser was used to 
check for primer sequence alignment and synthesised by Invitrogen 
(ThermoScientific™). Working stocks containing both forward (FW) and reverse 
(RV) primers at a concentration of 10μM were prepared. 
 
 




5.4.2.4.2. PCR efficiency 
 As performed for Ucp-1 mRNA expression, described in Chapter 3. 
 
Table 5.3. Gene description, primer sequences, qPCR parameters and primer efficiency 









Htr1a FW: CTCACCCTCAGTTTCTTTTC 165 60 30 106 
 
RV: TCTAAGTCTCCAACCTCTTG 
    
Htr2a FW: ATGAAAAGGTTAGCTGTGTG 208 60 30 95 
 
RV: GGCAATGTTAAAAGCATCAC 
    
Htr2c FW: GTCTGGATTTCACTAGATGTG 172 60 30 99 
  RV: GAAACTCCTATTGATATTGCCC         
Slc6a4 FW: TTTGCCATCATCTTCTTCCTCATG 363 60 30 100 
  RV: GGCCACCCAGCAGATCCTC         
Actb FW: GGCTGTATTCCCCTCCATCG 154 63 30 103 
 
RV: CCAGTTGGTAACAATGCCATGT 
    
 
5.4.3. Statistical analysis 
 Statistical analysis of the CSS effects on 5-HT receptor binding and mRNA 
expression was conducted using Statistical Package for the Social Sciences (version 
22, SPSS Inc., Chicago IL, USA). Gene expression analysis was carried out using the 
2-∆∆Ct method, with 𝛽-Actin as the control gene for normalisation. Independent 
Students’s t-test was conducted for each region within each receptor study. Statistical 












5.5.1. Serotonin 5-HT1A, 2A and 2C receptor binding 
5.5.1.1. Serotonin 5-HT1A 
The radioligand distribution of tritium-dependent signal was consistent with a 
high density of 5-HT1A receptors in DRN of the rodent brain. There was a significant 
increase in [O-methyl-3H]WAY 100635 binding in the DRN of CSS mice compared 
with CON mice (t(8.15)=-4.52, p≤0.01, Figure 5.4). There was no significant 
difference in [O-methyl-3H]WAY 100635 binding between the CSS and CON groups 











Figure 5.4. Representative computer-enhanced autoradiograms of [O-methyl-3H]WAY 
100635 total binding in mouse brain, CON and CSS groups. Coronal brain sections were 
incubated with 2nM [O-methyl-3H]WAY 100635 in Tris–HCl with 10μM pargyline for 2 
hours at room temperature. Non–specific binding was defined in the presence of 10mM 5–HT. 
ROIs outlined in white: (A) mPFC and NAcc. (B) Amy. (C) Hipp, VTA, Hyp. (D) DRN, based 
on Paxinos and Franklin (2004). Abbreviations: mPFC, medial prefrontal cortex; NAcc, 
nucleus accumbens; Amy, amygdala; Hyp, hypothalamus; VTA, ventral tegmental area; Hipp, 
hippocampus; DRN, dorsal raphe nucleus. 




Table 5.4. Quantitative autoradiography of 5-HT1A receptors visualised by means of [O-
methyl-3H]WAY 100635 in selected brain regions.  
Brain/region CON CSS Difference (%) p value  
mPFC 13.52 ± 1.10 13.80 ± 1.49 2.01 0.886  
NAcc 15.08 ± 1.25 18.83 ± 1.85 24.90 0.115  
Amy 12.42 ± 1.52 13.43 ± 1.76 8.13 0.671  
Hyp 6.10 ± 0.77 6.30 ± 0.46 3.26 0.834  
VTA 7.42 ± 1.15 7.55 ± 0.98 1.84 0.930  
Hipp 17.71 ± 2.53 21.44 ± 2.81 21.08 0.340  
DRN  10.63 ± 0.89 25.15 ± 3.09 136.58 0.002 ** 
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; Amy, amygdala; 
Hyp, hypothalamus; VTA, ventral tegmental area; Hipp, hippocampus; DRN, dorsal raphe 







Figure 5.5. Effects of 15-day chronic social stress (CSS, N=8), versus control handling (CON, 
N=8) on [O-methyl-3H]WAY 100635 specific binding at 5-HT1A receptor sites. Values 
presented as mean + SEM in nCi/mg. Abbreviations like in Table 5.4. **p≤0.01 for CSS versus 
CON mice following an independent Student’s t-test. Abbreviations: mPFC, medial prefrontal 
cortex; NAcc, nucleus accumbens; Amy, amygdala; Hyp, hypothalamus; VTA, ventral 
tegmental area; Hipp, hippocampus; DRN, dorsal raphe nucleus. 
 




5.5.1.2. Serotonin 5-HT2A 
The radioligand distribution of tritium-dependent signal was consistent with 
the lower density of 5-HT2A receptors in CSS mice compared with CON mice in both 
amygdala and VTA. There was a significant decrease in [3H]ketanserin binding in the 
VTA (t(14)=-4.83, p≤0.001) and amygdala (t(14)=2.32, p≤0.05) of CSS mice 
compared with CON mice (Figure 5.6B).  There was no significant difference in 









Figure 5.6. Representative computer-enhanced autoradiograms of [3H]ketanserin total 
binding in mouse brain, CON and CSS groups. Coronal brain sections were incubated with 
1nM [3H]ketanserin in Tris-HCl buffer with 1μM prazosin and 100nM tetrabenazine for 1h at 
room temperature. Non-specific binding was defined in the presence of 200μM methysergide. 
ROIs outlined in white: (A) mPFC and NAcc. (B) Amy. (C) Hipp, VTA, Hyp. (D) LC (Paxinos 
and Franklin, 2004). Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus 
accumbens; Amy, amygdala; Hyp, hypothalamus; VTA, ventral tegmental area; Hipp, 
hippocampus; LC, locus coeruleus. 




Table 5.5. Quantitative autoradiography of 5-HT2A receptors visualised by means of 
[3H]ketanserin in selected brain regions.  
Brain/region CON CSS Difference 
(%) 
p value  
mPFC 4.77 ± 0.68 3.11 ± 0.63 -34.70 0.098  
NAcc 2.02 ± 0.43 1.74 ± 0.48 -14.10 0.667  
Amy 1.30 ± 0.24 0.67 ± 0.14 -48.22 0.036 * 
Hyp 1.53 ± 0.35 1.25 ± 0.31 -18.16 0.607  
VTA 0.81 ± 0.08 0.32 ± 0.07 -60.62 0.0002 *** 
Hipp 0.95 ± 0.13 0.62 ± 0.13 -35.17 0.088  
LC  1.20 ± 0.20 0.74 ± 0.14 -38.21 0.082  
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; Amy, amygdala; 
Hyp, hypothalamus; VTA, ventral tegmental area; Hipp, hippocampus; LC, locus coeruleus. 





Figure 5.7. Effects of 15-day chronic social stress (CSS, N=8), versus control handling (CON, 
N=8) on [3H]ketanserin specific binding of [3H]ketanserin at 5-HT2A receptor sites. Values 
presented as mean + SEM. Abbreviations like in Table 5.5.*p≤0.05, ***p≤0.001 for CSS 
versus CON mice following an independent Student’s t-test. Abbreviations: mPFC, medial 
prefrontal cortex; NAcc, nucleus accumbens; Amy, amygdala; Hyp, hypothalamus; VTA, 
ventral tegmental area; Hipp, hippocampus; LC, locus coeruleus. 
 




5.5.1.3. Serotonin 5-HT2C 
There was a significant decrease in [125I]DOI binding in the DRN (t(13)=2.36, 
p≤0.05) of CSS mice compared with CON mice (Figure 5.8, Table 5.6). There was no 
significant difference in [125I]DOI binding between the CSS and CON groups in any 









Figure 5.8. Representative computer-enhanced autoradiograms of [125I]DOI total binding in 
mouse brain, CON and CSS groups. Coronal brain sections were incubated with 0.2nM 
[125I]DOI with 100nM MDL 100907 for 1h at room temperature. Non-specific binding was 
assessed using 10μM RS-102221. ROIs outlined in white: (A) mPFC and NAcc. (B) Amy. (C) 
Hipp, VTA, Hyp. (D) DRN. (E) LC (Paxinos and Franklin, 2004). Abbreviations: mPFC, 
medial prefrontal cortex; NAcc, nucleus accumbens; Amy, amygdala; Hyp, hypothalamus; 
VTA, ventral tegmental area; Hipp, hippocampus; DRN, dorsal raphe nucleus; LC, locus 
coeruleus. 




Table 5.6. Quantitative autoradiography of 5-HT2C receptors visualised by means of 
[125I]DOI in selected brain regions.  
Brain/region CON CSS Difference (%) p value  
mPFC 0.0203 ± 0.0041 0.0196 ± 0.0047 -3.88 0.901  
NAcc 0.0232 ± 0.0038 0.0204 ± 0.0047 -12.05 0.650  
Amy 0.0264 ± 0.0031 0.0237 ± 0.0044 -10.29 0.622  
Hyp 0.0228 ± 0.0026 0.0139 ± 0.0046 -38.93 0.099  
VTA 0.0264 ± 0.0039 0.0179 ± 0.0016 -32.01 0.080  
Hipp 0.0188 ± 0.0032 0.0137 ± 0.0022 -27.08 0.223  
DRN 0.0398 ± 0.0058 0.0232 ± 0.0041 -41.62 0.034 * 
LC 0.0297 ± 0.0070 0.0257 ± 0.0048 -13.25 0.645  
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; Amy, amygdala; 
Hyp, hypothalamus; VTA, ventral tegmental area; Hipp, hippocampus; DRN, dorsal raphe 




Figure 5.9. Effects of 15-day chronic social stress (CSS, N=8), versus control handling (CON, 
N=8) on [125I]DOI specific binding at 5-HT2C receptor sites. Values presented as mean 
+ SEM. Abbreviations like in Table 5.6. *p≤0.05 for CSS versus CON mice following an 
independent Student’s t-test. Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus 
accumbens; Amy, amygdala; Hyp, hypothalamus; VTA, ventral tegmental area; Hipp, 
hippocampus; DRN, dorsal raphe nucleus; LC, locus coeruleus. 
 




5.5.2. Brain-region specific – Htr1a, 2a, 2c and Slc6a4 mRNA expression 
(Experiment A) 
 In Experiment A, gene expression of Htr1a, Htr2a, and Htr2c were 
investigated in medial prefrontal cortex (mPFC), nucleus accumbens (NAcc), 
paraventricular nucleus of hypothalamus (PVN), basolateral amygdala (BLA), arcuate 
nucleus (ARC), ventromedial hypothalamus (VMH), ventral tegmental area (VTA) 
and raphe nuclei (RN) including DRN, by means of quantitative PCR.  
 
5.5.2.1. Htr1a 
 There were significant increases in Htr1a expression in CSS mice compared 
with CON mice in the mPFC (t(19)=2.92, p≤0.01), PVN (t(20)=2.08, p≤0.05), VMH 
(t(20)=3.15, p≤0.01) and RN (t(16)=2.18, p≤0.05) (Table 5.7, Figure 5.10). There was 
no CSS effect in the other regions studied. 
 
Table 5.7. Htr1a mRNA expression in selected brain regions.  
Brain/region CON ∆Ct CSS ∆Ct Difference (%) Fold change p value  
mPFC 6.92 ± 0.09 6.49 ± 0.11 -6.22 1.35 0.009 
** 
NAcc 9.94 ± 0.14 9.89 ± 0.21 -0.44 1.03 0.872  
PVN 7.12 ± 0.10 6.85 ± 0.08 -3.85 1.21 0.050 * 
BLA 7.60 ± 0.16 7.61 ± 0.19 0.08 1.00 0.981  
ARC 7.43 ± 0.12 7.01 ± 0.21 -5.74 1.34 0.100  
VMH 6.41 ± 0.13 5.95 ± 0.09 -7.23 1.38 0.005 ** 
VTA 7.02 ± 0.09 6.86 ± 0.15 -2.27 1.12 0.412  
RN 5.38 ± 0.10 5.12 ± 0.06 -4.67 1.19 0.044 * 
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial nucleus; VTA, ventral tegmental area; RN, raphe nuclei. *p≤0.05, **p≤0.01. 
Values of ∆Ct expressed as mean ± SEM. n=12 per group. 
 





Figure 5.10. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on region-specific Htr1a mRNA expression. Values presented as fold change + 
SEM. *p≤0.05, **p≤0.01 for CSS versus CON mice following an independent Student’s t-
test. Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial nucleus; VTA, ventral tegmental area; RN, raphe nuclei. 
 
5.5.2.2. Htr2a 
 There was a significant increase in Htr2a expression in CSS mice compared with CON 
mice in the BLA (t(14.14)=4.284, p≤0.001) (Table 5.8, Figure 5.11). There was no significant 






































































Table 5.8. Htr2a mRNA expression in selected brain regions.  
Brain/region CON ∆Ct CSS ∆Ct Difference (%) Fold change p value  
mPFC 6.55 ± 0.21 6.61 ± 0.09 0.92 0.96 0.797  
NAcc 10.07 ± 0.27 9.47 ± 0.19 -5.97 1.52 0.080  
PVN 6.32 ± 0.10 6.23 ± 0.10 -1.39 1.06 0.545  
BLA 5.80 ± 0.24 4.69 ± 0.11 -19.15 2.16 0.0004 *** 
ARC 7.95 ± 0.16 7.68 ± 0.11 -3.32 1.20 0.201  
VMH 6.56 ± 0.08 6.36 ± 0.09 -2.94 1.14 0.136  
VTA 8.32 ± 0.11 8.55 ± 0.16 2.76 0.85 0.268  
RN 8.73 ± 0.26 9.04 ± 0.11 3.53 0.81 0.288  
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial nucleus; VTA, ventral tegmental area; RN, raphe nuclei. ***p≤0.001. Values of 
∆Ct expressed as mean ± SEM, n=12 per group. 
 
 
Figure 5.11. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on region-specific Htr2a mRNA expression. Values presented as fold change 
+ SEM. ***p≤0.001 for CSS versus CON mice following an independent Student’s t-test. 
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
























































 No effect of CSS on Htr2c mRNA expression in any brain region of interest 
was observed (Table 5.9, Figure 5.12). 
 
Table 5.9. Htr2c mRNA expression in selected brain regions.  
Brain/region CON ∆Ct CSS ∆Ct Difference (%) Fold change p value  
mPFC 7.51 ± 0.07 7.38 ± 0.18 -1.68 1.09 0.535  
NAcc 5.50 ± 0.10 5.60 ± 0.19 1.93 0.93 0.648  
PVN 4.51 ± 0.04 4.40 ± 0.08 -2.52 1.08 0.254  
BLA 5.32 ± 0.12 5.60 ± 0.15 5.23 0.82 0.202  
ARC 7.41 ± 0.17 7.31 ± 0.11 -1.34 1.07 0.615  
VMH 4.43 ± 0.10 4.52 ± 0.14 2.13 0.94 0.590  
VTA 6.19 ± 0.06 6.22 ± 0.12 0.55 0.98 0.809  
RN 4.66 ± 0.08 4.46 ± 0.08 -4.24 1.15 0.087  
Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 
ventromedial nucleus; VTA, ventral tegmental area; RN, raphe nuclei. Values of ∆Ct 
expressed as mean ± SEM. n=12 per group. 
  
 
Figure 5.12. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on region-specific Htr2c mRNA expression. Values presented as fold change 
+ SEM. Abbreviations: mPFC, medial prefrontal cortex; NAcc, nucleus accumbens; PVN, 
paraventricular nucleus; BLA, basolateral amygdala; ARC, arcuate nucleus; VMH, 





















































 There was a significant increase in Slc6a4 expression in the RN of CSS mice 
compared with CON mice (t(18)=3.11, p≤0.05) (Table 5.10). Expression of Slc6a4 
was also investigated in some other brain regions (mPFC, NAcc, PVN, BLA, VTA, 
ARC and VMH). In NAcc and BLA, expression was increased in CSS compared with 
CON mice (data not shown). However, in all regions except RN, there were 
methodological issues with the expression signals in terms of delayed amplification; 
these were probably related to the low expression levels of Slc6a4 in these regions and 




Figure 5.13. Coronal, axial and sagittal view of mouse brain displaying regions where Slc6a4 
are found expressed, using in situ hybridisation data. Figures were taken from Allen Mouse 











Table 5.10. Slc6a4 mRNA expression in selected brain regions.  
Brain/region CON ∆Ct CSS ∆Ct Difference (%) Fold 
change 
p value  
RN 1.24 ± 0.15 0.58 ± 0.15 -53.56 1.59 0.006 ** 
Abbreviation: RN, raphe nuclei. **p≤0.01. Values of ∆Ct expressed as mean ± SEM. n=12 




Figure 5.14. Effects of 15-day chronic social stress (CSS, N=12), versus control handling 
(CON, N=12) on region-specific Slc6a4 mRNA expression. Values presented as fold change 











































Numerous lines of evidence favour the hypothesis that serotonergic 
neurotransmission is sensitive to diverse stressors and it is involved in the processes 
of adaptation to aversive events through stress-related eating behaviours. In this sense, 
the present study also hypothesised that CSS promotes changes in 5-HT receptor 
binding, which therefore can disturb the food-related reward mechanisms. Through 
the analysis of 5-HT receptor localisation, also referred to as “receptor mapping”, it 
was possible to quantify the specific binding of each receptor within the brain regions 
of interest in mice that underwent social stress and compare with controls. The present 
study aimed at investigating the effects of CSS particularly on 5-HT1A, 5-HT2A, and 
5-HT2C receptor binding by means of in vitro quantitative autoradiography, as well 
as Htr1a, 2a, 2c and Slc6a4 mRNA expression by means of quantitative PCR in mouse 
brain regions associated with reward processing. 
 
5.6.1. Serotonin 5-HT1A receptor and Htr1a 
The present study found a markedly increased 5-HT1A specific binding in the 
DRN of CSS mice, as well as Htr1a mRNA expression in the RN, in comparison with 
CON mice. In addition, Htr1a was also significantly increased in the mPFC, PVN and 
VMH of CSS mice compared with CON mice.  
 In the RN, 5-HT1A is a somatodendritic inhibitory autoreceptor located on 5-
HT neurons; it acts by reducing neuronal serotonergic firing rate and 5-HT release in 
all projection targets, including those of interest in this study. In the context of mood 
disorders, it has been shown that subjects with major depressive disorder (MDD) 
exhibit increased 5-HT1A receptor binding in several brain regions, including the RN 




(Hesselgrave and Parsey, 2013; Kaufman et al., 2016). Nevertheless, reduced 5-HT1A 
specific binding in the RN of patients with depression was also observed (Drevets et 
al., 1999; Sargent et al., 2000). In preclinical studies, higher levels of 5-HT1A 
autoreceptors augmented a depressive phenotype in mice (Richardson-Jones et al., 
2010). It is plausible that the present increase in Htr1a mRNA expression in RN, and 
the increase in the autoreceptor 5-HT1A binding activity in DRN in CSS mice can 
result in reduced serotonergic cell firing, diminished synaptic 5-HT levels and 
depressive-like behaviours.  
 In the context of feeding regulation, it was shown that activation of 5-HT1A 
receptors exerted hyperphagic effects (Williams and Dourish, 1992; De Vry and 
Schreiber, 2000; Voigt et al., 2002; Oury and Karsenty, 2011). Further, it has been 
proposed that this is mediated by 5-T1A autoreceptors and a decreased firing activity 
of serotonergic neurons that project from the RN to hypothalamic areas (Magalhães et 
al., 2010). In rats, injection of exogenous 5-HT in the DRN induced feeding, likely by 
promoting activation of 5-HT1A autoreceptors and thus decreasing firing rate of 5-HT 
neurons (Fletcher and Davies, 1990). In accordance with previous findings in the CSS 
model used here (Bergamini et al., 2016), Experiment B in the present study identified 
an increase in food intake in CSS mice compared with CON mice. Bringing these 
findings together, it is appropriate to suggest that the increased expression of 5-HT1A 
in the RN, potentially leading to a decreased 5-HT release, contributes to the increased 
feeding in CSS mice. There was no evidence for 5-HT1A specific binding changes in 
the hypothalamus in the present study.  
As a result of enhanced 5-HT1A binding activity, a decrease in extracellular 5-
HT concentrations could, through negative feedback, promote expression and 
externalisation of putative post-synaptic 5-HT receptors such as 5-HT1A, to maintain 




synaptic signalling in the projection areas. Indeed, CSS mice displayed increased 
Htr1a expression in the mPFC, PVN and VMH. In the mPFC, 5-HT1A receptors  seem 
to modulate anxiogenic-like behaviours in rats (Solati et al., 2011). Electrical 
stimulation of the mPFC, as well as application of the 5-HT1A agonist 8-OH-DPAT 
in the mPFC, can reduce the firing rate of DRN 5-HT neurons (Celada et al., 2001). 
Therefore, an increase in the mPFC Htr1a expression shown in this study would likely 
reduce the serotonerginc activity in the DRN thus decreasing 5-HT output in the 
terminal areas such as mPFC. Challis and Berton (2015) discussed that the 
socioemotional processing impaired in MDD is controlled by the serotonergic system 
in the mPFC-DRN pathway.  
In the PVN, 5-HT activity is shown to modulate the HPA axis, thus being 
involved in stressful stimulation processing (Goel et al., 2011). Rats treated with the 
5-HT1A agonist flesinoxan exhibited high levels of corticosterone, likely via CRH 
neurons in the PVN (Compaan, 1996). An increased Htr1a mRNA expression 
observed in the PVN in this study would be expected to increase the number of 5-
HT1A receptors and enhance the HPA-stress response in the socially stressed mice.  
Htr1a expression was also increased in the VMH of CSS mice in the present 
study. 5-HT1A immunoreactive neurons were previously described in the VMH from 
DRN ascending projections (Biagioni et al., 2016). Of note, one should not exclude 
sampling overlap of VMH with the surrounding regions such as ARC, considering the 
small size of these subregions. 5-HT binding to the 5-HT1A receptor in ARC was 
described to favour feeding behaviour (Oury and Karsenty, 2011). Thus, the increased 
expression of ARC/VMH Htr1a would enhance the appetite and food intake, 
consistent with the present observations.  
 




5.6.2. Serotonin 5-HT2A receptor and Htr2a 
The present study showed a decrease in the specific binding of 5-HT2A 
receptors in the amygdala and VTA of CSS mice in comparison with CON mice. In 
addition, an increase in Htr2a mRNA expression in the BLA of CSS mice versus CON 
mice was observed.  
The present increase in the binding of 5-HT1A in the DRN of CSS mice would 
be expected to decrease 5-HT release and, in turn stimulate an up-regulation of other 
5-HT receptors at different post-synaptic sites. Indeed, CSS mice showed a noticeable 
increase of Htr2a expression in BLA. Intriguingly, results of 5-HT2A receptor binding 
are at odds with Htr2a expression findings. It is commonly presumed that levels of 
protein are linked with levels of the mRNA for that gene. Although the production rate 
of a protein, in general, is proportional to the concentration and translational efficiency 
of its mRNA, there are at least three reasons assumed to be linked with the deficiency 
mRNA-protein correlation observed in the literature. Firstly, there are several complex 
post-transcriptional factors involved in converting mRNA into protein (Gout et al., 
2017). Secondly, half-lives of proteins might be significantly distinct in vivo. Thirdly, 
the generation of membrane asymmetry by vertical and lateral diffusion of 
phospholipids (i.e. flip-flop translocation), which are involved in protein 
internalisation and externalisation, may be linked with the different 5-HT2A specific 
binding and mRNA expression of its encoding gene found in this study (Contreras et 
al., 2010). Lastly, there is a considerable possibility of error coming from mRNA and 
protein experiments performed (for more information, see Greenbaum et al. (2003) 
and Hershey et al. (2012)). It is therefore important to consider all those 
aforementioned factors in the establishment of the gene expression and protein 
concentration and/or binding in any study. 




The present study also demonstrated a reduced 5-HT2A binding in the 
amygdala and VTA. The amygdala is an integrative centre of emotional processing, 
and 5-HT activity in this region has been linked with fear processing and development 
of stress-related disorders (Holmes, 2008; Bocchio et al., 2016). Administration of the 
5-HT2A antagonist MDL100,907 was shown to reverse increased CRH, ACTH and 
corticosterone release promoted by the 5-HT2A agonist DOI (Van de Kar et al., 2001; 
Hemrick-Luecke and Evans, 2002). It is theoretically possible that the present reduced 
5-HT2A binding activity in the amygdala may lead to a decreased HPA axis response 
in CSS mice. 5-HT2A receptors in the VTA are thought to play a role in anxiety and 
mood disorders by regulating monoaminergic systems (Doherty and Pickel, 2000; 
Blier and El-Mansari, 2013). Nonetheless, studies on this receptor in the VTA and its 
implication in mood disorders are limited.  
 
5.6.3. Serotonin 5-HT2C receptor and Htr2c 
The present study showed a decrease in the specific binding of 5-HT2C 
receptors in DRN in CSS mice. No change in Htr2c mRNA expression was found in 
any of the regions targeted. Similar to this study, Leventopoulos et al. (2009)  
described a reduced 5-HT2C binding in the DRN of adult rats exposed to early life 
stress. 
The 5-HT2C receptor has been shown to regulate 5-HT firing activity in the 
DRN. For instance, Boothman et al. (2003) demonstrated that the 5-HT2C agonist DOI 
decreased 5-HT cell firing. Inhibition of the 5-HT2C receptor using the receptor 
antagonist SB242,084 was shown to reverse cell firing inhibition promoted by the 
antidepressant SSRI citalopram (Sotty et al., 2009). Furthermore, Spoida et al. (2014) 
demonstrated that impaired 5-HT cell firing induced by DRN 5-HT2C activation 




relieved anxiety behaviour in mice. Thus, the decreased DRN 5-HT2C binding 
observed in this study might enhance 5-HT cell firing in stressed mice. This contradicts 
the present idea that increased 5-HT1A binding in stressed mice reduces 5-HT cell 
firing. It also differs from previous findings suggesting that stressed mice and 
depressed humans display reduced serotonergic activity (Smith et al., 1997; 
Stockmeier et al., 1998; Miyagawa et al., 2015) which may be ascribed to the different 
methodology of stress induction.  
 In the context of the regulation of feeding, evidence suggests the role of this 
receptor in controlling eating behaviour. Animals with a knockout of this receptor 
showed signs of mild hyperphagia, and stimulation of hypothalamic 5-HT2C 
promoted specific hypophagic effect, by accelerating the satiety process (Tecott et al., 
1995). Furthermore, the 5-HT2C agonist was shown to decrease food intake (De Vry 
and Schreiber, 2000). As mentioned, 5-HT2C receptor agonist lorcaserin was recently 
approved for the treatment of obesity (Brashier et al., 2014). The decreased 5-HT2C 
receptor binding in the DRN observed in the present study is consistent with the 
present and previous studies that demonstrated that CSS mice led to increased food 
intake, as discussed in the Chapter 3. 
 
5.6.4. Slc6a4 
 The present study showed an increase in the expression of Slc6a4 mRNA in 
the RN of CSS mice compared with CON mice, and as observed in previous studies 
(Filipenko et al., 2002; Zhang et al., 2012). Interestingly, various studies have 
suggested that depression-like behaviour  in rodents and depression in humans might 
be associated with decreased SERT binding and Slc6a expression (Arango et al., 1995; 
Malison et al., 1998; McKittrick et al., 2000; Willeit et al., 2000; Newberg et al., 2012, 




2015). It is not obvious why there are such conflicting results concerning the regulation 
of Slc6a4 and SERT protein in the various chronic stress-related studies. It is worth 
mentioning that acute stress has caused a decrease in Slc6a4 mRNA expression in the 
RN of rats (Vollmayr et al., 2000). Thus increased Slc6a4 mRNA expression could be 
a compensatory phenomenon observed in the long-term exposure to social stress used 
in this study, as also noted by others (Filipenko et al., 2002; Zhang et al., 2012). Further 
investigation into the possible causal factors is required. 
 






This study supports the hypotheses and demonstrates that CSS changes the 
expression and binding activity of 5-HT receptors and its transporter. In particular, 
CSS resulted in an upregulation of DRN 5-HT1A autoreceptor binding, as well as of 
Htr1a and Sert mRNA expression in RN, the brain area from which serotonergic 
neuronal cell bodies project to the limbic and cortical brain regions. CSS also led to 
changes in the gene expression and binding of the 5-HT2A and 5-HT2C in the 
important RN projection areas associated with emotional processing and reward-
seeking behaviour. Taken together, the present findings add new evidence to the 
relationship between social stress and the serotonergic system, of relevance to the 




























































The present study aimed at investigating the effects of chronic social stress on 
the regulation of feeding and metabolism in mice. The mouse model of CSS used in 
this thesis is representative of prolonged exposure to psychosocial stress in humans, 
as it results in behavioural, physiological and neurobiological states of relevance to 
human major depressive disorder (Pryce and Seifritz, 2011). This experimental mouse 
model was used here to investigate the relationship between CSS and energy allostasis, 
as it has been shown that CSS often increases feeding that is not reflected in 
corresponding body weight gain (Moles et al., 2006; Lutter et al., 2008; Razzoli et al., 
2011c; Bergamini et al., 2016). The underlying mechanisms by which stress-affected 
mice do not gain weight despite increased feeding are not understood. The present 
study hypothesised that CSS induces endocrine, metabolic and neurobiological 
changes that result in increased calorie intake in conjunction with elevated energy 
metabolism, that are ultimately associated with a lack of body weight gain. Chronic 
psychosocial stress has also been shown to lead to changes in the serotonergic system 
(McKittrick et al., 1995; Blanchard et al., 2001), and therefore the present study 
hypothesised that CSS affects the serotonergic system in brain regions essential for the 
regulation of feeding and emotional processing.  
 
6.1. Evaluation of the present findings against the 
background of existing research 
In order to evaluate the effects of CSS on energy balance, a number of variables 
such as food intake, body weight, adipose tissue mass, EE and iBAT activity were 
assessed. Experiments presented in this thesis consistently suggested that CSS mice 
required more calories to maintain their body weight. Increased energy demand and/or 




paucity of energy resources following CSS may be the underlying mechanisms by 
which stress promotes development of various diseases, including depression 
(Østergaard et al., 2018). Whilst experiments consistently indicated that CSS mice 
required more calories to maintain their body weight, there were some variations in 
the results of feeding and body weight between the Experiments B and C. Consistent 
with a previous study using the same mouse model (Bergamini et al., 2016), in 
Experiment B mice undergoing CSS increased their food intake with no change in 
body weight gain, in accord with Bergamini et al. (2016). In contrast, in Experiment 
C there was no CSS effect on food intake, but a decrease in body weight gain in CSS 
relative to control mice. Experiments B and C had identical protocols, consisting of 
the indirect calorimetry in addition to the CSS paradigm. Therefore, the current study 
highlights how individual or group responses to stress can vary in mice and/or how 
uncontrolled factors can influence specific outcomes. Conceivably, individual mouse 
variability in the response to stress may explain these differences. In addition, and 
rather more likely, differences in unidentified environmental variables may play a role 
(Chesler et al., 2002). Taken together with the individual stress-response variability, 
these differences demonstrate the complexity of experimental research on the effects 
of stress on energy metabolism in mice, and it is probably similar in humans.   
The studies presented in this thesis were the first to assess EE in the current 
CSS mouse model. The previous studies that used indirect calorimetry included longer 
stress periods than the 15-day CSS model used for this thesis, and included a much 
shorter period of acclimatisation to the metabolic cages (Moles et al., 2006; Sanghez 
et al., 2013; Coccurello et al., 2017). Given that a change of environment can be 
considered a stressor in itself, the short acclimatisation period used in the previous 
studies may have led to inaccuracies in the assessment of EE. Moreover, to my 




knowledge, this is the first study to record EE in mice fed a standard diet for a period 
longer than 20 hours (compared to 17 hours (Moles et al., 2006) and 20 hours 
(Coccurello et al., 2017), or 24 hours recording in mice fed an HFD (Sanghez et al., 
2013)), thus allowing an extended evaluation of the CSS effects on EE. This is of 
importance since the endocrinological and metabolic responses to stress do not remain 
constant over time, and adaptation can occur.  
The present study observed a significant increase in RER, suggesting that CSS 
mice have a higher carbohydrate oxidation in comparison with CON, possibly shifting 
towards glucose as the most rapid energy source. Increased carbohydrate oxidation 
allows the body to respond rapidly to the energy demands that stressful stimuli may 
generate. The previous studies that described an increased EE in socially stressed mice 
reported that this co-occurred with various combinations of changes in food intake and 
body weight; nonetheless, there was a consistent indication that increased EE in 
stressed mice was sufficient to reduce their body weight gain relative to CON mice 
(Moles et al., 2006; Sanghez et al., 2013; Coccurello et al., 2017). In my study with 
indirect calorimetry study, whilst a trend towards increased EE was observed in CSS 
relative to CON mice, this was not significant. Nevertheless, overall results presented 
in this thesis are consistent with an increased requirement for energy intake in CSS 
mice, which is in accord with the existing literature (Moles et al., 2006; Lutter et al., 
2008; Razzoli et al., 2011c; Sanghez et al., 2013; Bergamini et al., 2016). Taken 
together, these findings indicate that CSS may cause a shift to the utilisation of 
carbohydrates relative to lipids as fuel, and increased energy demand for the 
maintenance of body weight. However, it is still unclear whether the current CSS 
procedure leads to increased EE, or whether effects on other mechanisms such as gut 
nutrient absorption explain the requirement for additional energy intake.   




To evaluate the effects of CSS on the neuroendocrine regulators of feeding, 
ghrelin and leptin peripheral and central systems were assessed, as were circulating 
insulin levels and glucose homeostasis. Earlier studies have also looked at social stress 
effects on plasma ghrelin and leptin in mice (Chuang et al., 2011; Kumar et al., 2013; 
Patterson et al., 2013). However, to my knowledge, the studies presented in this thesis 
were the first to evaluate effects of CSS on the mRNA expression of ghrelin and leptin 
receptors in a number of brain regions. The current CSS model also represented a good 
opportunity to evaluate glucose homeostasis in the absence of body weight gain. The 
present results suggested that CSS led to an upregulation of the ghrelin system and a 
downregulation of the leptin system. In regard to ghrelin, this study observed that CSS 
increased plasma ghrelin and led to an upregulation of VMH Ghs-r1a mRNA 
expression. In regard to leptin, it was shown that CSS decreased plasma leptin 
concentrations and eWAT Lep mRNA expression but had no effect on eWAT or 
central Lepr mRNA expression. These findings are consistent with an increased 
motivation to eat, possibly due to a higher energy demand for maintenance of body 
weight. The glucose tolerance test in the present study revealed that CSS mice had 
significantly decreased plasma insulin concentrations compared with CON, which led 
to a slower initial clearance of glucose. Previous studies have also observed effects of 
chronic social stress on glucose homeostasis, however in the presence of increased 
weight gain (Chuang et al., 2010a; Tsuneki et al., 2013) or reduced weight gain 
(Balsevich et al., 2014). To my knowledge, the current study is the first to report 
alteration in glucose homeostasis independent of body weight changes in mice fed a 
standard diet. In the present study, reduced insulin availability in the plasma would 
limit the glucose influx into peripheral issues and thus reduce energy storage in CSS 
mice. These findings suggest that CSS increased the availability of peripheral glucose, 




further supporting the idea of increased energy demand. These findings are of 
importance to the evaluation of the underlying mechanisms of stress-related changes 
in energy allostasis and body weight. 
In order to investigate the effects of CSS on the serotonergic system and its 
involvement in feeding behaviour, the specific binding of 5-HT1A, 5-HT2A and 5-
HT2C receptors and mRNA expression of their respective encoding genes were 
investigated, as well as the expression of the serotonin transporter gene (Sert), in brain 
regions implicated in the regulation of food intake and emotional processing. Previous 
studies have looked into the effects of stress on the regulation of 5-HT synthesis 
(review by Miura et al., 2008) and the role of 5-HT and 5-HT receptors in the 
regulation of feeding (Lam et al., 2010). Nonetheless, the role of CSS in the 
modulation of 5-HT receptors and the 5-HT transporter in such a wide range of brain 
regions had not been studied previously. The increased specific binding of the 5-HT1A 
autoreceptor and increased Htr1a mRNA expression in the RN presented in this study 
suggest that CSS acts on the serotonergic system by decreasing neuronal activity in 
the RN, where serotonergic neuronal cell bodies are located, and is thus likely to cause 
a reduction in 5-HT availability in the projection areas. This result is of importance for 
several reasons. Firstly, because brain 5-HT deficiency can lead to increased 
susceptibility to psychosocial stress, as shown in genetically modified mice (Sachs et 
al., 2015). Secondly, reduced 5-HT activity has been proposed as an aetio-pathological 
factor in clinical depression (Stockmeier et al., 1998). Thirdly, with  regard to energy 
balance, as 5-HT is known to promote hypophagic effects (Gartner et al., 2018), 
reduced extracellular 5-HT would further increase feeding in CSS mice. Decreased 5-
HT2A specific binding but enhanced Htr2a mRNA expression in the amygdala 
described in the present study suggests the presence of a molecular error in translating 




mRNA into protein, possibly associated with post-transcriptional factors (Gout et al., 
2017). The present reduction in the 5-HT2A binding in the amygdala and VTA of CSS 
mice may play a role in the pathophysiology of fear processing and other stress-related 
behaviours (Doherty and Pickel, 2000; Blier and El-Mansari, 2013; Bocchio et al., 
2016). This study also observed a decreased 5-HT2C specific binding in the DRN. 
Impaired 5-HT2C activation has been shown to promote hyperphagia (Kursungoz et 
al., 2015), which may be an underlying mechanism for the increased calorie intake 
observed in this study. Lastly here, the present increased Sert mRNA expression in the 
DRN suggests that CSS increases re-uptake of 5-HT in pre-synaptic neurons, further 
limiting serotonergic activity in projecting areas. Although a link between 5-HT and 
feeding behaviour in the CSS model has been proposed in this thesis, it is done with 
caution, as there has been variation in terms of feeding results through our experiments 
with this mouse model. In the cohort of mice used for the 5-HT experiments, there was 
no difference in body weight, which would lead us to speculate food intake had 
increased in accord with our other experiments with no body weight change, but food 
intake was not measured. Nevertheless, the present data support the hypothesis that 
social stress alters the serotonergic system through changes in gene expression and 
binding activity of the 5-HT receptors and the 5-HT transporter. 
 
6.2. Additional limitations of the present study not 
discussed elsewhere 
- Quantitative mouse body composition was not performed in the present study, 
although it would help differentiate between fat or fat-free mass when evaluating EE. 




- Food intake was not evaluated in the animals used for the serotoninergic study 
(Experiment A) as discussed above. Measurements of food intake were then performed 
for the subsequent experiments.   
 
6.3. Future studies 
The results from the present study suggest that stressed mice have a greater 
energy demand that results in:   
1. an increased food intake but no change in body weight or  
2. no change in food intake but a lack of body weight gain.  
Such effects could be explained by an increased glucose uptake by peripheral 
organs such as the skeletal muscle and/or the liver. It is known that skeletal muscles 
increase membrane permeability to glucose upon contraction (Richter and Hargreaves, 
2013), important function to be exercised on “fight-or-flight” stressful situations. In 
the liver, it was observed that stressed mice increased expression of the glucose 
transporter 2 (GLUT2) (Chuang et al., 2010a). By looking at the expression of glucose 
transporters for instance, in skeletal muscles and liver, it would be possible to 
comprehend better the reasons behind CSS increased energy demand.  
These effects could also be tentatively explained by increased central glucose 
uptake. It has been suggested that the brain, under the conditions of psychosocial 
stress, acts by diminishing the energy supply (i.e. glucose) to peripheral organs and 
allocating it to itself, in what is called ‘allocative brain-pull mechanism’ (Peters, 
2011a, b). By this mechanism, the brain is thought to activate the stress system to 
favour glucose self-allocation. In the ‘direct brain-pull mechanism’, astrocytes can 
increase GLUT-1-dependent glucose transport via the blood-brain-barrier thus 




increasing intracerebral glucose supply (Pellerin et al., 2007). To verify this, mouse 
cerebral hemodynamic post-CSS would have to be measured by means of fMRI to 
monitor changes in local cerebral blood flow as an indicator of brain activity, or to 
measure brain regional glucose utilisation by means of PET; it would give an insight 
into the metabolic brain demands. 
Potential effects of stress on the GI nutrient absorption may also play an 
important role in the inefficient use of fuel observed in the present mouse model. 
Firstly, an assessment of the energy usage could be performed by looking at energy 
ingested versus energy excreted. Moreover, by examining the intestinal glucose 
absorption through gene quantification of duodenal sodium-dependent glucose 
transporter 1 (SGLT-1) and GLUT2 (Nguyen et al., 2015), it would be possible to 
further understand some of the physiological consequences of prolonged stress 
exposure and the underlying mechanism behind inefficient energy storage. In addition, 
there are new lines of evidence that social stress affects gut microbiota (Yarandi et al., 
2016; Szyszkowicz et al., 2017; Yang et al., 2017) which can alter the absorption of 
nutrients from the gut (Cani et al., 2019).  
 
 
6.4. Conclusion  
The present study demonstrated that CSS led to a range of endocrine, metabolic 
and neurobiological changes that are associated with an increased requirement for food 
in order to maintain body weight, possibly due to enhanced metabolic demands in 
mice. The results of this study encourage speculating that there is an increased demand 
for energy in the periphery and/or brain under CSS. The present thesis contributes 
novel insights into the underlying mechanisms of stress-related changes in energy 
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 Animal overview - Experiment A 
 
 
Group Cage Ear marking ID Phenotype Parents Date of Birth 
CON S1 R 1 BL/6 BW 66 25/04/2016 
CON S1 L 2 BL/6 BW 66 25/04/2016 
CON S2 R 3 BL/6 BW 72 29/04/2016 
CON S2 L 4 BL/6 BW 72 29/04/2016 
CON S5 R 9 BL/6 BW 75 29/04/2016 
CON S5 RL 11 BL/6 BW 75 29/04/2016 
CON S7 R 14 BL/6 BW 71 02/05/2016 
CON S7 L 15 BL/6 BW 71 02/05/2016 
CON S8 R 17 BL/6 BW 71 02/05/2016 
CON S8 L 18 BL/6 BW 71 02/05/2016 
CON S10 R 21 BL/6 BW 74 02/05/2016 
CON S10 L 22 BL/6 BW 74 02/05/2016 
CSS S5 R 5 BL/6 BW 73 29/04/2016 
CSS S6 L 6 BL/6 BW 73 29/04/2016 
CSS S7 R 7 BL/6 BW 73 29/04/2016 
CSS S8 L 8 BL/6 BW 73 29/04/2016 
CSS S10 L 10 BL/6 BW 75 29/04/2016 
CSS S12 R 12 BL/6 BW 75 29/04/2016 
CSS S13 L 13 BL/6 BW 75 29/04/2016 
CSS S16 RL 16 BL/6 BW 71 02/05/2016 
CSS S19 R 19 BL/6 BW 74 02/05/2016 
CSS S20 L 20 BL/6 BW 74 02/05/2016 
CSS S23 R 23 BL/6 BW 76 02/05/2016 




 Schedule - Experiment A 
 
 
Date  Procedure Group 1 Procedure Group 2 
11/07/2016 Weigh Handling   Handling   
12/07/2016 Weigh Handling   Handling   
13/07/2016 Weigh Handling   Handling   
14/07/2016 Weigh Handling   Handling   
15/07/2016 Weigh Activity Test   Activity Test   
16/07/2016           
17/07/2016           
18/07/2016 Weigh CSS1       
19/07/2016 Weigh CSS2   CSS1   
20/07/2016 Weigh CSS3   CSS2   
21/07/2016 Weigh CSS4   CSS3   
22/07/2016 Weigh CSS5   CSS4   




23/07/2016 Weigh CSS6   CSS5   
24/07/2016 Weigh CSS7   CSS6   
25/07/2016 Weigh CSS8 Faeces CSS7   
26/07/2016 Weigh CSS9   CSS8 Faeces 
27/07/2016 Weigh CSS10   CSS9   
28/07/2016 Weigh CSS11 Glucose Test CSS10   
29/07/2016 Weigh CSS12   CSS11 Glucose Test 
30/07/2016 Weigh CSS13   CSS12   
31/07/2016 Weigh CSS14   CSS13   
01/08/2016 Weigh CSS15   CSS14   
02/08/2016 Weigh   Faeces CSS15   
03/08/2016    Euthanize CSS   Faeces 
04/08/2016    Euthanize CON   Euthanize CSS 




 Animal overview - Experiment B 
 
 
Group Cage Ear marking ID Phenotype Parents Date of Birth 
CON S3 R 27 BL/6 BW 73 23/05/2016 
CON S3 L 28 BL/6 BW 73 23/05/2016 
CON S5 R 31 BL/6 BW 70 23/05/2016 
CON S5 L 32 BL/6 BW 70 23/05/2016 
CON S7 R 36 BL/6 BW 75 23/05/2016 
CON S7 L 37 BL/6 BW 75 23/05/2016 
CON S8 R 38 BL/6 BW 72 28/05/2016 
CON S8 L 39 BL/6 BW 72 28/05/2016 
CSS S25 R 25 BL/6 BW 67 25/05/2016 
CSS S26 L 26 BL/6 BW 67 25/05/2016 
CSS S29 R 29 BL/6 BW 73 23/05/2016 
CSS S30 L 30 BL/6 BW 73 23/05/2016 
CSS S33 R 33 BL/6 BW 75 23/05/2016 
CSS S34 L 34 BL/6 BW 75 23/05/2016 
CSS S35 RL 35 BL/6 BW 75 23/05/2016 
CSS S40 RL 40 BL/6 BW 72 28/05/2016 
CSS S41 R 41 BL/6 BW 69 22/05/2016 













 Schedule - Experiment B 
 
 
Date   Procedure 
08/08/2016 Weigh Handling 
09/08/2016 Weigh Handling 
10/08/2016 Weigh Handling 
11/08/2016 Weigh Activity test 
12/08/2016   Transfer to T’Spital 
13/08/2016   Adaptation 
14/08/2016   Adaptation 
15/08/2016 Weigh - 
16/08/2016 Weigh - 
17/08/2016 Weigh - 
18/08/2016 Weigh Baseline 1 
19/08/2016 Weigh Baseline 2 
20/08/2016 Weigh Baseline 3 
21/08/2016 Weigh Baseline 4 
22/08/2016 Weigh Baseline 5 
23/08/2016 Weigh CSS1 
24/08/2016 Weigh CSS2 
25/08/2016 Weigh CSS3 
26/08/2016 Weigh CSS4 
27/08/2016 Weigh CSS5 
28/08/2016 Weigh CSS6 
29/08/2016 Weigh CSS7 
30/08/2016 Weigh CSS8 
31/08/2016 Weigh CSS9 
01/09/2016 Weigh CSS10 
02/09/2016 Weigh CSS11 
03/09/2016 Weigh CSS12 
04/09/2016 Weigh CSS13 
05/09/2016 Weigh CSS14 
06/09/2016 Weigh CSS15 + Stress 1 
07/09/2016 Weigh Stress 2 
08/09/2016 Weigh Stress 3 
09/09/2016 Weigh Stress 4 
10/09/2016 Weigh Stress 5 
11/09/2016 Weigh Stress 6 
12/09/2016 Weigh Stress 7 + Euthanize 













 Animal overview - Experiment C 
 
 
Group Cage Ear marking ID Phenotype Parents Date of Birth 
CON S1 R 1 BL/6 BW 9 04/03/2017 
CON S1 L 2 BL/6 BW 9 04/03/2017 
CON S2 R 3 BL/6 BW 89 12/03/2017 
CON S2 L 4 BL/6 BW 89 12/03/2017 
CON S6 R 11 BL/6 BW 1 15/04/2017 
CON S6 L 12 BL/6 BW 1 15/04/2017 
CON S7 R 13 BL/6 BW 7 15/04/2017 
CON S7 L 14 BL/6 BW 7 15/04/2017 
CON S8 L 15 BL/6 BW 7 15/04/2017 
CON S8 R 16 BL/6 BW 7 15/04/2017 
CON S10 R 20 BL/6 BW 13 27/04/2017 
CON S10 L 21 BL/6 BW 13 27/04/2017 
CSS S3 R 5 BL/6 BW 89 12/03/2017 
CSS S3 L 6 BL/6 BW 89 12/03/2017 
CSS S4 R 7 BL/6 BW 89 12/03/2017 
CSS S4 L 8 BL/6 BW 89 12/03/2017 
CSS S5 R 9 BL/6 BW 8 28/03/2017 
CSS S5 L 10 BL/6 BW 8 28/03/2017 
CSS S9 R 17 BL/6 BW 12 27/04/2017 
CSS S9 L 18 BL/6 BW 12 27/04/2017 
CSS S9 RL 19 BL/6 BW 12 27/04/2017 
CSS S11 R 22 BL/6 BW 6 01/05/2017 
CSS S11 L 23 BL/6 BW 6 01/05/2017 

























 Schedule - Experiment C 
 
 
Date  Procedure Group 1 Procedure Group 2 
19/06/2017  Handling Handling 
20/06/2017  Handling Handling 
21/06/2017  Handling Handling 
22/06/2017  Handling Handling 
23/06/2017 Weigh Handling Handling 
24/06/2017 Weigh   
25/06/2017 Weigh   
26/06/2017 Weigh Activity Test Activity Test 
27/06/2017 Weigh T'Spital T'Spital 
28/06/2017 Weigh   
29/06/2017 Weigh Baseline 1  
30/06/2017 Weigh Baseline 2  
01/07/2017 Weigh Baseline 3  
02/07/2017 Weigh Baseline 4  
03/07/2017 Weigh Baseline 5  
04/07/2017 Weigh Baseline 6/CSS 1 Baseline 1 
05/07/2017 Weigh CSS 2 Baseline 2 
06/07/2017 Weigh CSS 3 Baseline 3 
07/07/2017 Weigh CSS 4 + Behav Baseline 4 
08/07/2017 Weigh CSS 5 Baseline 5 
09/07/2017 Weigh CSS 6 Baseline 6/CSS 1 
10/07/2017 Weigh CSS 7 CSS 2 
11/07/2017 Weigh CSS 8 + Behav CSS 3 
12/07/2017 Weigh CSS 9 CSS 4 + Behav 
13/07/2017 Weigh CSS 10 CSS 5 
14/07/2017 Weigh CSS 11 CSS 6 
15/07/2017 Weigh CSS 12 + Behav CSS 7 
16/07/2017 Weigh CSS 13 CSS 8 + Behav 
17/07/2017 Weigh CSS 14 CSS 9 
18/07/2017 Weigh CSS 15 / Stress 1 CSS 10 
19/07/2017 Weigh Stress 2 CSS 11 
20/07/2017 Weigh Stress 3 CSS 12 + Behav 
21/07/2017 Weigh Stress 4 CSS 13 
22/07/2017 Weigh Stress 5 CSS 14 
23/07/2017 Weigh Stress 6 (12:00 h) CSS 15 / Stress 1 
24/07/2017 Weigh Euthanize Stress 2 
25/07/2017 Weigh  Stress 3 
26/07/2017 Weigh  Stress 4 
27/07/2017 Weigh  Stress 5 
28/07/2017 Weigh  Stress 6 (12:00 h) 








 Animal overview – Immunohistochemistry experiment  
 
 
Group Cage Ear marking ID Phenotype Parents Date of Birth 
CON S1 R 1 WT Z84 16/07/2012 
CON S1 L 2 WT Z84 16/07/2012 
CON S5 L 12 WT Z88 25/07/2012 
CON S5 RL 13 WT Z88 25/07/2012 
CON S6 L 15 WT Z89 25/07/2012 
CON S6 RL 16 WT Z89 25/07/2012 
CON S7 R 17 WT Z98 25/07/2012 
CON S7 L 18 WT Z98 25/07/2012 
CON S10 L 25 WT Z99 29/07/2012 
CON S10 RL 26 WT Z99 29/07/2012 
CSS S1 RL 3 WT Z84 16/07/2012 
CSS S2 R 4 WT Z87 18/07/2012 
CSS S2 L 5 WT Z87 18/07/2012 
CSS S4 R 9 WT Z83 25/07/2012 
CSS S4 L 10 WT Z83 25/07/2012 
CSS S5 R 11 WT Z88 25/07/2012 
CSS S8 R 20 WT Z100 28/07/2012 
CSS S8 L 21 WT Z100 28/07/2012 
CSS S9 L 23 WT Z102 28/07/2012 




















 Brains for autoradiography 
 
 5-HT2A  5-HT2C 5-HT1A Bregma (mm)  
 mPFC & NAcc  mPFC & NAcc mPFC & NAcc 2.00 (Fig. 14)  
      
 Amy  Amy Amy -1.00 (Fig. 40)  
      
 Hipp & VTA  Hipp & VTA Hipp & VTA -2.80 (Fig. 54)  
     
 - - DRN -4.16 (Fig. 65)  
     
 LC  - - -5.34 (Fig. 75)  
      
 
 
Brain Done Comments 
CON 24 17.11.2015 Hipp and VTA missing. One slide more on 5-HT1A+ slide 
CON 23 17.11.2015 x 
CSS 18 18.11.2015 x 
CSS 21 18.11.2015 x 
CON 14 18.11.2015 Damaged on the left side (dorsal) 
CSS 2 19.11.2015 x 
CON 6 19.11.2015 x 
CSS 1 19.11.2015 x 
CSS 25 23.11.2015 x 
CON 5 23.11.2015 Damaged on the left side (ventral) 
CSS 16 23.11.2015 x 
CON 19 25.11.2015 x 
CSS 3 25.11.2015 Cracked on the dorsal side  
CON 15 26.11.2015 Less well perfused 
CON 10 26.11.2015 x 



































 Chapter 3/4/5 – Reverse transcription 
 
Master Mix 
4.2μL RNase-free water + 2l Buffer + 2l Random primers + 0.8l dNTPs + 1l enzyme 
 
 
 Chapter 3/4/5 - qPCR 
 
SYBR Mix 
6μL RNase-free water + 1l 20x FW + 1l 20x RV + 10l 2x SYBR + 2l cDNA 
  
NTC 
8μL RNase-free water + 1l 20x FW + 1l 20x RV + 10l 2x SYBR 
 
 
 Chapter 4 – Immunohistochemistry 
 
Materials: 
- Phosphate Buffered Saline (PBS) tablets, Cat. P4417, Sigma, UK 
- Hydrogen peroxide H2O2 (30%) , Cat. 216763, Sigma, UK 
- TritonTM X-100, Cat. X100, Sigma, UK 
- VECTASTAIN Elite ABC KIT, Cat. PK-6100, Vector Laboratories 
- 3’3 Diaminobenzidine, Cat. D8001, Sigma, UK 
- 1st Antibody (Rabbit Anti-GHS-R1a), Cat. H-031-31, Phoenix Pharmaceuticals 
- Ammonium nickel (ii) sulfate hexahydrate, Cat. A1827, Sigma, UK 
- Histomount medium, Cat. HS-103, National Diagnostics, UK 
 
Phosphate Buffer Solution PBS (10mM) 
1 tablet + 200mL of dH2O 
 
1% H2O2 in PBS 
100μL (30%) H2O2 + 2900μL of (10mM) PBS  
 
10% PBST stock 
1mL Triton X-100 + 9mL PBS 
 
0.01% PBST 
200μL 10% PBST + 200mL PBS 
 
Blocking solution (10% Normal Goat Solution) 
2700μL (0.01% PBST) + 300μL NGS  
 
1stAb (Rabbit Anti-GHS-R1a) 1:250 
890μL (10mM) PBS + 30μL NGS + 80μL Ab 
 
Blank 
970μL (10mM) PBS + 30μL NGS 
 
2nd Ab (Goat anti-rabbit IgG ABC kit) 
10mL (10mM) PBS+ 150μL NGS + 50μL biotinylated anti-rabbit Ab 
 
 






100μL reagent A (Avidin DH) + 100μL reagent B (Biotinylated Horseradish Peroxidase H) + 
10mL (10mM) PBS 
 
DAB ammonium-nickel-sulphate working solution 
0.05% DAB + 0.05% Nickel-ammonium-sulphate + 0.3% H2O2, pH 7.2 
- Reagents mixed in the following sequence:  
(1) 5ml PBS  
(2) 500μl 0.5% DAB  
(3) 250μl 1% Nickel-ammonium-sulphate  
(4) 250μl 0.3% H2O2 
 
 Chapter 4 – Glucose tolerance test 
 
Glucose solution 
The dose of glucose is 2 g/kg body weight 
Animal ~ 30g. 
 
1g BW - 2mg glucose 
30g – x (60mg) 
 
Administered as 20% D-glucose in PBS 
2g – 10mL PBS 
60mg – x (300µL) 
 
 Chapter 5 – Autoradiography  
 
Materials: 
- [O-methyl-3H]WAY 100635, Cat. ART 1554, specific activity: 83.0 Ci/mmol, radioactive 
concentration: 1 mCi/ml, American Radiolabel Chemicals, UK 
- [125I]DOI, Cat. ARI 0147, American Radiolabel Chemicals, UK 
- [3H]Ketanserin, NET791, Perkin Elmer, UK 
- Pargyline hydrochloride, Cat. P8013, Sigma-Aldrich 
- Serotonin, Cat. 14927, Sigma, UK 
- Prazosin hydrochloride, Cat, P7791, Sigma, UK 
- Tetrabenazine, Cat, T2952, Sigma, UK 
- Methysergide maleate, Cat, 1064, Tocris Biosciences, UK 
- MDL 100907, Cat. 4173, Tocris Bioscience, UK 
- RS 102221, Cat. 1050, Tocris Bioscience, UK 
- Metol, Cat. 69705, Sigma, UK 
- Soldium Sulfite, Cat. S0505, Sigma, UK 
- Hydroquinone, Cat. H17902, Sigma, UK 
- Sodium carbonate monohydrate, Cat. S4132, Sigma, UK 
- Potassium bromide, Cat. P0838, Sigma, UK 
 
Solutions for pH meter adjustment and calibration 
pH 4 – BDH®, Prod. No. 33189, Buffer powder diluted in 100mL of dH2O 
pH 7.00 ± 0.02 @ 25°C – BDH®, Prod. No. 3327420, Lot. CP079M1, Buffer capsules diluted 
in 100mL of dH2O 
pH 10.00 ± 0.02 @ 25°C – Russel, Buffer powder diluted in 100mL of dH2O 
pH Meter is a laboratorial instrument that measures the concentration of H+ on a solution and 
indicates its acidity or alkalinity based on its previous calibration, with the solutions above. 




Tris-HCl Buffer stock (0.5M) 
1L – 0.5mol 
250mL – x (0.125mol) 
 M.W. = 121.14 g/mol 
1mol – 121.14 g 
0.125mol – x (15.125g) 
- 15.125g of Tris diluted in 250mL of dH2O 
 
Tris-HCl working solution (50mM) 
CiVi = CfVf 
0.5mol x 250mL = 0.05mol x Vf? 
Vf = 2500mL 
- 2250mL of dH2O to be added to the stock solution 
 
5-HT1a – [3H]WAY 100635 
 
2nM of [³H] WAY 100635 
1mCi/mL = 1000µCi/mL 
50µCi/vial 
80Ci/mmol = 80µCi/nmol 
 
1000µCi – 1mL 
80µCi – x (0.08mL) 
0.08mL – 1nmol 
1000mL – x (12,500nmol) 
12.5µM 
CiVi = CfVf   
12.5µM x Vi = 2nM x 34mL (32 slides) 
- Vf = 5.5µL of stock solution 
 
Pargyline stock (5mM)1L - 5x10-3 mol 
5mL – x (25x10-6mol) 
 M.W.:195.69 g/mol 
1 mol – 195.69g 
25x10-6mol – x (4.89mg) 
- 4.89mg of pargyline in 5mL of Tris-HCl 
 
Pargyline for incubation (10µM) 
CiVi = CfVf   
5mM x Vi = 10µM x 34mL (32 slides) 
- Vf = 68µL of stock solution 
 
5-HT stock (5mM)  
1L - 5x10-3 mol  
5mL – x (25x10-6mol) 
 M.W.:212.68g/mol 
1mol – 212.68g 
25x10-6mol – x (5.31mg) 
- 5.31mg of 5-HT in 5mL of Tris-HCl 
 
5-HT for block incubation (10µM) 
CiVi = CfVf   
5mM x Vi = 10µM x 2mL (1 slide) 
- Vf = 4µL of stock solution 




Working Buffer Solution for total binding 
[O-methyl-³H] WAY 100635 + Pargyline + Tris-HCl Buffer 
 
5.5µL of (2nM) [O-methyl-³H] WAY                
68µL of (5mM) pargyline 
34ml of (50mM) Tris-HCl buffer 
 
Block Solution  
(HOCH2)3CNH2 (Tris) + Pargyline + [O-methyl-³H] WAY 100635 + 5-HT 
 
4µL of (5mM) unlabelled 5-HT             
2mL (50mM) Working Buffer Solution  
 
5-HT2a – [3H]Ketanserin 
 
1nM of [3H]Ketanserin 
1mCi/mL = 1000µCi/mL 
50µCi/vial 
43Ci/mmol = 43µCi/nmol 
 
1000µCi – 1mL 
43µCi – x (0.043mL) 
 
0.043mL – 1nmol 
1000mL – x (23,255nmol) 
23.3µM 
 
CiVi = CfVf   
23.3µM x Vi = 1nM x 34mL (32 slides) 
- Vf = 1.5µL of stock solution 
 
Prazosin stock (1mM) 
1L - 1x10-3 mol  
10mL – x (10-5mol) 
 M.W.:383.401g/mol 
1mol – 383.401g 
10-5mol – x (3.8mg) 
- 3.8mg of Prazosin in 10mL of dH2O 
 
Tetrabenazine stock (1mM) 
1L - 1x10-3 mol  
10mL – x (10-5mol) 
 M.W.:317.427g/mol 
1mol – 317.427g 
10-5mol – x (3.2mg) 
- 3.2mg of Tetrabenazine in 10mL of ethanol 
 
Methysergide stock (1mM)  
1L - 1x10-3 mol  
5mL – x (5x10-6mol) 
 M.W.:487.56g/mol 
1mol – 487.56g 
5x10-6mol – x (2.4mg) 
- 2.4mg of Methysergide in 5mL of Tris-HCl 




Methysergide for block incubation (400µM) 
CiVi = CfVf   
1mM x Vi = 200µM x 5mL 
- Vi = 1mL of stock solution 
TrisPT Buffer Solution (pre-incubation and ligand binding) 
(HOCH2)3CNH2 (Tris) + C19H21N5O4 (Prazosin) + C19H27NO3 (Tetrabenazine) 
 
100µL of (1mM) stock Prazosin      
10µL of (1mM) stock Tetrabenazine 
100mL of (50mM) Tris-HCl buffer 
 
Working Buffer Solution 
[3H]ketanserin + TrisPT Buffer 
 
4.7µL of (1nM) [3H]ketanserin        1nM double strength [3H]ketanserin 
45ml of (50mM) TrisPT buffer 
 
Block Solution 
(HOCH2)3CNH2 (Tris) + C21H27N3O2 (methysergide) + 3H C22H22FN3O3 (ketanserin) 
 
2.5ml of (400µM) methysergide       5ml of 200µM methysergide 
2.5ml of (2nM) ketanserin.  
 
 
5-HT2c – [125I]DOI 
 
0.2nM of [125I]DOI 
171.6µCi/mL 
2200Ci/mmol = 2200uCI/nmol 
 
171.6µCi – 1mL 
2200µCi – x (12.8mL) 
 
12.8mL – 1nmol 
1000mL – x (78nmol) 
78nM 
 
CiVi = CfVf   
78nM x Vi = 0.2nM x 50mL (48 slides) 
- Vf = 128µL of stock solution 
 
Assay Buffer (2.5L) 
50mM Tris-HCl pH 7.4 – 15.1425g 
0.5mM EDTA – 0.365g 
10mM MgSO4.7H2O – 6.155g 
0.1% Ascorbic Acid – 2.5g 
0.1% BSA – 2.5g 
10uM Pargyline – 3.975 
 
MDL 100907 stock (1mM)  
1L – 10-3mol 
5mL – x (5x10-6mol) 
 M.W = 373.49g/mol 
1mol – 373.49g 
 
 




5x10-3mol – x (1.86mg) 
- 1.86mg of MDL 100907 in 5mL of DMSO 
 
MDL 100907 for incubation (100nM)  
CiVi = CfVf   
1mM x Vi = 100nM x 50mL (48 slides) 
- Vf = 5.5µL of 1mM stock solution 
 
RS 102221 stock (1mM) 
1L – 10-3mol 
5mL – x (5x10-6mol) 
 M.W = 649.08g/mol 
1mol – 649.08g 
5x10-3mol – x (3.25mg) 
- 3.25mg of RS 102221 in 5mL of DMSO 
 
RS 102221 for block incubation (10µM) 
CiVi = CfVf   
1mM x Vi = 10µM x 3mL (2 slides) 
- Vf = 30µL of stock solution 
 
Working Buffer Solution for total binding 
[125I]DOI + MDL 100907 + Assay buffer  
 
102µL of (0.2nM) [125I]DOI               
4µL of (1mM) MDL 100907 
40mL of Assay Buffer 
 
Block Solution  
RS 102221 + Working buffer solution  
 
30µL of (1mM) RS 102221            





360g Soldium Sulfite 
32g Hydroquinone 
210g Sodium Carbonate 
20g Potassium Bromide 
Cold dH2O until 4L solution 
- In order to prepare developing solution, 2.5L of distilled water was warmed up until 
it reached 50 degrees Celsius. It was added a pinch of sodium sulphite to inhibit the initial 
oxidation of the metal for then add metol. Once dissolved, remaining sodium sulfate was added 
to the solution as well as the other chemicals, in order of appearance. Once reagents were 
dissolved, solution was covered in foil film for light protection and used on the following day.  
 
Stop Solution 
H20 + 2 drops of C2H4O2 (acetic acid) 
 
Fixer Solution (2.5L total volume) 
250 ml of the Fixer stock  + 2250 ml of distilled water 































Absorbance (A490/A620) was measured within 5 minutes and ghrelin concentration was 
determined via interpolation using the standard curve generated by plotting absorbance versus 
the corresponding concentration of ghrelin standard, as shown below. 
 
 
Figure 4. Standard curve of known active ghrelin concentration and the respective 





Absorbance (A490/A620) was measured within 30 minutes and leptin concentration was 
determined via interpolation using the standard curve generated by plotting absorbance versus 
the corresponding concentration of leptin standard, as shown below. 
 
 












Absorbance (A490/A620) was measured within 30 minutes and insulin concentration was 
determined via interpolation using the standard curve generated by plotting absorbance versus 




Figure 3. Standard curves of known insulin concentration and the respective coefficient of 




 Chapter 4 – Autoradiography 
 




Figure 5.5. [O-methyl-3H]WAY 100635 films’ standard curves developed for analysis of 
specific binding of 5-HT1A receptors according to the respective Relative Optical Density. 
 








Figure 13. [3H]Ketanserin films’ standard curves developed for analysis of specific binding 
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The Effects of Chronic Psychosocial Stress on Ghrelin Receptor Immunoreactivity in 
the Hypothalamus and Ventral Tegmental Area 
Simone Nascimento1, Giorgio Bergamini2, Carina M Brugger1, Atieh Fallah Rokni1, Luma 
Alem Martins1, Christopher R Pryce2, Jolanta Opacka-Juffry1 and Michael Patterson1 
 
Introduction:  Stress is known to affect feeding behavior in humans and animals. The 
direction of this effect is dependent on the stressor and individual, but there is good 
evidence linking chronic social stress with overeating. In the mouse chronic social stress 
(CSS) stress model, increased feeding is observed. Elevated circulating levels of ghrelin 
are thought to contribute to this effect. 
Aim: The aim of this study was to investigate the effect of CSS on ghrelin receptor (GSHR-
1a) immunoreactivity in areas of the hypothalamus (arcuate nucleus – ARC and 
ventromedial hypothalamus – VMH) and the ventrotegmental area (VTA).  
Methods: Adult male C57BL/6 mice were exposed to psychosocial stress with loss of social 
control for 15 days, 1-10 minutes daily (CSS). Control mice were handled daily in parallel. 
All in vivo procedures were conducted under a permit for animal experimentation 
(Switzerland). Indirect immunohistochemistry (IHC) with stereology was used to identify 
GHRS-1a positive cells in the brain regions of interest.  
Results: The effects of CSS on central GHSR-1a immunopositive cell density appeared to 
be region-dependent. While no effects were observed within the VTA and VMH, the 
GHRS-1a immunopositive cell density was elevated in the ARC in CSS compared with 
control mice.  
Conclusion: Chronic social defeat stress in mice can lead to upregulation of the ghrelin 
receptor in the hypothalamic arcuate nucleus which may contribute to the stress-related 



















Effects of chronic social stress on 5-HT1A, 2A, and 2C receptor binding in mouse 
brain regions associated with reward processing 
Simone Nascimento1, Michaela Buerge2, Simon Beyan1, Cherrelle Lewis1, Vivekan 
Varathanathan1, Christopher R Pryce2, Michael Patterson1, Jolanta Opacka Juffry1 
 
Introduction and aim: Serotonin (5-HT), via its various receptors, each of which is 
expressed in discrete brain regions, modulates aversion and reward processing and is 
implicated in various psychopathologies including eating disorders and depression. In 
mice, chronic social stress in adulthood leads to increased food intake in the absence of 
weight gain but reduces effortful motivation to obtain gustatory reward. The aim of this 
study was to investigate for stress effects on three 5-HT receptors, namely 1A, 2A and 2C, 
by quantifying their specific binding in some brain regions underlying reward processing: 
medial prefrontal cortex (mPFC), hippocampus (HIPP), amygdala (Amy), nucleus 
accumbens (NAcc), ventral tegmental area (VTA), dorsal raphe nucleus (DRN) and locus 
coeruleus (LC). 
Methods: Adult male C57BL/6 mice were exposed to chronic social stress (CSS) or control 
handling (CON) for 15 days. Brains were collected on day 16. In coronal sections, receptor 
autoradiography was applied to quantify specific binding of 5-HT1A, 5-HT2A and 5-
HT2C, using [3H]WAY100635, [3H]ketanserin and [125I]DOI, respectively. 
Results: 5-HT1A binding was significantly increased (236%) in DRN of CSS compared 
with CON mice. 5-HT2A was significantly decreased in VTA (32%) and Amy (10%) of 
CSS compared with CON mice. 5-HT2C binding was significantly decreased (42%) in 
DRN of CSS compared with CON mice. There were no significant CSS effects in the other 
regions. 
Conclusion: These region- and receptor type-specific stress-induced changes in 5-HT 
receptor binding might contribute to the deficit in gustatory motivation. On-going studies 



























The Effects of Chronic Social Stress on Energy Balance and The Potential Role of 
Neuroendocrine Regulators of Feeding  
Simone Nascimento1, Christopher R Pryce2, Jolanta Opacka-Juffry1 and Michael Patterson1  
 
Introduction and Aim: Stress is known to affect energy metabolism in humans and animals 
and regulation of feeding and energy expenditure (EE) are thought to contribute to this 
effect. This study aimed to investigate the effects of chronic social stress (CSS) on food 
intake (FI), body weight (BW), white adipose tissue (WAT), EE, respiratory exchange ratio 
(RER), and peripheral and central neuroendocrine regulators of feeding. 
Methods: Adult male C57BL/6 mice were exposed to 15 days of social stress, 1-10 minutes 
daily (CSS), or control handling. FI and BW were measured daily. Indirect calorimetry was 
performed prior to and following CSS. At termination, blood was collected for ghrelin and 
leptin determination, WAT was weighed, and brains were collected for quantification of 
expression of central mRNA leptin and ghrelin and their respective receptors.  
Results: Relative to controls, CSS mice had similar FI, attenuated increase in BW, no 
change in EE, increased RER, increased plasma ghrelin, decreased plasma leptin, decreased 
WAT mass, and decreased mRNA leptin expression. Increased RER indicates greater 
carbohydrate utilization in CSS versus CON mice. The similar EE with a relatively low 
BW indicates greater requirement of EE for other metabolic processes, possibly brain 
function.  
Conclusion: Chronic social stress in mice led to peripheral metabolic changes consistent 
with increased energetic requirements and with important implications for brain function: 
Firstly, changes in central regulators of energy metabolism and feeding would be expected 
and are under investigation. Secondly, stress-induced changes in the brain may further 





























The Effects of Chronic Social Stress on Gut Microbiome  
Simone Nascimento1, Maria Wiese3, Christopher R Pryce2, Michael Patterson1, Jolanta 
Opacka-Juffry1 and Adele Costabile1 
 
Introduction and Aim: The brain's response to stress has a direct effect on the gut, and stress 
is known to increase the permeability of the gut lining, which gives gut bacteria easier 
access to both the immune and the central nervous system. This study aimed to investigate 
the effects of chronic social stress (CSS) on the gut microbiota composition in the mouse 
model, in which immune, neural and behavioural changes have been demonstrated.  
Methods: Adult male C57BL/6 mice were exposed to 15 days of social stress, 1-10 minutes 
daily (CSS), or control handling. On days 7 and 15 freshly-voided faeces were collected 
from each mouse and stored at -80°C until the analysis, in which total bacterial DNA was 
extracted from the faeces and the gut microbiota composition was characterized by next-
generation sequencing of the V3 to V4 region of the 16S rRNA gene. The 16S rDNA 
sequences within the assembled metagenomes were taxonomically selected using the 
Qiime pipeline and the Greengenes database. Biostatistic analyses of metagenomic data 
were performed with R and nonparametric ANOSIM significance tests. 
Results: ANOSIM data have shown significantly increased populations of Bacteroides spp. 
(Bacteroidaceae) and F. prausnitzii (Ruminococcaceae) in CSS versus control between 
days 7 and 15.  
Conclusion: Our data demonstrate an impact of long-term social stress on the gut 
microbiota composition. This pilot study with its rigorous 16S rRNA sequencing of gut 
microbiome contributes novel observations on the effects of chronic social stress that can 






























Animal-Model Evidence for Involvement of Leptin in the Regulation of Stress-
induced Changes in Energy Balance  
Simone Nascimento1, Christopher R Pryce2, William Powell1, Michaela Uebel1, 
Jolanta Opacka-Juffry1 and Michael Patterson1 
 
Introduction: Stress is known to affect energy balance in humans and animals, due to its 
effects on both feeding and energy expenditure. The adipokine leptin contributes to the 
regulation of energy balance and could be a mediator of stress effects thereon. This study 
in mice investigated the effects of chronic social stress (CSS) on food intake, body weight 
(BW), energy expenditure (EE), respiratory exchange ratio (RER), white adipose tissue 
(WAT) mass, and peripheral levels of leptin and central expression of its receptor. 
Methods: Adult male C57BL/6 mice were exposed to 15 days of social stress, 1-10 minutes 
daily (CSS), or control handling. Food intake and BW were measured daily. Indirect 
calorimetry was performed prior to and following CSS. At termination, blood was collected 
for plasma leptin immunoassay, WAT for quantification of expression of mRNA leptin 
(Lep) and leptin receptor (Lepr), and brains for frozen tissue microdissection and brain 
region-specific mRNA Lepr quantification using RT-PCR (arcuate nucleus of 
hypothalamus, paraventricular nucleus, ventromedial hypothalamus, ventral tegmental 
area, nucleus accumbens, medial prefrontal cortex). 
Results: Relative to controls, CSS mice had similar food intake, lower BW gain (-69%, 
p<0.005), a trend to significantly increased EE (p<0.07), increased RER (p<0.005), lower 
plasma leptin level (-90%, p<0.0001), lower WAT mass (-42%, p<0.001), lower WAT Lep 
mRNA expression (0.54 fold change, p<0.01), similar WAT and brain-region specific Lepr 
mRNA expression. Therefore, CSS led to reduced conversion of food intake to increased 
BW, coupled with a trend to increased EE associated with a relative increase in 
carbohydrate metabolism. The lower plasma leptin levels are consistent with the increase 
in energy demand.  
Conclusion: Chronic social stress in mice led to peripheral metabolic changes consistent 
with an increase in energy needs that were not met by a corresponding increase in energy 
intake. These changes included decreases in WAT mass, plasma leptin and WAT Lep 
mRNA expression. These findings suggest that altered leptin signalling might be a major 
determinant of attempted maintenance of energy balance in the face of stress and a potential 
target for treatment of stress-related changes in energy balance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
